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Abstract
A tyrosine-dependent sorting signal in membrane-proximal region of the envelope protein cytoplasmic tail
domain is conserved across all primate lentiviruses. It is known to be involved in mediating endocytosis of
envelope from the cell surface and in directing sorting of envelope to the basolateral membrane in polarized
cells, and its strict conservation implies that this motif is critical for viral function. Our laboratory has
previously shown that ablation of two amino acids from this motif produces a virus, SIVmac239∆GY, that
replicates well in rhesus (RhM) and pig-tailed macaques (PTM), but fails to infect macrophages in vivo and
spares CD4+ T cells in gastrointestinal lamina propria. Further, while 90% of SIVmac239∆GY-infected PTM
control the virus to undetectable levels, a small subset of PTM and all RhM progressed to AIDS without
evidence of increased gut damage and microbial translocation, uncoupling this source of immune activation
from development of AIDS. Additional mutations in the gp41 cytoplasmic tail in progressors were correlated
with development of disease.
In this thesis, we identify in vitro properties that distinguish SIVmac239∆GY from its parent and evaluate a
number of putative compensatory mutations for their ability to restore a wildtype phenotype to
SIVmac239∆GY in these assays. We
determined that SIVmac239∆GY virions have reduced envelope levels on virions that are partially rescued by
addition of one of two compensatory mutations, S727P or R722G. Growth of SIVmac239∆GY was reduced
in macaque PBMCs and modulated by mutations that arose in vivo during chronic SIVmac239∆GY infection.
We also identified differences in Env cellular localization and impaired endocytosis and basolateral sorting
resulting from the ∆GY mutation. A novel ∆QTH mutation that arose in vivo produced functional tyrosine-
dependent motifs that restored basolateral sorting and endocytic function to SIVmac239∆GY, the latter in an
AP-2 dependent manner. Compared to SIVmac239, SIVmac239∆GY-containing mutants also exhibited
differences in cell surface distribution of envelope that may contribute to reduction in envelope content of
virions.
To test if putative compensatory mutations were sufficient to reconstitute an SIVmac239-like phenotype in
animals, we then inoculated naïve PTM with SIVmac239∆GY R722G or SIVmac239∆GY R722G + ∆QTH
(YFQL). We assessed key differentiators of SIVmac239 and SIVmac239∆GY, including the ability to infect
macrophages and to deplete gut CD4+ T cells. Although full pathogenicity and macrophage infection were
not restored, 3/6 animals became progressors and developed high peak viral loads, with trends toward
increased depletion of gut CD4+ T cells, and two died. Engineered mutations were stable throughout
infection, and in progressing SIVmac239∆GY + R722G infected animals, additional mutations arose that
appear to reconstitute endocytosis signals. These findings serve to further highlight the exceptional
importance of the membrane-proximal tyrosine motif to optimal function of SIV in vivo.
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ABSTRACT 
 
THE ROLE OF THE GP41 MEMBRANE-PROXIMAL TYROSINE MOTIF IN 
SIMIAN IMMUNODEFICIENCY VIRUS PATHOGENESIS 
 
Samra E. Elser 
 
James A. Hoxie, M.D. 
 
 
A tyrosine-dependent sorting signal in membrane-proximal region of the 
envelope protein cytoplasmic tail domain is conserved across all primate lentiviruses. 
It is known to be involved in mediating endocytosis of envelope from the cell surface 
and in directing sorting of envelope to the basolateral membrane in polarized cells, 
and its strict conservation implies that this motif is critical for viral function. Our 
laboratory has previously shown that ablation of two amino acids from this motif 
produces a virus, SIVmac239∆GY, that replicates well in rhesus (RhM) and pig-
tailed macaques (PTM), but fails to infect macrophages in vivo and spares CD4+ T 
cells in gastrointestinal lamina propria. Further, while 90% of SIVmac239∆GY-
infected PTM control the virus to undetectable levels, a small subset of PTM and all 
RhM progressed to AIDS without evidence of increased gut damage and microbial 
translocation, uncoupling this source of immune activation from development of 
AIDS. Additional mutations in the gp41 cytoplasmic tail in progressors were 
correlated with development of disease. 
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In this thesis, we identify in vitro properties that distinguish SIVmac239∆GY 
from its parent and evaluate a number of putative compensatory mutations for their 
ability to restore a wildtype phenotype to SIVmac239∆GY in these assays. We 
determined that SIVmac239∆GY virions have reduced envelope levels on virions that 
are partially rescued by addition of one of two compensatory mutations, S727P or 
R722G. Growth of SIVmac239∆GY was reduced in macaque PBMCs and modulated 
by mutations that arose in vivo during chronic SIVmac239∆GY infection. We also 
identified differences in Env cellular localization and impaired endocytosis and 
basolateral sorting resulting from the ∆GY mutation. A novel ∆QTH mutation that 
arose in vivo produced functional tyrosine-dependent motifs that restored basolateral 
sorting and endocytic function to SIVmac239∆GY, the latter in an AP-2 dependent 
manner. Compared to SIVmac239, SIVmac239∆GY-containing mutants also 
exhibited differences in cell surface distribution of envelope that may contribute to 
reduction in envelope content of virions. 
 
To test if putative compensatory mutations were sufficient to reconstitute an 
SIVmac239-like phenotype in animals, we then inoculated naïve PTM with 
SIVmac239∆GY R722G or SIVmac239∆GY R722G + ∆QTH (YFQL). We assessed 
key differentiators of SIVmac239 and SIVmac239∆GY, including the ability to infect 
macrophages and to deplete gut CD4+ T cells. Although full pathogenicity and 
macrophage infection were not restored, 3/6 animals became progressors and 
developed high peak viral loads, with trends toward increased depletion of gut CD4+ 
	   vii	  
T cells, and two died. Engineered mutations were stable throughout infection, and in 
progressing SIVmac239∆GY + R722G infected animals, additional mutations arose 
that appear to reconstitute endocytosis signals. These findings serve to further 
highlight the exceptional importance of the membrane-proximal tyrosine motif to 
optimal function of SIV in vivo. 
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Overview 
 Since its identification in 1983, human immunodeficiency virus (HIV) and the 
associated acquired immune syndrome (AIDS) has become one of the most 
significant infectious diseases of the era. The Centers for Disease Control estimate 
about 50,000 new cases of HIV currently occur in the United States per year.1 Despite 
substantial improvements in diagnosis and treatment, efforts to develop a vaccine 
against HIV have been disappointing. Of the nearly 200 vaccine trials to date, just 
five have progressed to efficacy studies, and only one of these demonstrated any level 
of protection against acquisition of HIV.2 Factors contributing to the difficulty in 
vaccine development include the remarkable sequence diversity of HIV-1, the 
inability of most infected individuals to naturally clear or suppress the virus, and 
failure of researchers to identify immune correlates of protection against infection.3,4  
 
As known methods for vaccine development have failed to produce an 
effective HIV vaccine, a goal for the field has been to increase our understanding of 
viral pathogenesis, with the idea that successful drug or vaccine strategies should 
target vulnerable aspects of the viral life cycle.5 These discoveries have led to the 
development of multiple classes of antiretroviral drugs that act at distinct points in the 
HIV reproductive pathway, allowing multidrug therapy regimens that inhibit virus 
replication by several different mechanisms.6 Antiretroviral therapy (ART) has 
greatly improved the quality and duration of life for HIV-positive individuals, but 
treatment is expensive, lifelong, and inaccessible to a large percentage of infected 
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individuals, particularly those in developing countries.7 In addition, ART does not 
eliminate the chronic immune activation induced by HIV infection, and long-term 
sequelae of infection and side effects of treatment continue to plague many patients.8 
As such, the need for a prophylactic vaccine remains urgent.  
 
Prevention of infection appears to require blocking viral replication prior to 
establishment of a latent reservoir.9 Ideally, early steps of the viral life cycle should 
be targeted, as clearance of the virus from infected individuals has thus far proven 
nearly impossible.10 The envelope protein (Env), which HIV uses to enter cells, is 
functional during early stages of infection and contains conserved sequences that are 
critical to pathogenesis.11 Understanding how these domains contribute to natural 
history in hosts and their importance to the virus allows both development of antiviral 
agents that exploit these regions and identification of aspects of pathogenesis that 
should be targeted by vaccines. Additionally, these motifs may drive immunogen 
design as we determine what components of Env are most effective in eliciting 
protective responses against pathogenic challenge. 
 
Vaccines often aim to target antigens on the virion surface, allowing for 
neutralization of the pathogen before it interacts with target cells.12–15 HIV Env, 
present on the virion surface, is an attractive vaccine target for several reasons. It is 
critical for the virus to enter permissible cells, it is present and exposed on the virion 
surface at the earliest stages of infection, and it has conserved regions that are 
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relatively consistent across strains. In the 1970s, researchers induced protective 
humoral immune responses against hepatitis B virus (HBV) by administration of 
purified, inactivated HBV surface antigen (HBsAg) from sera of infected humans.15 
This approach resulted in the licensing of a successful vaccine against HBV.14,15 
Shortly thereafter, a system to produce HBsAg in yeast yielded the first recombinant 
vaccine, still relying on induction of antibody responses against the HBV surface 
protein.16 However, similar approaches were not effective against HIV, prompting the 
need for additional research to identify the role of conserved motifs in pathogenesis 
and to improve our understanding of how immunogens can be designed to elicit 
relevant immune responses.17   
 
Primate Lentivirus Structure and Life Cycle 
 HIV and its evolutionary precursor simian immunodeficiency virus (SIV) 
have analogous virion structures typical of retroviruses. Virions are roughly 100 nm 
in diameter, enveloped, and contain all constituents necessary for infection and 
reproduction by the virus, including an RNA genome.18 Approximately 7-14 Env 
trimers stud the surface of the virion.19,20 Env spikes are trimers of heterodimers, 
consisting of a gp120 surface domain and a gp41 transmembrane domain. Env is 
heavily glycosylated co-translationally with N-linked and O-linked 
oligosaccharides.21,22 These glycans, which contribute half of the molecular mass of 
gp120, aid in shielding epitopes from recognition by the immune system.11 The first 
step in the viral life cycle involves the virus binding to cells, which may initially 
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occur via attachment factors such as DC-SIGN or proteoglycans on the cell surface.23 
Following nonspecific attachment, the Env gp120 binds to the primary cellular 
receptor, CD4.24,25 Engagement of CD4 causes conformational changes in Env that 
allow binding of the gp120 V3 loop and the newly formed bridging sheet domain to a 
coreceptor, most commonly CCR5.26,27 While HIV uses CCR5 or sometimes CXCR4, 
SIV relies primarily on CCR5, but can also utilize alternative coreceptors such as 
GPR15 and CXCR6.28–30 Coreceptor binding exposes the fusion peptide region of 
gp41, which inserts into the cell membrane and undergoes a conformational change 
that brings the virion and cell membranes into apposition.31 Membrane mixing allows 
delivery of the virion contents into the host cell.32 Following entry, uncoating of 
capsid releases the positive-sense RNA genome, from which DNA is reverse 
transcribed by the viral reverse transcriptase.33 A pre-integration complex forms and 
undergoes nuclear import, and viral DNA is integrated into the host genome, 
mediated by the viral integrase protein.34 In a subset of cells, typically resting cells, 
the virus may remain dormant. These latently infected cells contain the viral 
reservoir, a sequestered population of virus that has been a significant obstacle to 
cure, as identification and eradication of latently infected cells remains a challenge 
for clinicians and researchers.9,34 However, most infected cells are in an activated 
state and are undergoing transcription, and integrated DNA is transcribed by host 
enzyme RNA Pol II into viral mRNA, giving rise to all viral proteins.35 Finally, 
various host factors are exploited to direct virion assembly and trafficking of viral 
proteins to sites of budding, primarily at the plasma membrane.36 Immature virions 
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are released, and viral capsid protein is cleaved by viral protease post-budding to 
form the mature, infectious virion.37  
 
Virus Assembly and Budding 
HIV and SIV assembly and budding involve interactions between the viral 
Gag and Env proteins and recruitment of host proteins to facilitate production of 
virions (Fig. 1). Importantly, budding can occur in the absence of Env, implying that 
Gag and Env targeting to assembly sites may occur through separate mechanisms.38 
The Gag polyprotein precursor (PrGag) is synthesized in the cytosol. This molecule 
has four major components: matrix (MA), capsid (CA), nucleocapsid (NC) and the p6 
domain, as well as two spacer peptides (Fig. 1).36 Following synthesis, PrGag is 
targeted to the plasma membrane through interaction of a basic region in MA with 
host phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].39,40 Binding of a second 
region of the MA domain to PI(4,5)P2 induces a conformational change in MA that 
exposes a myristyl group at the N-terminus of of the domain.41 This myristyl group 
aids in targeting and binding of PrGag to the plasma membrane, and mutation of the 
myristoylation target glycine impairs these functions.42 PI(4,5)P2 binding both 
exposes the myristyl and serves as a direct anchor for MA to the plasma membrane, 
promoting association of PrGag with the membrane. Saturated fatty acids such as 
myristyl preferentially target lipid raft domains, providing further evidence for the 
current hypothesis that HIV-1 release occurs at lipid raft microdomains.41  
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 NC contains sequences called zinc knuckle domains that bind a packaging 
signal at the 5’ end of the viral genomic RNA, effectively capturing the genome 
within the assembling virion. Viral assembly is initiated by interactions between 
PrGag and RNA, but the primary driver of multimerization is CA. As  PrGag 
accumulates, it assembles into hexamers, which form a lattice at the inner leaflet of 
the plasma membrane.43 The CA domains assemble deep to this lattice, and although 
the precise structure of this region and of interactions between CA monomers is not 
fully resolved, there is some evidence in for a similar organization of the MA and CA 
domains.44,45 
Following assembly of the PrGag lattice, the virus recruits components of the 
cellular ESCRT complex to facilitate virion budding. Late domains in PrGag bind, 
specifically a PTAP motif in the p6 region, bind the host protein TSG101, a 
component of the ESCRT-1 complex.46 A second late domain, YPXL, binds the 
accessory protein ALIX, enhancing viral release.47,45 Ubiquitylation of viral Gag may 
also aid in recruitment of ESCRT complexes, although this function is not fully 
understood. Targeting of ESCRT family members to sites of budding is critical for 
membrane scission, though conflicting hypotheses exist for a mechanism. One model 
involves ESCRT-III protein assembly into rings that pinch off membranes by 
constriction, but some imaging suggests that ESCRT proteins localize into the virion 
head and promote fission from the interior of the virion.48,49 Additionally, ESCRT-III 
recruitment of VPS4, an ATPase, is an energy source for scission and also recycles 
ESCRT following budding.45 Incorporation of Env into virions, which is dispensible 
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for the process of assembly and budding, appears to occur through a separate 
mechanism and will be discussed below. The process of viral assembly and release 
thus requires appropriation of multiple cellular pathways to organize viral 
components for production of new virions.     
 
 
Envelope Glycoprotein Structure and Trafficking  
The envelope protein of primate lentiviruses has been of interest to the field as 
an immunogen and therapeutic target. The earliest studies of candidate HIV vaccines 
used recombinant Env immunogens to induce neutralizing antibody responses in 
humans.50 These approaches modeled similar designs for Herpes Simplex Virus and 
Hepatitis B (glycoprotein D and Hepatitis B surface antigen, respectively), which 
targeted viral surface antigens and elicited a humoral immune response.15,51 HIV 
neutralizing antibodies (NAb), which are directed against the Env protein, had been 
shown to protect macaques from SIV acquisition, and induction of such responses 
was the prime goal of initial vaccine designs.52–55 A limitation of this approach is that 
the majority of antibodies that develop in HIV-infected individuals are strain specific; 
that is, they target regions of Env that are highly variable.56 The ability of HIV to 
mutate the exposed Env variable loops while maintaining protein function is a key 
strategy for the virus to evade humoral immunity.57 Over time, patients may develop 
serum antibodies that are capable of neutralization, but these typically neutralize the 
viral strain that initiated infection in the individual, and do not extend neutralization 
to heterologous strains of HIV, or even to chronic virus from the same individual, 
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severely limiting their clinical relevance.58 In contrast, a much smaller proportion of 
patients develop broadly neutralizing antibodies (BNAbs), which neutralize multiple 
strains of HIV and target conserved regions of Env.5 Design of an Env immunogen 
that elicits BNAbs has proved elusive, but would be an effective antibody-based 
strategy for vaccine design.  
 
The HIV and SIV envelope is synthesized in the rough endoplasmic reticulum 
as a 160kDa protein precursor, which is co-translationally glycosylated.11,59 The 
precursor oligomerizes, primarily forming trimers, and is transported to the Golgi 
apparatus, where it is cleaved by host furin into mature gp120 (surface, SU) and gp41 
(transmembrane, TM).60 The processed subunits remain associated as a trimer of 
heterodimers, forming a single Env spike, 7-14 of which are typically incorporated 
into each virion.19,20,61  
 
The gp41 cytoplasmic tail domains of HIV and SIV Envs contain motifs that 
mediate endocytosis of the protein from the cell surface and direct protein trafficking 
within infected cells. These motifs are similar in structure to cellular trafficking 
signals, allowing viral proteins to hijack cellular machinery for use in production and 
assembly of nascent virions. 62 At least two endocytosis signals have been identified 
in the SIV cytoplasmic tail. The first, a tyrosine-dependent signal located proximal to 
the membrane spanning region of gp41, is conserved across all HIV and SIV 
isolates.63 The second known endocytosis motif in gp41 is a C-terminal dileucine,  
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Figure 1-1: Schematic of primate lentivirus assembly and budding.
Envelope synthesis occurs in the RER and the protein is trafficked to the plasma membrane through 
the Golgi and TGN via the secretory pathway. Sites of budding are targeted through a mechanism 
thought to involve the membrane-proximal tyrosine motif, as well as interactions of the gp41 
cytoplasmic tail domain with matrix and host factors, including TIP47. The polyproteins PrGag and 
GagPol are synthesized from genomic RNA in the cytoplasm and targeted and bound to lipid rafts on 
the plasma membrane through interactions of MA with PIP(4,5)P2 and of the MA myristyl group 
with the membrane. The RNA genome is recruiting and packaged by interaction with CA. The host 
ESCRT complexes and ALIX are recruited to facilitate membrane scission and viral release.
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characterized in the Env of HIV HXB2. This motif functions as efficiently as, and 
independently of, the membrane-proximal tyrosine motif.64 It has been shown both in 
HIV and SIV that these two motifs bind to the cellular adapter complex AP-2 and 
mediate clathrin-dependent endocytosis.64–66  
 
The membrane-proximal tyrosine motif is of particular note due to its strict 
conservation and implication in a multitude of Env functions. Tyrosine-dependent 
domains of this structure have been well characterized in eukaryotic cells as 
multifunctional sorting signals. This motif is present in a diverse set of cellular 
proteins, including the lysosomal LAMP family, cell adhesion molecules, and the 
protease furin.62 The sequence in eukaryotic proteins is YxxΦ, in which x represents 
any amino acid and Φ represents an amino acid with a bulky hydrophobic sidechain.67 
In primate lentiviruses, a glycine preceding the tyrosine has also been shown to be 
important in mediating efficient endocytosis. While the specific amino acid sequence 
varies between viruses, e.g. GYRPV in SIVmac239 and SIV BK28 and GYSPL in 
HIV-1 HXB2,63,66,68 the glycine, tyrosine, proline, and bulky hydrophobic residue are 
consistently present.69 Endocytosis signaling has also been attributed to the 
corresponding tyrosine residue in HIV-1, implying that this motif is both structurally 
and functionally conserved across primate lentiviruses.70 Mapping experiments using 
alanine substitution or other mutational analysis have localized endocytic function to 
the glycine, tyrosine, and a proline at the Y+2 site, with endocytosis rate being 
significantly decreased when the relevant residues are replaced.65,66  
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Multiple groups have shown binding of this motif, in lentiviral and eukaryotic 
proteins, to the µ subunits of the cellular adapter complexes AP-1 and AP-2.71,72 
Within eukaryotic cells, AP-1 is located in the trans-Golgi network (TGN) and 
believed to mediate trafficking of cargo to endosomes or lysosomes. AP-2 is found 
primarily at the plasma membrane and functions in clathrin dependent endocytosis, 
removing transmembrane proteins from the surface of the cell.62,72–75 Our 
laboratory has previously shown that an SIV with a Y723C mutation at the tyrosine 
residue and a cytoplasmic tail truncation has roughly 25-fold increased expression of 
Env on the cell surface.63 In SIVmac239, which expresses a full length cytoplasmic 
tail, Y723C confers a four-fold increase of Env expression, consistent with the 
presence of additional endocytosis signals downstream from the membrane-proximal 
tyrosine motif.63 Other groups have demonstrated that HIV and SIV Env are first 
expressed on the cell surface,76,77 and following internalization via clathrin-mediated 
endocytosis, appear to co-localize with lysosomal markers, though this may represent 
a recycling rather than a degradative pathway.66,76,78–80  
 
In addition to its role in endocytosis, the membrane-proximal tyrosine motif 
also directs sorting of proteins trafficking to the cell surface. Within eukaryotes, some 
cells have distinct regions or domains of the plasma membrane with unique 
biochemical properties. For example, epithelial cells are frequently polarized and 
have dissimilar compositions on their apical or lumenal versus basolateral surfaces 
that contribute to the function of the tissue.81 Leukocytes, particularly T cells in  
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Figure 1-2: Intracellular envelope trafficking and host protein interactions.
Synthesis of the envelope precursor gp160 occurs in the rough endoplasmic reticulum, where the 
protein is co-translationally glycosylated. gp160 is transported to the Golgi apparatus, cleaved by 
host furin into gp120 and gp41, and trafficked through the trans-Golgi network. The protein follows 
the secretory pathway to endosomes, where it is targeted to lipid rafts on the plasma membrane and 
preferentially to the basolateral membrane in polarized cells by association with the adapter complex 
AP-1. Palmitoylation and the LLP domains are thought to be involved in lipid raft association. Env 
is then either incorporated into new virions, likely through interactions with viral MA, or removed 
from the plasma membrane by clathrin dependent endocytosis. The latter is mediated by AP-2 
binding and results in targeting of the protein either to lysosomes for degradation or to endosomes 
for return to the plasma membrane.
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lymph nodes, are also polarized, with distinct localization of actin, adhesion 
molecules, and other surface proteins to aid in migration and adhesion.82,83 AP-1 
adapter complexes bind cellular sorting signals and direct relevant proteins from the 
TGN to the basolateral membrane in such cells.81,84,85 It has long been known that 
tyrosine-based motifs in cellular proteins and in the surface glycoprotein G of 
vesicular stomatitis virus (VSV) can direct proteins to the basolateral surface.86 
Similarly, in polarized cell lines and in lymphocytes, wildtype HIV Env preferentially  
targets the lymphocyte pole that is analogous to the basolateral surface of epithelial 
cells, and is thought to determine in part the sites from which virions bud from the 
plasma membrane.87–89 Further investigation localized the determinant of polarized 
budding to gp41 and specifically the membrane-proximal tyrosine motif.89,90 
Although Env is dispensable for budding of virions (this is determined by 
components of the Gag polyprotein), there is evidence for an interaction between Env 
and matrix (MA) during viral assembly that suggests Env is responsible for directing 
specific sites of budding at the plasma membrane.61,87,91–94 While the membrane-
proximal tyrosine motif has not been a candidate motif for interaction with MA, it has 
been shown to be a regulator of Env incorporation into virions, strengthening the case 
for its role in correctly targeting Env to assembly sites on the plasma membrane.95–97     
 
As mentioned above, Env targeting to assembly sites is not required for viral 
budding and release, but, predictably, is necessary for production of infectious 
virions. The Env cytoplasmic tail has been implicated in directing incorporation into  
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Figure 1-3: Location of the membrane-proximal tyrosine motif in SIVmac239 gp41
The membrane spanning domain (MSD) of gp41 is indicated by the gray box. Amino acids of the 
cytoplasmic tail domain from the membrane spanning domain to the stop codon are numbered 
according to the SIVmac239 sequence. The membrane-proximal tyrosine motif (GYxx!) is 
highlighted in yellow.
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virions, and several studies have provided evidence that interactions between the Env 
tail and MA are determinants of this function.94,98,99 In HIV-1, interactions between 
Env and MA have been mapped by demonstrating that point mutations in MA can 
prevent incorporation of Env into virions, and that deletions in the Env tail that 
abrogate Env incorporation can be rescued by additional MA mutations.100,101,91,102 
Interestingly, in viruses with MA mutations that block Env incorporation into virions, 
Env incorporation is restored if the cytoplasmic tail is truncated.92,102,91,100 
Interactions between Env and MA are less well characterized for SIV, and for both 
viruses, the exact nature of the association remains controversial. One study found a 
direct interaction between the proteins when produced in prokaryotic cells.103 More 
recent work demonstrated that TIP47, a eukaryotic trafficking protein, was a mediator 
of interaction between Env and MA, but not required for their binding or for 
incorporation of Env into virions.99,104,105 With regard to trafficking of Env to sites of 
viral budding, the cytoplasmic tail also contains signals that confer localization to 
lipid raft microdomains at the plasma membrane. As mentioned earlier, these regions 
of the membrane are rich in cholesterol, glycosphingolipids, and GPI-anchored 
proteins, and are thought to be preferred budding locations for HIV assembly and 
release.106,107 The signals that dictate localization to lipid rafts, the lentiviral lytic 
peptides (LLP) 1-3, are amphipathic α-helices at the C-terminus of the gp41 
cytoplasmic tail domain.107 
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Incorporation of Env is a critical step in formation of infectious virions; Env 
levels on HIV virions have been shown to correlate with particle infectivity and as 
such, regulation of this feature is a critical determinant of productive infection.91,95 At 
least one study of SIV found that an increase in Env on virions correlated with 
increased infectivity, which may be due in part to greater resistance to antibody-
mediated neutralization.108,109 Consequently, the function of the membrane-proximal 
tyrosine motif in directing sorting of Env may be critical to production of fully 
infectious particles. However, the direct role of this motif in Env incorporation into 
virions is not fully understood. A second possible implication for this region of gp41 
is in directing Env to aid in creation of the virological synapse, a mechanism by 
which cell-to-cell spread occurs in infected tissues.110 Interestingly, as for viral 
budding and release, lipid rafts have been associated with virological synapses, 
further implicating Env targeting in their formation.111  
 
Direct cell-to-cell, rather than cell-free spread of infection is advantageous to 
the virus for a number of reasons; it is more efficient, requiring fewer infectious 
particles, it limits exposure of the virus to the host immune system, particularly 
neutralizing antibodies, and it may reduce the effectiveness of restriction factors such 
as tetherin.110 Cell-to-cell spread commonly occurs between T cells, but infected 
dendritic cells and macrophages can also transfer virus to uninfected T cells.112,113 
This transfer is thought to be important in the spread of virus from sites of 
transmission at mucosal surfaces, such as the GI tract, to secondary lymphoid 
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tissue.113,114 In both types of interaction, virological synapses, named for their 
structural resemblance to an immunological synapse, form via interaction between 
HIV Env expressed on an infected cell and CD4 on an uninfected cell.115 A slightly 
different, CD4-independent mechanism, allows formation of a virological synapse 
that mediates spread of HIV from T cells to epithelial cells in the GI tract and renal 
tubules, which may contribute to viral reservoirs.116 In the canonical virological 
synapse, high concentrations of HIV Gag are recruited to the uropod membrane of 
polarized T cells, a region rich in characteristic adhesion molecules.115 After Env-
CD4 binding, these adhesion molecules are thought to further stabilize the interaction 
between the cells.113 Once the connection has been established, HIV particles 
assemble and bud from the plasma membrane within the synapse, efficiently 
transferring large numbers of particles to the recipient cell.113,117 As cell-to-cell 
transfer via the virological synapse may be the main mediator of spreading infection 
in tissues, targeting of Env to sites of budding is likely critical to productive infection 
in vivo, and particularly relevant at mucosal sites where cell-to-cell spread may be the 
dominant mechanism of viral propagation.110,113,117 It is possible that disruption of 
Env targeting could impair the ability of the virus to efficiently spread in GALT and 
have serious repercussions for pathogenicity. 
 
Pathogenicity 
Within the Retroviridae family, HIV and SIV are classed as lentiviruses, from 
the Latin lente, meaning slow, as their pathological effects occur over extended time 
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periods.118–120 Both cause disease by depleting subsets of lymphocytes that are critical 
to immune function, as well as by inducing a chronic state of inflammation and 
immune activation in the host.121 CD4+ cells, particularly those expressing high levels 
of CD4 and CCR5, are the primary targets of HIV.122 These cells are predominantly 
CD4+ T lymphocytes, but can also include monocytes and macrophages, which have 
lower CD4 density, as well as high levels of CCR5.123–125 Specifically, memory CD4+ 
T cells express the highest levels of CCR5, with effector memory T cells representing 
the primary subset for replication, although resting and naïve CD4+ T cells (which 
express higher levels of CXCR4) can also be infected.10,123,126,127 Similarly, there is 
increased contribution to viral production from macrophages and monocytes later in 
the disease course, and these cells are infected by variants of HIV that are capable of 
using lower CD4 densities for entry.123,124,126 
 
During acute infection, large numbers of CD4+ T cells are killed by multiple 
mechanisms, the details of which are an area of ongoing investigation and include 
direct infection, apoptosis, and bystander pyroptosis resulting from abortive 
infection.128–130 Cell-mediated immune responses are also important in killing of 
infected cells and thus controlling viral replication in the acute phase. HIV-specific 
CD8+ T cell precursors are present as early as three weeks post-infection, and their 
presence correlates with decreases in viremia.131 There is also evidence for HIV-
specific CD4+ T cell responses, which may provide help to CD8+ cytotoxic T 
lymphocytes (CTLs) or function in a direct antiviral role as cytotoxic CD4+ cells.132 
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Further evidence for the importance of CTL responses in control of viremia is 
provided by nonhuman primate models, in which the evolution of escape variants 
with mutations in Tat CTL epitopes is seen immediately following the acute phase of 
SIV infection.133 During chronic infection, viral replication decreases as adaptive 
immune responses arise, and the host is able to reconstitute sufficient CD4+ T cells 
for immune function.134 Over time, control of viremia cannot be maintained, plasma 
viral load rises, and CD4+ cells in peripheral blood gradually decline, eventually 
reaching a level that permits opportunistic infections and contributes to the death of 
the host.135 
 
The majority of CD4+ T cells are found in lymphoid tissues, rather than in 
peripheral blood, and thus the majority of viral replication appears to occur in these 
sites.136 Infected activated CD4+ T cells are commonly found in the lymph node 
paracortex, as well as in peripheral blood.137,138 The gut-associated lymphoid tissue 
(GALT), the largest compartment of lymphoid tissue, is an essential site of early viral 
replication.139,140 CD4+ T cells in GALT are rapidly and irreversibly depleted very 
early in infection, in conjunction with GI inflammation that leads to epithelial damage 
and translocation of bacteria from the gut lumen into the lamina propria.140–143 
Microbial translocation is thought to be a major contributor to the chronic immune 
activation that is a hallmark of AIDS.144 
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Immune activation leads to increased recruitment of activated CD4+ T cells, 
fueling viral replication. Studies of both HIV and SIV have shown an increase in 
circulating microbial products such as lipopolysaccharide (LPS) in chronically 
infected hosts. Notably, Brenchley et al.145 demonstrated an association between 
circulating LPS and intestinal bacterial load in SIV-infected macaques, suggesting 
that LPS in plasma is primarily derived from translocation of bacteria from the 
intestine through a damaged gut epithelium. They also identified a correlation 
between plasma LPS and plasma soluble CD14 (sCD14), the soluble form of the 
surface LPS receptor CD14, which is shed by activated CD14+ monocytes following 
LPS stimulation.145,146 Further, natural hosts of SIV such as sooty mangabeys, which 
do not develop persistent immune activation or AIDS despite chronically high plasma 
viral loads, do not have increased plasma LPS or sCD14 compared to uninfected 
control animals.147 Microbial translocation also appears to be related to variations in 
disease course across species of macaques. Pig-tailed macaques (PTM), discussed in 
greater detail below, appear to be more susceptible than rhesus to the pathologic 
effects of SIV infection in that they progress more quickly to AIDS despite similar or 
even slightly lower average plasma viremia.148 Investigation of the gastrointestinal 
health of PTM revealed damage to the epithelium of the gastrointestinal tract in the 
absence of SIV infection, leading to high baseline levels of microbial translocation. 
This correlated with increased immune activation as measured by T cell turnover and 
proliferation, and more memory and effector T cells, including a higher percentage of 
CCR5+ T cells.149 
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SIV models 
Simian immunodeficiency virus (SIV) shares a common ancestor with HIV-1 
and, like HIV-1, can induce immunopathology following infection of a susceptible 
host.150 HIV-1 originated from three independent cross-species transmission of 
SIVcpz from chimpanzees to humans, likely due to ingestion of nonhuman primate 
products (bushmeat) by humans in western equatorial Africa.151,152 Non-human 
primate (NHP) models recapitulate many features of HIV-1 infection in humans and 
have been implemented in vaccine development and pathogenesis research. The two 
most common species currently used in HIV research are the rhesus macaque 
(Macaca mulatta) and the pig-tailed macaque (Macaca nemestrina).153 Inoculation 
via intravenous (IV) or mucosal routes with swarm or molecularly cloned pathogenic 
SIV induces AIDS-like pathology in an accelerated model, mimicking human 
infection with HIV-1 and providing a biologically relevant model for studies of 
pathogenesis.153–158 
 
 The rhesus macaque model has been extensively studied using a variety of 
SIV strains, the best characterized being SIVmac239, an infectious molecular clone 
originating from the SIVmac251 swarm.159–161 SIVs were first noted after several 
cases of lymphoma and opportunistic infections occurred in macaques at multiple 
primate centers.162 Contemporaneously, experimental induction of leprosy via tissue 
transfer from sooty mangabeys (SM) to rhesus macaques resulted in AIDS in 
macaques at Tulane National Primate Research Center.163 SIVs were isolated from 
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these animals and later shown via phylogenetic analysis to have originated from 
asymptomatic SMs.150 The discovery of a pathogenic lentivirus infection in non-
human primates suggested that macaques were, analogous to humans, non-natural 
hosts of SIV, and could represent a new model for HIV pathogenesis.164 
 
 When SIV infects a non-natural host such as the rhesus macaque, animals 
develop simian AIDS, a syndrome that closely mirrors AIDS in humans. Disease is 
characterized by high viremia followed by a decrease to set-point, early depletion of 
CD4+ T cells in the GALT, declining CD4+ T cells in peripheral blood, chronic 
immune activation, opportunistic infections, neoplasias, weight loss, and eventual 
death.148,159 Unlike HIV-associated AIDS in humans, which manifests over a period 
of years to decades, within the macaque model, simian AIDS develops within 1-2 
years, greatly accelerating the course of disease and facilitating studies of 
pathogenesis.148 
 
 In addition to more general studies of pathogenesis, the rhesus macaque model 
has also been used to study variations in susceptibility to SIV transmission throughout 
the menstrual cycle in females.165,166 Studies of viral transmission dynamics, 
including identification and characterization of transmitted founder viruses, have also 
been performed in rhesus macaques, as animals can be experimentally infected with 
quantified inocula and with genetically modified tagged viruses.156,157,167 These early 
infection events, which are critical to understanding viral kinetics and dissemination, 
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are difficult or sometimes impossible to perform in human subjects. Studies of dose 
and route of infection in rhesus macaques have optimized our ability to recapitulate 
mucosal HIV transmission in a consistent animal model.158 
 
While many seminal discoveries have been made in rhesus, in the early 2000s 
a shortage of this species due to their popularity for vaccine and pathogenesis 
research prompted investigation into alternative models.168,169 Early studies 
comparing pig-tailed to rhesus macaques suggested that they would represent 
similarly appropriate models for HIV infection.170 Subsequently, pig-tailed macaques 
gained popularity for pathogenesis studies due to their larger size, cooperation in oral 
dosing of ART, and resilience under stress. They also progress more rapidly to AIDS 
(average 42 weeks versus 69 weeks for rhesus macaques) in association with 
thrombocytopenia, a characteristic hematologic change observed in human 
patients.148 Initially, major histocompatibility complex (MHC) alleles had not been 
characterized in pig-tailed macaques. Given that certain MHC alleles in humans and 
rhesus are associated with a long term nonprogressor (LTNP) phenotype, concern 
arose over consistency of phenotype in PTM models.171 Similar protective alleles in 
pig-tailed macaques have now been identified, though there remains some 
controversy regarding their contribution to phenotype.172–174 An additional advantage 
of the PTM model is that while the majority of rhesus macaques express Trim5α, a 
host restriction factor that blocks HIV replication in macaques, pig-tailed macaques 
instead express a TRIM5α-Cyclophilin A fusion termed TRIM-Cyp, which is more 
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permissive to HIV infection.175–177 As a result, minimal modifications to HIV allow it 
to replicate in pig-tailed macaques, that has shown some promise for creating a novel 
model for vaccine studies as an alternative to SHIVs.178  
 
SIV live attenuated vaccines (LAVs) are historically the most effective 
immunogens in eliciting protective responses in macaque models.179 Although the 
risk of reversion to pathogenicity precludes the use of LAVs in humans, models of 
protection are useful for identifying immune responses that correlate with protection 
from challenge, as well as testing novel immunogens.180 Genetically modified SIVs 
also provide an elegant system in which to examine the roles of various proteins or 
domains in pathogenesis, as the effect of removing or mutating portions of the 
genome can be studied in vitro or in animal models. Several modifications to the 
pathogenic molecular clone SIVmac239 have been examined as LAVs. These altered 
viruses result in nonpathogenic infection in rhesus macaques, which are then 
protected against challenge with homologous or heterologous pathogenic SIV. 
SIVmac239 deletion mutants include those with deletions in nef  (SIVmac239Δnef); 
in nef, vpr, and upstream U3 sequences of the long terminal repeat (SIVmac239Δ3); 
nef, vpx, and U3 (SIVmac239Δ3x); and nef, vpr, vpx, and US (SIVmac239Δ4).181,182 
Another method of producing an attenuated vaccine strain involves engineering SIVs 
limited to single-round infection (single cycle SIV, scSIV).183 
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A myriad of studies have characterized SIV mutants to determine the effect of 
various mutations on pathogenesis. As early as the mid-1990s, researchers have 
engineered mutations into SIVmac239 and other SIV molecular clones and evaluated 
their effect on viral structure and function.63,184–186 The most comprehensively studied 
SIVmac239 mutant is Δnef. While Nef, an accessory protein, is not required for 
replication in most cell culture systems, elimination of the functional gene product 
decreases replicative capacity and has a substantial effect on viral growth in 
vivo.187,188 Throughout infection, rhesus macaques infected with SIVmac239Δnef 
exhibit plasma viral loads approximately 100-fold lower than those infected with the 
SIVmac239 parent, although virus persists after inoculation.187 Despite persistent 
virus, animals typically remain clinically well for up to three years post-inoculation, 
though there has been documentation of pathogenic SIVmac239Δnef infection in both 
adult and neonatal rhesus maacques.189–192 Most SIVmac239Δnef infections, however, 
do not cause clinical disease, and many groups have reported the development of 
protective immune responses against SIV in these animals.187,189,193–198 In one study, 
27 months after infection with SIVmac239Δnef, four rhesus macaques resisted a 
high-dose intravenous (IV) homologous challenge with either SIVmac239 or 
SIVmac251. These animals did not display detectable viral antigen (p27, Gag) in 
plasma and remained healthy, while control animals became infected by challenge 
virus and succumbed to AIDS.197 A second study intravenously challenged 10 
SIVmac239Δnef-infected animals with a heterologous strain, SIVsmE660. In contrast 
to the results of the homologous challenge, eight of 10 vaccinated animals became 
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infected with the heterologous challenge virus and exhibited detectable SIVsmE660 
in plasma; the remaining two animals showed increased viremia post-challenge, but 
only the vaccine strain could be detected. No animals had neutralizing antibody 
activity against SIVsmE660.199 The same group also performed a heterologous 
intrarectal challenge of SIVmac239Δnef-infected animals, finding delayed acquisition 
and improved control of viremia in vaccinees.195 In both studies, multiple animals 
experienced recombination between the vaccine strain and the challenge strain.195,199 
 
Comparisons between SIVmac239Δnef and other deletion mutants 
(SIVmac239Δ3, Δ3x, Δ4) demonstrate that additional deletions result in greater 
attenuation as measured by peak plasma viral load.182 Mutations in vif have been 
shown to render viral particles less infectious and attenuate replication in vitro.184 
There is evidence that vpx is important for macrophage tropism in animal models, but 
that AIDS can develop in the absence of this phenotype.200 Deletion of vpr did not 
prevent development of AIDS in rhesus macaques, but disease progression was 
delayed, and two animals remained healthy, suggesting some degree of attenuation 
for a Δvpr virus.186 A large subset of mutagenesis studies have focused on alterations 
to env. Multiple groups have evaluated mutations in the constant regions of env, 
including their effects on entry, replication, and gp160 processing.185,201 Importantly, 
these studies have also mapped residues that are determinants for interaction of Env 
with CD4 and made comparisons to analogous residues in HIV-1.201,202 This work led 
to identification of amino acid determinants of CD4-independent entry and 
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macrophage tropism in SIV by comparison of SIVmac239 Env sequence with the 
CD4-independent, macrophage-tropic SIVmac316.203 Determinants of coreceptor 
tropism have also been identified using similar techniques of site-directed 
mutagenesis.204 
 
HIV and SIV Envs are known to have long cytoplasmic tail domains (CTDs) 
relative to other retroviruses.205 An unexpected finding during study of SIVs was that 
the Env CTD spontaneously truncates when these viruses are propagated in human 
cell lines, and revert to full-length sequence when grown in NHP cells.206,207 As such, 
there has been interest in studying truncations of the CTD to determine its 
contribution to viral phenotype. Tail truncations enhance replication in the context of 
some SIV gp120s, but not all; SIVmac239 replication in vivo is not enhanced by this 
mutation, and truncated SIVs quickly revert to full-length tails in animals.207–210 
Additionally, some viruses with short CTDs have increased surface expression of Env 
on infected cells, likely owing to the removal of endocytosis motifs present toward 
the C-terminus of gp41.63,66,211,212 Studies of HIV and SIV have also demonstrated a 
relationship between tail truncation and conformational changes to the gp120 
ectodomain, which may have implications for immunogen design and interaction of 
gp120 with cellular receptors.212,213 Short-tail SIVs have also provided evidence for 
interaction between the Env and matrix proteins; viruses with matrix mutations that 
are defective in virion Env incorporation are rescued by Env tail truncation.91,102 
Further, tail-truncated SIVs often display increased Env on virions and improved 
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infectivity.97,214 Paradoxically, mutations at the C terminus of Env can dramatically 
decrease Env incorporation into virions and therefore particle infectivity, implying 
that the CTD contains both positive and negative regulators of Env incorporation into 
virions.96,214 The large body of work on engineered SIVs has yielded valuable insight 
to viral factors important for pathogenicity as well as characteristics of effective 
immunogens and goals for relevant protective immune responses. 
 
Goals of This Thesis 
The strict conservation of the gp41 membrane-proximal tyrosine motif among 
primate lentiviruses implies that this domain is a critical component of the structure 
or function of the envelope protein.  While it has been implicated in a variety of 
functions, including endocytosis, intracellular trafficking, plasma membrane 
localization, and incorporation of Env into virions, the specifics of its effect on 
virologic and pathogenic properties have not been well characterized. Here I present a 
comprehensive investigation of a mutant SIVmac239 lacking this signal, together 
with viruses containing possible compensatory mutations. In Chapter 2, I address in 
vitro virologic properties such as growth in primary macaque cells, Env quantification 
on virions, and Env distribution on the cell surface, as well as cell-dependent 
phenotypes of total Env production, subcellular localization, and endocytosis and 
sorting function. This SIVmac239 mutant virus is rapidly controlled and non-
pathogenic in an in vivo model in pig-tailed macaques, lacking pathogenic signatures 
of SIVmac239 infection, and induces immune responses that allow resistance or 
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control of pathogenic challenge viruses.  In Chapter 3, I assess whether putative 
compensatory mutations added to this virus can restore pathogenicity in pig-tailed 
macaques. In Chapter 4, I summarize these findings and propose further experiments 
to continue the investigation of this motif and its role in viral pathogenesis. Mutation 
of this highly conserved sequence, and subsequent evolution by the virus to restore its 
function, provides a valuable tool to study determinants of pathogenicity in SIV and 
to characterize protective immune responses elicited by a novel live-attenuated 
vaccine.  
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CHAPTER 2 
 
 
 
 
In vitro Characterization of an SIVmac239 Variant With a Deletion in the Tyr-
Dependent Trafficking Signal of the Env Cytoplasmic Tail 
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Abstract 
The envelope (Env) protein of primate lentiviruses contains a tyrosine-
dependent trafficking motif in the cytoplasmic tail domain of gp41 that is strictly 
conserved. To investigate the function of this GYxxΦ domain, we deleted glycine-
720 and tyrosine-721 from the SIVmac239 infectious molecular clone (IMC) to 
produce a virus termed SIVmac239∆GY. In vivo, SIVmac239∆GY replicated acutely 
to peaks comparable to SIVmac239, but failed to infect macrophages and spared gut 
CD4+ T cells. Most pig-tailed macaques (19/21) controlled SIVmac239∆GY and 
remained healthy. However, 4/4 rhesus macaques and 2/21 pig-tailed macaques 
developed intermediate set-points and progressed to AIDS. Envelope cytoplasmic tail 
mutations in progressors included R722G, S727P, and ∆QTH, a deletion of amino 
acids 734-736, which produced novel YxxΦ motifs. We assessed in vitro properties 
of SIVmac239∆GY and these putative compensatory mutations that could explain the 
unique phenotype of this virus in macaques. 
 
Mutations that arose in vivo mitigated the effects of SIVmac239∆GY, which 
included reduced envelope on virions and impaired Env trafficking, as demonstrated 
in assays for endocytosis and basolateral sorting. Infection of macaque peripheral 
blood mononuclear cells (PBMCs) by IMCs revealed slight attenuation of 
SIVmac239∆GY and variable effects of additional mutations. By imaging flow 
cytometry in CEMx174 cells, a decreased proportion of SIVmac239∆GY-infected 
cells exhibited clustered distribution of Env, which might represent alterations in Env 
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surface expression in microdomains and possibly explain the decreased Env content 
on virions. This effect was not changed by addition of R722G or ∆QTH, though the 
former did increase surface envelope expression and restored Env content on virions. 
Together, these results indicate important functions of the membrane-proximal 
tyrosine motif of SIV in directing envelope protein trafficking within the cell and 
potentially to sites of virion budding that are necessary for optimal viral function. 
Further understanding of its role may provide insight to the mechanism by which 
SIVmac239∆GY is controlled in pig-tailed macaques. In Chapter 3, we will assess the 
ability of mutations arising in vivo to restore pathogenicity to SIVmac239∆GY. 
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Introduction 
Infection of non-natural hosts by human immunodeficiency virus (HIV) and 
the closely related simian immunodeficiency virus (SIV) is characterized by several 
pathologic features. These include high and persistent viremia, chronic immune 
activation, rapid and sustained depletion of CD4+ T cells in the gastrointestinal 
lamina propria, infection of tissue macrophages, and eventual loss of CD4+ T cells in 
peripheral blood.8,159,163,215–219 Humans are a non-natural host of HIV, while 
analogous hosts of SIVmac are Asian macaque species, including rhesus (RhM, 
Macaca mulatta) and pig-tailed macaques (PTM, Macaca nemestrina).153,220 Infection 
of these species by SIVmac239 recapitulates many features of HIV-1 natural history: 
animals typically lose peripheral CD4+ T cells and develop AIDS within one year, 
with PTM being particularly rapid progressors.148 It has been hypothesized that the 
more rapid progression seen in PTM may be due in part to the greater levels of gut 
microbial translocation, immune activation, and T cell turnover in this species prior to 
SIV infection.149 
 
We have described the virus SIVmac239∆GY, which is identical in sequence 
to SIVmac239 except for a deletion of glycine-720 and tyrosine-721 in the envelope 
protein cytoplasmic tail.221,222 This deletion ablates two key residues in the 
membrane-proximal tyrosine motif, which is conserved across all HIVs and SIVs.66 
In eukaryotic proteins, the YxxΦ motif, in which x is any amino acid and Φ is an 
amino acid with a bulky hydrophobic sidechain, is known to mediate clathrin 
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dependent endocytosis via the adaptor complex AP-2.71 In primate lentiviruses, the 
motif extends to include an upstream glycine (GYxxΦ).76 This motif mediates 
endocytosis of Env from the surface of infected cells, decreasing Env expression on 
the cell surface, and the tyrosine residue has been implicated in directing basolateral 
sorting of Env in polarized epithelial cells.63–66,90 Some cellular GYxxΦ motifs, 
particularly those just downstream of transmembrane domains, are involved in 
lysosomal targeting of transmembrane proteins.62 Additionally, the cytoplasmic tail of 
Env has been associated with modulating incorporation of Env into virions, although 
the underlying mechanism is unclear.92,96 The conservation of these features points to 
this SIV membrane-proximal tyrosine motif as an important player in the modulation 
of Env expression and targeting within infected cells.  As described further below, the 
∆GY mutation produces a virus with a strikingly different natural history in RhM and 
PTM compared to SIVmac239.222,223 
 
In RhM, infection with either SIVmac239 or SIVmac239∆GY produced a 
peak viremia of equivalent magnitude. However, SIVmac239∆GY had a lower set-
point viremia and only transient infection and mild depletion of CD4+ T cells in the 
GI lamina propria, in contrast to the profound and sustained depletion seen in 
SIVmac239 infection.139,224 Additionally, SIVmac239∆GY showed markedly 
decreased infection of macrophages and absence of virus in the central nervous 
system infection at all stages of infection.222,225 Despite lack of gut damage, 
SIVmac239∆GY-infected RhM eventually developed increased plasma viremia, loss 
	   36	  
of peripheral CD4+ T cells, and systemic immune activation, with progression to 
AIDS. In progressing animals, novel mutations arise in the Env cytoplasmic tail that 
we hypothesized were compensatory for ∆GY. These include point mutations R722G 
and S727P, as well as a remarkable deletion of nine nucleotides (∆QTH 734-736), 
which overlaps with the second exon open reading frame of rev and tat (Fig. 1B) and 
produces novel YxxΦ motifs YFQI and YFQL. This deletion affects the sequence of 
all three proteins and is an unusual development in a relatively conserved region of 
the SIV genome. As such, in this species, the SIVmac239∆GY mutation was not 
sufficient to render the virus nonpathogenic.222 In PTM, there is evidence for greater 
baseline immune activation and T cell turnover, as well as more rapid progression to 
AIDS following SIVmac239 infection.148 In this species, as in RhM, SIVmac239∆GY 
had an acute peak viremia of equivalent magnitude and kinetics to SIVmac239, but 
failed to deplete GI lamina propria CD4+ T cells or to infect macrophages throughout 
the course of infection. However, by 20 weeks post-infection, 19/21 PTM controlled 
viremia to a set-point of <100 copies/ml. These animals maintained normal levels of 
CD4+ and CD8+ T cells in GI lamina propria as well as in peripheral blood and did 
not develop systemic immune activation or progress to AIDS over extended periods 
of time.223 Remarkably, SIVmac239∆GY-controlling PTM have been shown to 
become resistant to intravenous challenge with SIVmac239, and a majority of animals 
resist or control challenges with heterologous SIVsmE660 and the pathogenic SHIV 
SF162P3N, making protection afforded by control of this virus one of the most 
effective described to date (A. Lackner & J. Hoxie, unpublished data). Accordingly, 
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there are compelling reasons to understand 1) the virologic effects of the ∆GY 
mutation; 2) the mechanism for its control by the host; and 3) how host immune 
responses that control SIVmac239∆GY can confer broad protection to pathogenic 
challenge viruses. 
 
In this study, we evaluated the effect of the ∆GY mutation in SIVmac239 on a 
variety of virologic parameters in an effort to understand how a minor sequence 
alteration so drastically alters the ability of the virus to cause disease in a susceptible 
host. We then addressed the ability of novel gp41 mutations that arose in vivo to 
compensate for ∆GY by mediating functions of the GYxxΦ. These findings elucidate 
a role for this gp41 membrane-proximal tyrosine motif in the incompletely 
understood process of Env incorporation into virions and provide evidence that this is 
likely to be an active process requiring coordination between viral proteins and 
cellular machinery.  
 
Methods 
Env mutagenesis, cloning, and plasmid generation  
Relevant mutations (ΔGY, R722G, S727P, ΔQTH YFQI and ΔQTH YFQL) were 
introduced into env genes in pVP2 plasmids using QuikChange PCR (Agilent 
Technologies) as previously described.63,221 Env DNA was isolated from bacteria 
using the QIAamp DNA minikit (Qiagen) as per the manufacturer’s protocol, and 
sequenced with env specific primers to identify clones with the correct sequence.  
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Proviral constructs were produced by linearizing digestion of pVP2 and p239Spsp5’ 
plasmids with SphI followed by gel purification and ligation with T4 ligase. 
Successful ligation was confirmed by restriction enzyme digestion and gel 
electrophoresis, followed by full genome sequencing of each construct.  
 
Cell lines & primary cells  
Viral stocks for growth assays and infection of cell lines were produced in HEK293T 
cells.  Virions were produced in HEK293T cells, CEMx174 cells, or rhesus macaque 
peripheral blood mononuclear cells (PBMCs). CF2-Luc cells, a modified Cf2th cell 
line stably expressing the luciferase gene under the HIV-1 long terminal repeat, were 
used for coreceptor dependence assays.226,227 HeLa cells were used for Env 
localization and endocytosis assays. Madin-Darby canine kidney II (MDCKII) cells, a 
subclone of the MDCK cell line (Sigma, 85011435) were used for polarized 
trafficking assays. Rhesus and pig-tailed macaque cells were obtained from Gregory 
del Prete, Specimen Support Core, Leidos Biomedical Research, Inc., Frederick 
National Laboratory for Cancer Research; additional pig-tailed macaque cells were 
obtained via Tulane National Primate Research Center and Washington National 
Primate Research Center. HEK293T and CF2-Luc cells were grown in Dulbecco’s 
Modified Eagle’s Media (DMEM) supplemented with 10% fetal bovine serum, 1% 
penicillin/streptomycin, and 1% L-glutamine. CEMx174 cells and PBMCs were 
grown in Roswell Park Memorial Institute (RPMI) media supplemented with 10% 
fetal bovine serum, 1% penicillin/streptomycin, and 1% L-glutamine. RPMI for 
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PBMCs was supplemented with rHu IL-2 as described for growth assays. MDCKII 
cells were grown in RPMI with Hepes, pH 7.0 and supplemented with 0.2% bovine 
serum albumin (BSA). 
Virions & western blotting 
Rhesus macaque PBMCs were infected with each virus as for growth assays above. 
On Day 6 post-infection, cultures were centrifuged and cell-free supernatant was 
removed. Virions were pelleted through a 20% sucrose gradient by ultracentrifugation 
for 120 minutes. Supernatant was removed and virus resuspended in 1X TNE buffer 
and quantified by p27 ELISA. Virion preps were reduced by combining NuPAGE 
10X Reducing Agent (Life Technologies) and NuPAGE 4X LDS Sample Buffer (Life 
Technologies) and incubating at 95°C for 10 minutes. Equal quantities of p27 were 
loaded into individual wells for PAGE. Protein was transferred to a PVDF membrane 
by semi-dry transfer and blocked with 5% NFM for 1 hour at room temperature. The 
membrane was then cut in half and the top (gp120) half remained in blocker 
overnight. The bottom (p27) half was incubated overnight with mouse anti-Gag 
monoclonal 3A8 at 1:1000 dilution. On day 2, the top half was incubated with mouse 
monoclonal anti-gp120 (DA6) at 1:2000 dilution for one hour. Blots were then 
washed 4x 5 minutes and incubated with goat anti-mouse HRP conjugated secondary 
antibody for 1 hour, washed 4x 5 minutes, and developed with Luminata Forte 
Western HRP Substrate (Merck Millipore). 
 
CD4-SIV Env chimeras 
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(Assays performed by Dr. Scott Lawrence, University College London, in the 
Laboratory of Dr. Mark Marsh) 
CD4-SIV Env chimeras were constructed by fusing the ecto- and membrane-spanning 
domains of human CD4 to a short section of the cytoplasmic domain of SIVmac239 
Env (residues 716-745) as previously described.66 The cytosolic domain of the CD4-
SIV Env chimera included amino acids from the cytoplasmic domain of CD4 to place 
the SIV endocytosis signal (YxxΦ) the requisite distance from the membrane for 
functional activity.76 CD4-SIV Env constructs with relevant point mutations and 
deletions as shown in Figure 1 were constructed by site-directed mutagenesis as 
described above. The structure of CD4-SIV Env chimeras is shown in Figure 4. 
 
CD4-SIV Env construct subcellular localization 
(Scott Lawrence, University College London) 
HeLa cells expressing CD4-SIV Env chimeras (Fig. 4) were fixed with 3% 
formaldehyde in PBS, permeabilized with 0.05% saponin and 0.2% bovine serum 
albumin in PBS, and immunolabeled with 5 µg/ml anti-CD4 antibody (Q4120, 
NIBSC, ARP318) at 37°C for 3 hours. Free antibody was washed away and cells 
incubated with secondary anti-mouse antibody conjugated to Alexa-Fluor 488 
(Molecular Probes, Invitrogen). For antibody feeding experiments,  cells were 
incubated with Q4120 before permeabilization. Images were acquired using a Zeiss 
Axioplan2 with 40x neofluar objective and a Hamamatsu camera (C4742-95).   
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Endocytosis assays 
(Scott Lawrence, University College London) 
HeLa cells expressing CD4-SIV Env chimeras (Fig. 4 & Fig. 7) were selected with 
400 µg/ml G418 and incubated with an anti-CD4 antibody (Q4120, NIBSC, ARP318) 
at 4°C. Free antibody was washed away with ice cold RPMI + 0.2% BSA and 
endocytosis was initiated by incubating the cells in 37°C media. After incubation for 
specified times, the cells were cooled to 4°C and then incubated with a 1:1000 
dilution of secondary antibody on ice (anti-mouse IgG HRP conjugate (G-21040, 
Invitrogen). Cells were washed with ice cold RPMI + 0.2% BSA followed by PBS. 
Cells were lysed and Amplex Red (Molecular Probes, Invitrogen) was added. Amplex 
Red (HRP) signal was read on an EnVision® Multilabel Reader. 
 
AP-2 depletion & protein quantification 
(Scott Lawrence, University College London) 
HeLa cells expressing CD4-SIV Env chimeras (Fig. 4) were selected with 400 µg/ml 
G418 and transfected once with an siRNA targeting the µ2 subunit of adaptor-related 
protein complex 2 (AP-2) as previously described.228 48 hours after transfection total 
cell protein (30 µg) was separated by SDS-PAGE and transferred to nitrocellulose 
membranes. Membranes were incubated with antibodies to AP-2 subunits (anti-ɑ-
adaptin, BD Biosciences 610502 or anti-µ2, AP50, BD Biosciences 611350), or with 
a loading control (anti-VDAC, Abcam ab15895). Membranes were then washed and 
incubated with secondary antibodies (IRDye680 or IRDye800, Li-COR®) and 
	   42	  
imaged and quantified using the LiCOR® Odyssey. The percentage AP-2 subunit 
depletion was calculated by comparison to mock conditions for all cell lines. 
Measurement of endocytosis rates of CD4-SIV Env chimeras in AP-2 depleted cells 
was performed as described for previous endocytosis assays. 
 
Polarized Env trafficking in MDCKII cells 
(Scott Lawrence, University College London) 
MDCKII mixed stable cell lines that express CD4-SIV Env constructs with 
SIVmac239 sequence or mutant chimeras with a short Env (Fig. 4) or full-length 
cytoplasmic tail were selected with 400 µg/ml G418. MDCKII cell lines were seeded 
at 2.7x105/cm2 on polyester Transwell 0.4 µm clear filters (Corning) and cultured for 
6 days to establish a polarized epithelial monolayer (trans-epithelial resistance of 80-
100 Ω/cm2). Cells were fixed with 3% formaldehyde in PBS, quenched and stained 
with an anti-CD4 antibody (Q4120) either with (total) or without (surface) 0.05% 
saponin for permeabilization. Antibody was washed away and cells were then 
incubated with an anti-mouse secondary antibody conjugated to Alexa-Fluor 488. Z 
stacks of cell monolayers were acquired on a Leica SPE-3 with consistent settings. 
Images shown are of the orthogonal projection and white vertical lines separate 
different images. The ratio of apical to basolateral CD4 staining of the images was 
quantified from the orthogonal sections using Image J to measure intensity of CD4 
staining (arbitrary units) in the apical and basolateral membranes.  
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Preparation of viral stocks  
Viral stocks were produced in HEK-293T cells using a standard 5 hour calcium 
phosphate transfection protocol with full length viral genome constructs. Stocks were 
harvested 48 hours post-transfection and quantified using the SIV p27 Antigen 
Capture Assay (Advanced Bioscience Laboratories). All stocks were stored at -80°C.  
 
Viral replication assays  
Viably cryopreserved rhesus or pig-tailed macaque peripheral blood mononuclear 
cells (PBMCs) were thawed, counted, and cultured for 72 hours in RPMI + 5 µg/ml 
Concanavalin A (Sigma-Aldrich #L7647) at a concentration of 2-3 x 106 cells/ml. 
After 72 hours cells were washed, counted, and resuspended at 1 x 106 cells/ml in 
RPMI + rHu IL-2 (Aldesleukin, Prometheus Laboratories, Inc.). Five million cells 
were infected with 250 ng p27 of each virus and allowed to incubate for 24 hours. 
After 24 hours (Day 0), excess virus was washed off and 1 ml of culture supernatant 
was ultracentrifuged at 45,000 RPM for 30 minutes. The resulting supernatant was 
removed and the viral pellet resuspended in 50 µl Tris buffer for reverse transcriptase 
(RT) assay. Every 3 days, cells were counted and the concentration maintained at ~2 
x 106 cells/ml, adding IL-2 and RPMI as needed. RT assay measurements were taken 
at Day 0, 3, 6, 10, and 14 post-infection. 
 
Serial passaging assays for viral evolution in vitro 
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CEMx174 cells were counted and plated at a concentration of 1 x 106 cells/ml. 293T 
viral stocks (SIVmac239, SIVmac239∆GY, or SIVmac239∆GY + ∆QTH) were 
added to 5 ml of cell culture at a ratio of 50 ng viral p27 per 1 x 106 cells. After 24 
hours (Day 0), excess virus was washed off and cultures were monitored visually for 
development of cytopathic effect (CPE). When this was observed (typical, 3-4 days 
for SIVmac239, 4-7 days for others), cell-free supernatant was collected and added to 
uninfected CEMx174 cells (1 ml supernatant per 5 x 106 cells). After 10 or 20 
passages, cells were collected and DNA was isolated using the QIAamp DNA Mini 
Kit (Qiagen) per the manufacturer’s protocol. Purified DNA was then amplified by 
PCR with SIV Env-specific primers and bulk sequencing was performed. 
 
Imaging flow cytometry & image capture 
CEMx174 cells were infected with each virus at 100 ng p27/million cells. Cultures 
were visually monitored for CPE. At peak infection, as determined by CPE (day 6-7 
post-infection for SIVmac239∆GY, day 3-4 for others), 10 ml of CEMx174 cells 
were centrifuged at 5,000 rpm for 5 minutes. Cells were washed with FACS buffer 
(1X PBS + 0.1% BSA) and resuspended in 500 µl FACS buffer. 100 µl cells were 
incubated with 10 µg/ml primary anti-Env antibody (7D3, Julian Bess, Leidos 
Biomedical Research, NCI.) for 30 minutes on ice. Cells were washed with FACS 
buffer, resuspended in 50 µl FACS buffer, and incubated with 0.1 µl FITC-conjugated 
goat anti-mouse secondary antibody (Santa Cruz Biotechnology) for 30 minutes on 
ice. Cells were then washed and fixed by resuspension in 100 µl Fix & Perm Medium 
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A (Thermo Fisher Scientific) for 15 minutes at room temperature. Cells were washed 
with FACS buffer + 0.01% saponin and resuspended in 100 µl Fix & Perm Medium 
B. 0.5 µl Alexa-Fluor 647-conjugated FA2 Anti-Gag229 (NIH AIDS Reagent 
Repository, conjugation performed in-house with Thermo Fisher Scientific kit) and 
0.2 µg/ml DAPI were added and cells were incubated for 15 minutes, covered, at 
room temperature. Cells were washed with FACS buffer + 0.01% saponin and 
resuspended in 50 µl FACS buffer + 0.01% saponin. 200 µl 2% paraformaldehyde 
was added and cells were allowed to settle overnight. 150 µl of supernatant was 
removed and cells were vortexed to resuspend in the residual 100 µl of buffer. 
Imaging flow cytometry was performed on an ImageStreamX (Amnis, EMD 
Millipore) with 3 active lasers (405, 488, and 658 nm). Acquisition was performed at 
60X magnification using an extended depth of field (EDF) filter. A minimum of 
30,000 events were collected for each sample. Uninfected cells were stained as a 
negative control. 
 
Envelope distribution gating  
IDEAS Software version 6.1 was used for offline analysis. Single cells that were in 
focus were selected based on brightfield images (see Supplemental Figure 1-3 for 
details on gating parameters).  Cells with single nuclei were selected based on DAPI 
images. Gag positive cells were then gated, and of those, Env positive cells were 
selected (Supp. Fig. 2). Gag and Env gates were maintained across samples within 
each experiment via file batching to ensure consistency. Single, focused, and DAPI 
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gates were applied to each sample individually to accurately represent the appropriate 
cell populations. 
 
Following selection of DAPI+Gag+Env+ singlets (minimum 500 cells per 
sample), masking of cell regions based on fluorescent signal was used to determine 
median pixel intensity of Env in the region of the plasma membrane versus the 
interior of the cells (see Supp. Fig 1B) as well as area of plasma membrane that was 
positive for Env. Area of Env intensity vs. median pixel intensity of Env in the 
plasma membrane was charted and cells were gated into punctate, diffuse, or 
intermediate Env distribution phenotype (Supp. Fig. 3). Masking and phenotype gates 
as shown in Supplemental Figures 1 and 3 were batched across all experiments to 
ensure unbiased comparisons. 
 
CF2-Luc entry assay for coreceptor dependence 
CF2-Luc cells were plated in 6-well plates at 1x106 cell/well in DMEM + 10% fetal 
bovine serum (FBS) without antibiotic. After 24 hours, cells were transfected with 
RhM CD4 and RhM CCR5 using a standard lipofectamine transfection protocol and 
incubated overnight. Cells were then replated into 48-well plates, allowed to recover 
for 4-6 hours, and spinoculated with equivalent quantities of SIVmac239, 
SIVmac239ΔGY, or vesicular stomatitis virus as a positive control. The next day, 
virus was washed off and replaced with fresh media. 48 hours after infection, cells 
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were lysed and luciferase activity was read on a Luminoskan AscentTM (Thermo 
Labsystems, Thermo Scientific). This assay has been described previously.226,227 
 
Statistical analysis 
All statistical analyses were performed with GraphPad Prism v6.0g (GraphPad 
Software, Inc., La Jolla, CA). Pairwise comparisons were conducted using non-
parametric tests (Kruskal-Wallis or Friedman tests), as samples sizes were 
insufficient to assess normality. Dunnett’s or Holm-Sidak tests were used to adjust p-
values for multiple comparisons. Where applicable, results are expressed as mean ± 
standard error of mean. 
 
Results 
Mutations in gp41 modulate Env incorporation into virions 
Because ∆GY disrupts a highly conserved trafficking motif in the cytoplasmic 
tail of gp41, we evaluated the effect of this mutation on Env incorporation into 
virions. Virions were produced by infection of rhesus macaque PBMCs with 
SIVmac239 or mutant infectious molecular clones (Fig. 1A) and harvested at day 6 
post-infection, the previously determined peak of replication.  
 
A representative western blot is shown in Figure 2A. Compared to 
SIVmac239, SIVmac239∆GY virion Env content was significantly decreased, to 45% 
of SIVmac239 (Fig. 2B). We next evaluated whether Env content was affected by  
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Figure 2-1: gp41 cytoplasmic tail mutations selected for study in vitro
(A) Partial Env cytoplasmic tail sequences of SIVmac239 mutants selected for study in 
vitro. Mutations were originally identified in !GY-infected rhesus or pig-tailed 
macaques that developed AIDS. All mutations were either identified in at least 2 animals 
or appeared to reconstitute YXX" motifs. (B) Nucleotide sequence of !QTH mutants 
creating YFQI and YFQL motifs. YFQI and YFQL were created by deletions of nine 
nucleotides from env that overlapped the second exon open reading frame of rev and 
tat. YFQI versus YFQL sequence was determined by a one basepair frameshift of the 
mutation. Both !QTH mutations were observed in vivo only in the presence of R722G. 
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gp41 mutations that arose in vivo during SIVmac239∆GY infection. In rhesus 
macaque PBMCs, only the R722G mutation had a significant effect on Env content of 
virions; SIVmac239∆GY R722G virion Env content was 2.0 times greater than 
SIVmac239∆GY (p<0.01, Fig. 2B). Other mutations did not increase Env 
significantly over SIVmac239∆GY alone. This is in contrast to our observations in 
293T-produced virions, in which all mutations arising in vivo conferred an increase in 
virion Env content (Fig. 3A). The findings for SIVmac239∆GY R722G YFQI or 
YFQL were somewhat less consistent in CEMx174 cells, though the reduction in Env 
for with ∆GY and its restoration by R722G remained clear (Fig. 3B). 
 
gp41 mutations regulate intracellular Env trafficking 
If the trafficking mediated by GYxxΦ is important for efficient viral 
replication or evasion of host immune responses, there might be in vivo selection for 
Env mutations that restore the function of this sequence. To determine whether any of 
the putative compensatory mutations rescue the trafficking function lost in 
SIVmac239∆GY, we constructed CD4-SIV Env chimeras as previously described and 
generated stable cell lines (Fig. 4).76 These chimeras encode a truncated Env 
cytoplasmic domain containing only the membrane-proximal GYxxΦ trafficking 
motif, excluding any downstream endocytosis signals. As trafficking signals can alter 
the cellular distribution of a protein, we first determined the steady state localization 
of the chimeras. Constructs with the SIVmac239 wildtype sequence GYRPV had an 
intracellular perinuclear distribution and a small amount of the CD4 reporter at the  
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Figure 2-2: Env incorporation into virions produced in 
rhesus macaque PBMCs
(A) Representative western blot of purified virions produced 
in RhM PBMCs. Virions were pelleted through a sucrose 
cushion, depleted of CD45 to remove microvesicles, 
denatured, and blotted using anti-gp120 and anti-p27 
antibodies. n!9 for all samples.
Top band: gp120 Env; bottom band: p27 Gag
(B) p27 values by densitometry were normalized and the 
fold change determined in the gp120:p27 ratio relative to 
SIVmac239. n!9 for all samples. 
* denotes significant difference from !GY (**, p".01)
+ denotes significant difference from theoretical SIVmac239 
value of 1 (++, p"0.01; ++++, p"0.0001). 
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cell surface. The principally intracellular distribution of wildtype Env reflects its 
known transport pathway.64,80 After synthesis and post-translational modification, 
Env is trafficked to the cell surface and then rapidly endocytosed, with subsequent 
localization to endosomes.66,68,70,77,230 In contrast, the SIVmac239∆GY Env lacked 
this intracellular pattern and exhibited a more diffuse surface distribution. While 
SIVmac239ΔGY R722G showed a similar cell surface distribution to 
SIVmac239ΔGY, likely indicating a lack of new endocytic information, 
SIVmac239ΔGY ∆QTH (YFQI or YFQL) showed an increase in the amount of 
perinuclear intracellular staining (Fig. 5A).  
 
To determine if chimeric constructs were expressed on the cell surface and 
subsequently endocytosed, an “antibody feeding” experiment was performed in which 
cells stably expressing the CD4-SIV gp41 tail chimeras were incubated with an anti-
CD4 antibody for 3 hours at 37°, washed, and permeabilized. Cells expressing the 
chimera bearing the wildtype SIVmac239 cytoplasmic tail exhibited intracellular 
CD4 staining, consistent with this construct being expressed on the cell surface, 
endocytosed, and trafficking to an intracellular compartment, most likely endosomes 
(Fig. 5B). As expected, antibody binding to the SIVmac239∆GY R722G chimera, 
which does not contain a recognizable endocytosis signal, was localized 
predominantly at the cell surface. Of note, because the images shown in Figure 4 are 
not confocal images, the observed punctae are a combination of cell surface 
microvilli and intracellular labeling. In contrast, for SIVmac239∆GY ∆QTH chimeras  
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Figure 2-3: Env incorporation into virions produced in cell lines
p27 values by densitometry were normalized and the fold change 
determined in the gp120:p27 ratio relative to SIVmac239. n between 7 and 
28 for 293T cells and between 3 and 17 for CEMx174. 
* denotes significant difference from !GY (****, p!0.0001); + denotes 
significant difference from theoretical SIVmac239 value of 1 (+, p!0.05; ++, 
p!0.01; ++++, p!0.0001).
(A) gp120:p27 ratio as fold change of SIVmac239; virions produced by 
transfection of 293T cells. (B)  gp120:p27 ratio as fold change of 
SIVmac239; virions produced by infection of CEMx174 cells.
B
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CD4 (human) ...MALIVLGGVAGLLLFIGLGIFFCVRCRHRRRQAERMSQIKRLLSEKKTCQCPHRFQKTCSPI!
          !
! ! ! ! ! ! ! ! ! ! !    Yxx? ! ! ! ! !   !
CD4-SIVEnv  ...MALIVLGGVAGLLLFIGLGIFFCVRCRHRKLRQGYRPVFSSPPSYFQQTHIQQDPALPT!
!
       !       ! ! ! ! ! !           Yxx? ! ! ! !!
! ! ! ! ! !SIVmac239 ! ! KLRQGYRPVFSSPPSYFQQTHIQQDPALPT !!
 ! ! ! ! ! !∆GY! ! ! ! KLRQ--RPVFSSPPSYFQQTHIQQDPALPT!
 ! ! ! ! ! !!
! ! ! ! ! !∆GY R722G ! ! KLRQ--GPVFSSPPSYFQQTHIQQDPALPT!
! ! ! ! ! !∆GY S727P ! ! KLRQ--RPVFSPPPSYFQQTHIQQDPALPT!
!    ! ! ! ! !∆GY ∆QTH (YFQI) ! KLRQ--RPVFSSPPSYFQ---IQQDPALPT!
  ! ! ! ! ! !∆GY ∆QTH (YFQL) ! KLRQ--RPVFSSPPSYFQ---LQQDPALPT!
Figure 2-4: Structure of CD4-SIV Env chimeras
Top: Human CD4 sequence is displayed in the top line, with the membrane spanning domain 
underlined.
Center: CD4-SIV Env chimeric sequence bearing the CD4 ectodomain fused to a truncated SIV 
envelope cytoplasmic tail. The membrane proximal tyrosine motif is shown in red.
Bottom: SIV cytoplasmic tail sequences with engineered mutations. The location of the tyrosine 
motif is marked above (red).
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containing either YFQI or YFQL sequences, the anti-CD4 antibody was readily 
detectable in intracellular compartments, consistent with their expression on the cell 
surface and subsequent endocytosis. These data strongly suggest that the novel YxxΦ 
motifs created by the ∆QTH deletion, selected in vivo, restored endocytic trafficking 
functions that were lost with the ∆GY mutation. 
 
Novel YxxΦ motifs reconstitute functional endocytosis signals and modulate Env 
endocytosis 
Given differences in the steady state distribution of the CD4-SIV Env 
chimeras and the results of the antibody feeding experiment, we next directly 
assessed the endocytic rates of these constructs. As noted, the ∆GY mutation  
completely ablates endocytic function of the SIV GYxxΦ signal. To assess 
quantitatively the ability of putative compensatory mutations to restore endocytic 
trafficking, endocytic rates of the CD4-SIV tail chimeras stably expressed on HeLa 
cells were measured using a modification of a previously described assay (Fig. 6).66 
The CD4-SIV Env chimera containing the wildtype SIVmac239 tail was endocytosed 
at a rate of 11.9% per minute, reflecting the robust function of the SIV GYRPV 
signal. For the chimera containing the ΔGY tail, endocytosis was reduced to 
approximately 2% per minute (1.8% ± 0.6%, Fig. 6B), comparable to bulk membrane 
turnover and reflecting a nearly complete loss of endocytic function. For the ΔGY tail 
construct, 72% ± 6% of the protein remained at the cell surface after 30 min at 37°C 
in contrast to 13% ± 2% for the CD4-SIVmac239 chimera (Fig. 6A and B). For  
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Figure 2-5: gp41 mutations regulate intracellular Env trafficking
Data provided by Scott Lawrence.
(A) Total anti-CD4 staining for CD4-SIV Env chimeras in permeabilized 
HeLa cells. (B) Antibody feeding experiment; anti-CD4 staining for CD4-
SIV Env chimeras in HeLa cells incubated with anti-CD4 prior to 
permeabilization. Size bar = 25 !m. 
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Figure 2-6: Novel Yxx! motifs reconstitute functional 
endocytosis signals and mediate Env endocytosis
Data provided by Scott Lawrence.
Endocytosis of CD4-SIV Env chimeras from the surface 
was measured by quantifying CD4 expression on the 
surface of transfected HeLa cells over time.
n!4 for all samples. (A) Percent of time zero anti-CD4 
signal at cell surface over time for each mutant. (B) Rate 
of CD4 endocytosis from the cell surface over first 5 
minutes after warm up. 
B
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constructs containing ∆GY with mutations acquired in vivo, S727P had no effect, 
while R722G conferred a minimal increase in endocytosis to a rate of 3.98% per 
minute (59% ± 6% remaining at the surface after 30 minutes, p=0.014). However, the 
∆QTH mutations creating either the YFQI or YFQL sequences conferred a marked 
gain of endocytic function to full or near wild type levels (5.74% and 12.76% per 
minute, respectively) (Fig. 6B). Thus, mutations that arose in vivo in the context of 2 
of 6 SIVmac239∆GY-infected macaques that progressed to AIDS restored endocytic 
function lost by the ∆GY mutation to near wildtype levels. 
To test whether the novel YxxΦ sequences conformed to a conventional 
YxxΦ motif, alanine scanning mutagenesis was performed on CD4-SIV Env 
chimeras containing ∆GY and the ∆QTH (YFQL) sequence (Fig. 7A) and endocytic 
rates determined in HeLa cells stably expressing these constructs. As shown in 
Figures 7B and C, Ala substitutions of the Y (position 0) or Φ (Y+3 position) residues 
markedly reduced endocytosis, with minimal decreases observed for Ala substitutions 
at the Y+1, +2 or +5 positions.  Thus, the YFQL motif created by the ∆QTH mutation 
functioned as a classical Tyr-dependent YxxΦ motif, with the major contributions 
coming from the Tyr and the Φ amino acid (i.e. Leu). 
 
Novel YxxΦ motifs depend on AP-2 to mediate endocytosis 
 YxxΦ motifs interact with AP-2 through insertion of bulky hydrophobic side 
chains of the Y and the Y+3 amino acid into hydrophobic pockets in the AP-2 µ2 
subunit.62 As such, endocytosis of YFQI and YFQL chimeras should be dependent  
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CD4 (human) ...MALIVLGGVAGLLLFIGLGIFFCVRCRHRRRQAERMSQIKRLLSEKKTCQCPHRFQKTCSPI!
          !
! ! ! ! ! ! ! ! ! ! !    Yxx? ! ! ! ! !   !
CD4-SIVEnv  ...MALIVLGGVAGLLLFIGLGIFFCVRCRHRKLRQGYRPVFSSPPSYFQQTHIQQDPALPT!
!
       !       ! ! ! ! ! !           Yxx? ! ! ! !!
! ! ! ! ! !SIVmac239 ! ! KLRQGYRPVFSSPPSYFQQTHIQQDPALPT !!
 ! ! ! ! ! !∆GY ∆QTH (YFQL) ! KLRQ--RPVFSSPPSYFQ---LQQDPALPT!
! ! ! ! ! !S730A ! ! ! KLRQ--RPVFSSPPAYFQ---LQQDPALPT!
! ! ! ! ! !Y731A ! ! ! KLRQ--GPVFSSPPSAFQ---LQQDPALPT!
! ! ! ! ! !F732A ! ! ! KLRQ--RPVFSPPPSYAQ---LQQDPALPT!
!    ! ! ! ! !Q733A ! ! ! KLRQ--RPVFSSPPSYFA---LQQDPALPT!
  ! ! ! ! ! !L737A ! ! ! KLRQ--RPVFSSPPSYFQ---AQQDPALPT!
! ! ! ! ! !Q738A ! ! ! KLRQ--RPVFSSPPSYFQ---LAQDPALPT!
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Figure 2-7: Alanine scanning mutagenesis reveals that YFQL 
conforms to the conventional Yxx! motif
Data provided by Scott Lawrence.
HeLa cells expressing CD4-SIV Env chimeras with indicated 
alanine substitutions were incubated with an anti-CD4 antibody 
4°C, then incubated at 37°C. After incubation, cells were cooled 
to 4°C and anti-CD4 remaining at the cell surface was quantified. 
n=3 for all samples. (A) Sequence of CD4-SIV Env chimeric 
constructs with alanine substitutions. (B) Percent of initial (time 
zero) anti-CD4 signal at cell surface over time for each mutant. 
(C) Rate of CD4 endocytosis from the cell surface over the first 5 
minutes after warm up. 
C
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Figure 2-8: AP-2 is required for endocytosis of CD4-SIV Env chimeras 
containing a Yxx! motif 
Data provided by Scott Lawrence.
(A) Expression of AP-2 subunits (!-adaptin or "2) in anti-"2 siRNA 
transfected or mock transfected HeLa cells. VDAC is shown as a loading 
control. Blots were imaged and quantified using the LiCOR® Odyssey. (B) 
Percent of AP-2 subunit depletion relative to mock siRNA transfected HeLa 
cells. (C) Endocytosis of CD4-SIV Env chimeras in AP-2 depleted or non-
depleted cells. Results are expressed as the rate of CD4 endocytosis from the 
cell surface over the first 5 mins. n!3 for all samples.
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upon AP-2. To assess this possibility, AP-2 µ2 subunits were depleted with siRNA 
and the endocytic rates of CD4-SIV Env chimeras measured (Fig. 8). Depletion of µ2 
is known to destabilize the AP-2 complex and results in a decrease in AP-2 as 
measured by reduced binding to an α-adaptin antibody.231 Efficient µ2 depletion was 
achieved (69% ± 12%) and was associated with a reduction of AP-2 (53% ± 13%) 
(Fig. 8B). Following AP-2 knockdown, the internalization rates of all chimeras 
containing a YxxΦ motif were substantially reduced (Fig. 8C). Specifically, 
SIVmac239 chimera internalization decreased from 12.0% to 5.3% per minute, while 
endocytosis of the CD4-SIV Env chimera containing ∆GY remained at near 
background levels and was essentially unaffected (2% vs. 1.5%). AP-2 depletion also 
had no effect on endocytosis of CD4-SIV Env chimeras containing ∆GY and R722G 
mutations (i.e. 3.9% with vs. 3.2% without depletion). In contrast, internalization of 
YFQI and YFQL were each reduced  by depletion of AP-2, with a greater effect seen  
for YFQL (13.6% to 4.4%) than for YFQI (5.6% to 3.5%) (Fig. 8C). Collectively, 
these findings confirm a role for AP-2 in endocytosis mediated by the YFQI and 
YFQL sequences and further demonstrate that these mutations acquired in vivo 
function as classical YxxΦ endocytosis motifs.  
 
Novel YxxΦ motifs regulate basolateral sorting of Env in polarized cells 
The tyrosine residue of the HIV-1 GYxxΦ motif noted above has also been 
shown to be important for the basolateral targeting of Env in polarized MDCK 
cells.88,90 Although a similar function has not been demonstrated for this motif 
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(YRPV) in an SIV Env, SIVmac Envs with truncated cytoplasmic tails were shown to 
be sorted to the basolateral surface less efficiently than the full-length protein, with 
removal of the region containing the proximal tyrosine motif having a stronger effect 
than more conservation truncations.232 For HIV-1, basolateral sorting of surface Env 
also mediates polarized budding of infectious virions.89,90 We considered the 
possibility that if basolateral sorting of Env and/or the polarized budding of viral 
particles were important in vivo, preservation  of this function could have also 
contributed to the selection of the ΔQTH mutation and the generation of new Tyr-
based signals (i.e. YFQI and YFQL).  
 
To assess basolateral sorting potential of CD4-SIV Env chimeras with 
parental, SIVmac239∆GY, and SIVmac239∆GY + ∆QTH sequences, we created 
MDCKII cells that stably expressed these constructs. Cells were cultured on 
Transwell filters to form polarized monolayers and the expression of constructs 
analyzed by immunofluorescence microscopy for total (i.e. following 
permeabilization) or surface CD4-SIV Env (i.e. non-permeabilized, Fig. 9) 
expression. For chimeras containing either the short (Fig. 4) or full-length (long) 
SIVmac239 Env tails, the majority of protein was intracellular and localized to a 
perinuclear region (Fig. 9A). Cell surface expression was low but was predominantly 
located on the basolateral plasma membrane. Loss of the YxxΦ motif (YRPV) by 
either the ΔGY or a Y721I mutation, resulted in redistribution of constructs to both 
the basolateral and apical plasma membranes. This loss of polarized expression was  
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Figure 2-9: Novel Yxx! motifs rescue polarized Env trafficking lost in "GY
Data provided by Scott Lawrence.
(A) Total expression of CD4-SIV Env chimeras in polarized MDCKII cells. 
(B) Surface expression of CD4-SIV Env chimeras in polarized MDCKII cells. 
(C) Ratio of apical to basolateral CD4 expression of the images in (B), calculated by 
measurement of intensity of CD4 staining in each membrane. n of images analyzed 
is between 4 and 9 and the number of cells per image is between 10 and 29 for all 
samples.
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demonstrated both for chimeras with short and full-length Env cytoplasmic tails (Fig. 
9). This finding is consistent with studies of HIV-1 Env showing that the membrane-
proximal tyrosine (i.e. Tyr-712) is required for basolateral sorting of Env.88,89 
Remarkably, in CD4-SIV Env ∆GY constructs that contained the new YxxΦ motifs 
generated by the ∆QTH deletion, YFQI or YFQL, basolateral sorting was restored. 
Higher cell surface expression was also observed for these mutants compared to 
wildtype SIVmac239. The mechanism behind this difference has not been evaluated, 
but could be due to reduced degradation, possibly through differences in lysosomal 
targeting. Unlike the wildtype proximal tyrosine motif (GYRPV), YFQI and YFQL 
lack the proximal glycine, and as a GYxxΦ is a preferred signal for lysosomal and 
late endosomal targeting (as opposed to YxxΦ for endocytic signaling), it is possible 
that the absence of this residue may have conferred endocytic rates similar to 
SIVmac239 without fully recapitulating the intracellular distribution patterns of the 
chimera containing the wildtype SIVmac239 protein.62,233 Together, these findings 
demonstrate that the novel YFQI and YFQL sequences acquired in SIVmac239∆GY-
infected progressing macaques are able to reconstitute both endocytic and basolateral 
sorting functions of the parental SIVmac239 tail that were lost as a result of the ∆GY 
mutation. The acquisition of these functions through the highly novel ∆QTH mutation 
strongly suggests that they were selected for in vivo. 
 
Growth of infectious molecular clones in macaque PBMCs  
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In vivo in both rhesus and pigtail macaques, SIVmac239∆GY replicates to an 
acute peak that is identical to that of SIVmac239, and in early studies we reported that 
its in vitro replication kinetics were similar to wildtype SIV.222,223 As noted 
previously, we observed that the ∆GY mutation resulted in a reduction in Env content 
on virions produced in cell lines and in macaque PBMCs. Because virion Env content 
has been shown to correlate directly with infectivity, we re-examined the effects of 
the ∆GY mutation on viral replication in primary macaque lymphocytes as well as the 
effects of mutations that occurred in SIVmac239∆GY-infected animals that 
progressed to disease.109 Although SIVmac239∆GY replicated in both rhesus and pig-
tailed macaque PBMCs, compared to parental SIVmac239, a small but consistent 
decrease in peak reverse transcriptase activity (~0.5 log) was observed in multiple 
replicates of this assay (Fig. 10). This finding indicates a subtle but reproducible 
attenuating effect of the ∆GY mutation that was not observed in earlier studies. We 
considered whether this effect could be due to changes in dependence on CCR5 for 
entry, but SIVmac239∆GY and SIVmac239 did not differ in the level of  infection 
seen in cells transfected with various quantities of RhM CCR5 (Fig. 11).  
 
We next examined replication of ∆GY viruses containing mutations that were 
acquired in vivo.  Interestingly, viruses containing ∆GY and the ∆QTH mutations that 
generated the YFQI or YFQL alone were markedly defective in replication (Fig.  10). 
However, this defect was largely corrected by the addition of the R722G mutation 
flanking the ∆GY mutation. While the mechanism for the R722G rescue in this  
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Rhesus macaque Pig-tailed macaque
Figure 2-10: Growth of infectious molecular clones in macaque PBMCs
n!3 for all samples. * denotes significant difference from theoretical 
SIVmac239 value of 1 *, p<0.05; **, p".01;  ***, p".001; ****, p"0.0001.
(A). Viral RT activity at peak infection timepoint in rhesus macaque PBMCs 
as fold change of SIVmac239. (B). Viral RT activity at peak infection 
timepoint in pig-tailed macaque PBMCs as fold change of SIVmac239. 
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context is unclear, it is notable that in vivo the ∆QTH mutation always occurred in 
association with ∆QTH mutations, suggesting a complementing effect and/or that the 
R722G mutation was acquired prior to the ∆QTH mutation. Although the ∆QTH 
produces deletions of two amino acids in the second exons of Rev and Tat that could 
impair their functions (Fig. 1B), the R722G mutation is proximal to this reading 
frame and does not affect the Rev and Tat sequences. 
 
Mutations that arise in vivo are selected for in serial passage of SIVmac239∆GY 
and derivatives in vitro  
In earlier studies, we showed in competition assays in the human B/T cell 
hybrid line CEMx174 cells that SIVmac239 will outcompete SIVmac239∆GY, 
indicating some fitness cost to the ∆GY mutation.221,234 The slightly reduced 
replication kinetics of  SIVmac239∆GY compared to SIVmac239 in PBMCs are 
consistent with this observation. In light of this defect, we performed serial passage of 
SIVmac239, SIVmac239∆GY, SIVmac239∆GY YFQI, and SIVmac239∆GY YFQL 
in CEMx174 cells, to determine if changes in SIVmac239∆GY that were observed in  
progressing animals could be recapitulated in vitro. The CEMx174 cell line was 
chosen for this assay because, unlike many human lymphocyte cell lines, growth in 
these cells does not result in SIV cytoplasmic tail truncations even during long term 
serial passaging of virus.221 SIVmac239 and SIVmac239∆GY were each serially 
passaged 20 times, and PCR amplification and bulk sequencing performed on the env 
gene at passage 10 and 20. No changes were observed in the cytoplasmic tail of  
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Figure 2-11: CCR5 dependence of SIVmac239 and SIVmac239!GY
n=3 for all samples. Quantitative infection of CF2-luc cells for infectious 
molecular clones, as measured by luciferase reporter activity. The quantity of 
CCR5 used to transfect cells is indicated on the x axis.
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parental SIVmac239 (Fig. 12A). However, at passage 10, SIVmac239∆GY Env 
exhibited a mixed genotype of Ser and Pro residues at amino acid position 727, and 
by passage 20 this residue was entirely Pro. The finding that an S727P mutation 
occurred during serial passaging of virus in vitro as well as becoming fixed in 1 of 4 
SIVmac239∆GY-infected RhM that progressed to AIDS strongly suggests that this 
mutation conferred a fitness advantage and was unlikely to have been generated by 
pressures from the host immune system.    
We next evaluated SIVmac239∆GY YFQI and YFQL in a similar serial 
passage assay. Because growth of these viruses was severely attenuated in PBMCs 
(Fig. 10), we questioned whether this was a phenomenon limited to culturing in 
PBMCs or whether it reflected a more generalized intrinsic defect in replication of 
these mutants. Because addition of the R722G so strikingly improved replication in 
PBMCs (Fig. 10), we hypothesized that this point mutation might be selected for in  
serial passage in CEMx174 cells if its primary role was to restore replication fitness. 
As in PBMCs, SIVmac239∆GY containing the YFQI and YFQL without the R722G 
replicated slowly in CEMx174 culture; viral syncytia in CEMx174 cells were not 
observed until 7 days post-infection. However, after 16 (YFQI) or 18 (YFQL) 
passages, viral syncytia began to appear 3-4 days after each passage, consistent with 
more accelerated kinetics of viral replication. Bulk sequencing of viral env at passage 
20 revealed that R722G had appeared in both viruses and appeared to correlate with 
more rapid development of syncytia (Fig. 12B). These observations recapitulate the 
results of viral replication in PBMCs in which the R722G mutation restored the  
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Figure 2-12: Mutations that arise in vivo are selected for in serial passage of SIVmac239!GY 
and derivatives in vitro
CEMx174 cells were infected with the indicated viruses and cell freesupernatant was passaged onto 
uninfected cells 20 times with bulk sequencing performed at passage 10 and 20. Mutations that 
evolved during passage are shown in red. (A) Sequence of SIVmac239, and SIVmac239!GY at 
passage 10 (top) and passage 20. Parental SIVmac239 shown above. (B) Sequence of SIVmac239 
and SIVmac239!GY + YFQI or YFQL at passage 10 and 20. Parental SIVmac239 shown above.
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replication defect of ∆GY viruses containing only the ∆QTH mutations. The finding 
that this R722G mutation was generated de novo during serial propagation in vitro 
indicates that strong selection pressures was operative in vitro and in vivo to create 
this specific change. 
 
∆GY-containing mutants exhibit differences in cell surface distribution of Env in 
comparison to SIVmac239 
The ΔGY mutation disrupts a highly conserved YxxΦ trafficking motif in 
gp41, ablating Tyr-dependent signals for both endocytosis and basolateral sorting. 
However, as described above, ∆GY also results in a reduction in Env content on 
virions, with an increase in steady state surface expression on infected cells. The 
latter finding led us to hypothesize that the effect of this mutation could be to impair 
targeting of Env to sites of budding at the plasma membrane. If Env incorporation 
requires active clustering of Env at predetermined budding locations, changes in 
distribution of Env on the cell surface could explain a decrease in Env on virions. We 
addressed this question using the Amnis ImageStreamX, which enables multicolor 
flow cytometric analysis of protein expression to be performed with direct 
visualization of protein expression on individual cells, combining the analytical 
power of flow cytometry with fluorescence microscopy.235 Using this technique, we 
sought to examine the expression levels and distribution on SIV-infected cells (Fig. 
13A). CEMx174 cells were chosen for this experiment because they are highly 
permissive to SIV infection, enabling data on a large number of infected cells to be 
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generated.  Cells were infected with SIVmac239 or SIVmac239ΔGY at 100 ng of 
p27-Gag/106 cells and cultures were monitored for the onset of infection by assessing 
cytopathic effects (i.e. syncytia formation) and by fluorescence microscopy for p27-
Gag expression. When >50% of cells were infected, cultures were stained for Env on 
the cell surface and intracellular p27-Gag using monoclonal antibodies. Flow 
cytometry and image capture were performed and Env expression analyzed with 
Amnis IDEAS software. Intact single cells were identified by DAPI staining and 
analytical gates used to isolate p27 positive cells. 
 
By mean fluorescent intensity (MFI), SIVmac239ΔGY infected cells had 
higher levels of Env expression on the cell surface than cells infected by SIVmac239. 
On average, SIVmac239ΔGY Env expression was 1.72 ± 0.19-fold greater than 
SIVmac239 (Fig. 13B). Addition of R722G increased surface Env expression further, 
to average 2.37 ± 0.22-fold greater than SIVmac0239, while SIVmac239ΔGY R722G 
YFQL had Env levels similar to SIVmac239ΔGY (average fold increase 1.68 ± 0.14). 
Images of individual cells were then analyzed for Env distribution on the cell surface. 
Amnis IDEAS software was used to generate a mask that identified the plasma 
membrane (rim) of cells, and the area and intensity of Env signal within this region 
was measured. (Complete masking and gating strategies are described in Methods and 
in Supplemental Figures 1-3). Although cells exhibited varying patterns of Env 
distribution ranging from punctate to a diffuse pattern, there was a statistically 
significant difference between SIVmac239 and ΔGY-containing mutants in the  
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Figure 2-13: Env surface distribution on infected CEMx174 cells 
(A) Representative images of SIVmac239 (left) and !GY (right) infected 
CEMx174 cells at peak infection. Green, Env; red, Gag; blue, DAPI; 
grayscale, brightfield. (B) Mean fluorescent intensity of Env on DAPI
+Gag+Env+ CEMx174 cells at peak infection expressed as fold change of 
SIVmac239. * denotes significant difference from theoretical SIVmac239 
value of 1 (**, p!.01; ***, p!0.001)(C) Pecentage of DAPI+Gag+Env+ 
cells with punctate Env surface distribution. * denotes significant 
difference from SIVmac239 (*, p!0.05; **, p!.01)
A
B C
SIVmac239 ΔGY
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percentage of cells with a punctate distribution (Fig. 13C). On average, 15.8% of 
SIVmac239-infected cells showed a punctate Env distribution (as defined by the 
gating strategy shown in Supp. Fig. 3), in contrast to 3.5% for SIVmac239ΔGY-
infected cells (p<0.05, Fig. 13C). While overlap in expression patterns was observed 
between the viruses (i.e., some SIVmac239ΔGY-infected cells had punctate Env 
expression, and some cells infected with SIVmac239 had diffuse Env distribution), an 
overall trend was observed toward more diffuse expression by SIVmac239ΔGY. As 
will be discussed, these differences may reflect a failure of the SIVmac239∆GY Env 
to traffic to sites of viral budding and is also consistent with the finding of decreased 
Env incorporation on SIVmac239ΔGY virions. Addition of R722G to the ∆GY 
mutation, with or without YFQL, did not rescue the punctate distribution phenotype 
seen with SIVmac239, as there was no change in the percentage of punctate 
phenotype cells in these mutants (2.8% ± 0.6% and 3.9% ± 1.3% of SIVmac239ΔGY 
R722G of SIVmac239ΔGY R722G YFQL, respectively). However, given the higher 
MFI of R722G on cells (fold increase over SIVmac239 2.37 for  
SIVmac239∆GY R722G vs. 1.72 for SIVmac239∆GY), it is possible that an increase 
in Env on the cell surface could partially compensate for the defect imposed by the 
∆GY mutation by increasing passive Env incorporation into virions. Further studies 
are needed to characterize the possible microdomains of Env localization to sites of 
viral budding. 
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Discussion 
SIVmac239ΔGY differs from its parent virus SIVmac239 by only a two 
amino acid deletion in the membrane-proximal tyrosine motif of the cytoplasmic tail 
of gp41. It has been previously described as having a unique attenuated phenotype in 
rhesus and pig-tailed macaques, with a high acute peak in both species followed by 
control to <100 copies/ml by 20 weeks post-infection in 19/21 of pig-tailed 
macaques.222,223 In RhM and PTM, SIVmac239ΔGY infection is distinctive in that 
even when animals develop AIDS and chronic immune activation, this occurs with 
sparing of mucosal CD4+ T cells in the gut lamina propria and lack of macrophage 
infection, both of which are associated with parental SIVmac239 
infection.140,225,236,237 Possibly as a consequence of the preservation of CD4+ cells in 
the gut lamina propria during chronic infection, SIVmac239ΔGY infected pig-tailed 
macaques generate robust polyfunctional CD4+ T cell responses originating from 
cells in this compartment, which may contribute to control of SIVmac239ΔGY 
viremia as well as protection from pathogenic challenge.223 Due to the striking in vivo 
phenotype of this virus, we sought to identify in vitro properties that could 
differentiate SIVmac239ΔGY from SIVmac239 and explain their marked differences 
in pathogenicity.  
 
It is known that infectivity of primate lentiviruses is affected by virion Env 
levels on virions, with viruses expressing higher per-particle Env levels being more 
infectious.109 The cytoplasmic tail of gp41 has been previously implicated in 
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modulating envelope incorporation into budding virions, and thus modifications to 
the gp41 tail sequence could exert some effect on infectivity.61,76,91,96,102,205 The 
mechanism of this process, as well as interactions of the cytoplasmic tail, the viral 
matrix protein, and cellular proteins that may affect Env targeting to sites of budding, 
are poorly characterized.11,98,104,205,238–240 The gp41 membrane-proximal Tyr-
dependent trafficking motif GYxxΦ binds the cellular adaptor complexes AP-1 and 
AP-2 and, via the latter, mediates clathrin-dependent endocytosis of Env from the 
surface of infected cells.64,65,71 In addition, during HIV-1 infection of polarized cells, 
the tyrosine residue plays a role in mediating sorting of Env and viral budding to the 
basolateral surface.90 Because of its role in Env trafficking, we hypothesized that 
disruption of this signal might alter the incorporation of Env into virions and 
contribute to the divergent natural history of SIVmac239 and SIVmac239ΔGY 
infection in PTM.  
 
In this Chapter, we evaluated comprehensively SIVmac239∆GY in 
comparison to SIVmac239 in an attempt to identify in vitro correlates of its altered 
phenotype. We assessed virion Env levels and growth in macaque primary cells as 
measures of viral function. We also evaluated Env localization, endocytosis, and 
sorting to basolateral membranes of polarized cells to determine how loss of the 
tyrosine motif affected these characteristics. Functional defects that distinguish 
SIVmac239∆GY from its parent demonstrate the role of the proximal cytoplasmic tail 
motif in the SIV life cycle. In addition to direct comparisons of SIVmac239∆GY with 
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SIVmac239, we used the same assays to evaluate effects of mutations acquired in 
vivo in SIVmac239∆GY-infected rhesus and pig-tailed macaques that progressed to 
disease. We viewed these putative compensatory mutations as potentially valuable 
tools to assess the relevance of in vitro differences in SIVmac239∆GY to 
SIVmac239. The ability of these mutations to compensate for the ∆GY mutation in 
vivo will be addressed in Chapter 3. 
 
Here we demonstrate that disruption of the membrane-proximal tyrosine motif 
results in a reduction of Env incorporated into virions. This effect is consistent across 
multiple cell types, including lymphocyte cell lines and macaque PBMCs. The 
reduction in Env is associated with a loss of punctate distribution of Env on infected 
cells as determined by imaging flow cytometry and a decrease in peak growth in 
primary cells. Paradoxically, though not unexpectedly, ablation of this endocytosis 
motif results in an increase in Env expression on the surface of infected cells. While 
the increase in expression is modest, possibly due to the presence of redundant 
endocytosis motifs at downstream positions in the gp41 cytoplasmic tail, it provides 
critical insight into the role of this motif in the viral life cycle.66 Because HIV and 
SIV virions typically bud from the plasma membrane, it could be hypothesized that 
increased expression of Env on the cell surface would result in a concomitant increase 
in Env on virions produced by the cell.42,241–243 However, the discordance between 
cell surface Env and virion Env instead implies that to be incorporated into virions, 
Env must be actively targeted to appropriate sites on the plasma membrane.  
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Because the GYxxΦ signal is known to mediate protein sorting and targeting 
as well as endocytosis, its role in primate lentiviruses may be relevant to the process 
of Env incorporation.62,240,244 We propose a mechanism in which the membrane-
proximal tyrosine motif interacts with cellular proteins to be targeted from the trans-
Golgi network to specific budding sites on the plasma membrane.66,68,70,76,95,245 As 
budding is mediated by viral Gag and does not require Env, these budding sites are 
likely determined by interactions of Gag and cellular proteins, with Env targeting 
occurring through a separate mechanism.79 Interactions between HIV-1 matrix and 
the Env tail have been implicated in Env incorporation, but these determinants have 
not been mapped for SIV, and the mechanism of these interactions is poorly 
understood.92,94,102,246,247 Failure of Env to target to sites where Gag assembly has 
occurred in preparation for budding would result in a diffuse distribution of Env on 
the cell surface, with reduced incorporation of the protein into nascent virions. The 
higher Env expression on the cell surface in SIVmac239ΔGY is attributable to the 
second role of the GYxxΦ as an endocytosis signal.68,70,244 This motif interacts with 
AP-2 to mediate endocytosis of Env from the surface of infected cells.64,65,230 
Additional downstream endocytosis motifs are present and can also function to 
reduce Env expression on the cell surface, while the small but reproducible increase 
in cell surface Env detectable on SIVmac239∆GY-infected cells can be explained by 
ablation of the function of the membrane-proximal tyrosine motif.64,66,245 
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Although neither S727P nor R722G reconstitute endocytosis motifs in gp41, 
both of these mutations, especially the R722G, increase Env incorporation into 
virions in the context of the ΔGY mutation, with R722G restoring Env incorporation 
to levels equivalent to SIVmac239. Greater levels of Env on virions are associated 
with increased infectivity, and this mutation in SIVmac239ΔGY could contribute to 
its altered pathogenicity in rhesus and pig-tailed macaques.108,109 Further, these 
mutations arose in multiple animals in both RhM and PTM. S727P was observed in 
two rhesus macaques and was correlated with disease progression in both 
animals.221,222 Interestingly, this mutation was also observed in an SIVmac239Δnef 
that became pathogenic in vivo, and correlated with a gain of function in reducing 
rhesus tetherin expression.190,248 R722G arose at least transiently in all rhesus and pig-
tailed macaque progressors, always independently of S727P, and became fixed in 2 of 
6 progressing animals (both PTM).222,223 However, it is also possible that the higher 
set-point viral loads in SIVmac239ΔGY progressors permitted evolution of additional 
mutations that were selected for by enhancing replication fitness, and that R722G is 
only a correlate, rather than a cause, of increased pathogenicity in vivo. In addition to 
being identified in the six progressing animals, R722G was also seen in one pig-tailed 
macaque that ultimately controlled SIVmac239ΔGY.223 This sequence analysis was 
performed on plasma viremia following CD8 depletion of two SIVmac239ΔGY PTM 
controllers, with R722G being identified in one of the two. Single genome sequencing 
was not performed on all controllers, and thus we lack complete information on the 
correlation of R722G with disease progression. While the identification of this 
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mutation in one PTM controller suggests that R722G alone is not adequate to restore 
a pathogenic phenotype, it does not exclude the possibility that the disease 
progression is multifactorial and is determined by the kinetics of viral replication and 
of host immune responses. As such, R722G may indeed be sufficient to confer a 
pathogenic phenotype to SIVmac239ΔGY, but this mutation may not have arisen at 
an early enough time for the virus to overcome host immune responses. Innate 
immune responses such as interferon-α and upregulation of downstream interferon 
stimulated genes are activated within days of infection, while the first adaptive 
immune responses via specific cell-mediated immunity are on the order of 
weeks.5,249,250 The window for the virus to replicate rapidly and evade these responses 
may be so limited that such a compensatory mutation would need to be present at the 
start of infection, rather than following several rounds of replication. In Chapter 3, we 
address this question by inoculating naïve pig-tailed macaques with an SIV 
containing both the ΔGY and the R722G Env mutations.  
 
In virions produced in cell lines, novel endocytosis motifs YFQI and YFQL, 
with R722G as they appeared in vivo, have a modulating effect on Env. While R722G 
raises Env above wildtype levels, addition of YFQI or YFQL lowers Env levels 
toward those of SIVmac239. In rhesus macaque PBMCs, the effect of S727P or 
R722G alone is more modest, and addition of R722G with YFQI or YFQL does not 
improve virion Env incorporation over SIVmac239ΔGY. Based on previously 
published data on correlations between Env content and infectivity, viruses with 
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lower Env content were predicted to be less infectious and thus attenuated in 
replication.109,214,251–253 We hypothesized that mutations acquired in vivo that restore 
Env content might also enhance replication of the virus in cell culture. 
 
Despite robust replication in vivo, the decrease in Env on SIVmac239ΔGY 
virions is associated with a small but repeatable decrease in replication fitness in 
PBMC cultures. Compared to SIVmac239, in both rhesus and pig-tailed macaque 
PBMCs, the peak of SIVmac239ΔGY replication as determined by reverse 
transcriptase activity is lower than wildtype SIVmac239. Consistent with previous 
reports that virion Env is correlated with infectivity, SIVmac239∆GY containing the 
YFQI or YFQL in the absence of R722G showed a marked reduction in replication. 
These mutations are associated with low levels of Env on virions produced in cell 
lines, and we were unable to evaluate Env on PBMC-produced virions due to poor 
replication in these cells. Strikingly, addition of the R722G, which raises Env levels 
on virions, restored replication of SIVmac239ΔGY YFQI or YFQL to levels similar 
to SIVmac239ΔGY alone. This finding supports earlier work and our initial 
hypothesis that sufficient Env incorporation into virions is critical for viral replication 
in primary cells and that mutations arising in vivo may compensate for the ΔGY 
mutation by restoring Env content and improving infectivity. 
 
Initially, it was hypothesized that YFQI and YFQL were detrimental to 
replication due to their disruption of the tat and rev genes; the ΔQTH deletion that 
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creates the YFQI and YFQL overlaps with the splice acceptor site of the second 
exons of Rev and Tat. As discussed, we established that an alternative splicing pattern 
is utilized by these viruses to generate largely intact proteins (Fig. 1B). The use of 
this alternative splice acceptor site has been described for SIVmac239 grown in 
CEMx174 cells, indicating a precedent for the virus to use this splice acceptor even 
when the canonical site is available.254 However, the ΔQTH deletion ablates the 
preferred splice acceptor site by removal of two residues, which alters the protein 
sequence downstream of the second exon splice site and could have other effects on 
Rev and Tat function. Tat enhances transcription efficiency of viral genes and is 
known to be critical for efficient viral replication.120 Additionally, the second exon, 
though not required for viral replication in vitro, has been specifically implicated in a 
number of functions. This region has been shown to modulate the HIV-1 stimulated 
innate immune response in dendritic cells and macrophages, delay apoptosis of 
infected T cells, and is important for efficient replication of macrophage-tropic HIV-1 
in vitro.255–257 The Rev deletion occurs in a multimerization (MM) domain that is 
functionally conserved between HIV and SIV.258–262 The MM domain is critical for 
nuclear localization of Rev, and in the absence of successful oligomerization of the 
protein, Rev is distributed throughout the cell, even when a functional nuclear 
localization signal is present.259 Rev is involved in regulation of nuclear export of 
mRNA and controls expression of SIV regulatory and structural proteins, including 
Env.263,264 Further, Rev is specifically involved in regulating env expression by 
enhancing transport of env mRNA out of the nucleus, and by stabilizing the mRNA in 
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the cytoplasm.265–268 Thus, it is reasonable, to hypothesize that defects in replication 
in viruses with mutations in rev and tat, particularly in functional regions, could be 
due in part to loss of function of these proteins. This does not directly explain, 
however, the gain of function observed with the addition of R722G, which does not 
overlap with rev and tat exons. One possibility is that there is a decrease in Rev 
protein function, and therefore a decrease in overall cellular Env levels, that is 
compensated by the addition of R722G. The introduction of R722G, YFQI, and 
YFQL to an SIVmac239 without ΔGY could be used to determine the effect of these 
mutations on an otherwise fully competent virus. Measuring mRNA transcripts or 
protein expression of rev, tat, and env in these various mutants may provide 
additional insight as to the mechanism by which R722G rescues the replication 
defects imposed by YFQI and YFQL. While it is clear than addition of R722G 
increases virion Env content and confers a replication advantage to SIVmac239ΔGY 
YFQI and YFQL viruses in PBMCs, whether there is an additional effect unrelated to 
Env has not yet been explored. 
 
Despite being associated with poor replication in vitro, YFQI and YFQL were 
selected for in two different SIVmac239ΔGY infected rhesus macaques that 
progressed to disease, and in vivo the virus appears to tolerate and even prefer these 
deletions provided they are in the presence of R722G. This finding indicates that they 
are likely to impart a gain of function for SIVmac239ΔGY that is relevant in vivo, 
thus compensating for the loss of the proximal tyrosine motif. The mechanism 
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underlying SIVmac239ΔGY’s altered pathogenesis is not yet fully characterized, but 
results in impaired mucosal infection, as evidenced by preservation of CD4+ T cells in 
gut, and severely reduced or absent infection of macrophages and microglia 
cells.222,223 One possible explanation for this phenotype is that SIVmac239∆GY is 
specifically impaired in its ability to spread cell-to-cell through a virological 
synapse.113 Virological synapses formed by retroviruses have been imaged in vivo, 
and synapse formation by HIV-1 has been demonstrated in vitro.269–271 Formation of 
the synapse is mediated by Env, and there is substantial evidence that Env must be 
targeted to particular locations on the originating cell for efficient cell-to-cell 
spread.89,271–274 Further, recruitment of Env to sites of viral assembly has been shown 
to be dependent on the cytoplasmic tail.275 Inability to properly direct Env to these 
sites could result in lowered budding efficiency or failure to form a synapse at the 
appropriate pole of the cell.88,90,276,277 If SIVmac239∆GY budding occurs more 
diffusely, the virus may rely more heavily on cell-free spread as its primary mode of 
transmission. This process is thought to be less efficient than cell-to-cell spread, and 
renders the virus more exposed to targeting by antibodies.278–280 This reduced 
efficiency is reflected by greater receptor dependence; cell-to-cell spread appears to 
tolerate lower CD4 expression than cell-free.114 As macrophages express a lower 
density of CD4 than CD4+ T cells, SIVmac239∆GY may be unable to infect them due 
to a greater dependence on cell-free spread for transmission.114,124,281 Unlike other 
attenuated SIVs such as SIVmac239∆nef, SIVmac239∆GY achieves an acute peak in 
vivo identical to that of its parent virus, which suggests that it has not lost the ability 
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to replicate well in animals.187,197,222,223 Instead, SIVmac239∆GY appears to be 
exquisitely sensitive to host immune responses that arise sometime after two weeks 
post-infection, an attribute that may be partially explained by impaired cell-to-cell 
spread and the preservation of CD4+ T cells in the GI compartment.282  
 
The novel SIVmac239 variant SIVmac239∆GY provides insight into new 
roles for the proximal tyrosine motif in regulating Env trafficking, including cell 
surface distribution and incorporation into virions. The effects of these alterations on 
viral growth, infectivity, and pathogenesis in vivo imply that this motif is critical to 
aspects of the viral life cycle and that its disruption represents a significant 
impairment to function in the host. In this study, we identified multiple attributes that 
distinguish SIVmac239∆GY from its parent virus, including reduced virion Env 
content, impaired endocytic, trafficking, and basolateral targeting function, and 
attenuated growth in multiple cell types. A key finding is that SIVmac239∆GY 
exhibits defects in mediating a clustered Env phenotype on infected cells, which 
could explain poor Env incorporation into virions and have implications for formation 
of virological synapses that mediate cell-to-cell spread. Together, the differences in 
properties measured by in vitro assays could largely explain the susceptibility of 
SIVmac239∆GY to immune control by the host. This phenomenon appears to be 
related to CD8+ cell mediated immunity and also confers protection from an 
expanded array of pathogenic challenge viruses. The defects in these in vitro 
functions were partially restored by mutations that appear to recapitulate the motif 
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ablated in SIVmac239∆GY and which correlate with progression to AIDS in 
SIVmac239∆GY-infected macaques. Understanding the effect of this signal on in 
vitro properties is important to elucidate the mechanism by which SIVmac239∆GY is 
controlled by host immune responses, and may direct rational design of immunogens 
in future vaccine efforts. Putative compensatory mutations that restore function in in 
vitro assays and which correlate with disease progression in vivo inform us on what 
virologic attributes are important for pathogenesis in a host. In Chapter 3, we will 
address questions regarding the compensatory function of these mutations by 
inoculating naïve macaques with a modified SIVmac239∆GY that also contains 
mutations that restore Env function in vitro. We will use these novel viruses to 
determine whether such mutations are sufficient to restore an SIVmac239 natural 
history to SIVmac239∆GY. In vivo assessment of novel mutant viruses will aid in 
mapping determinants of pathogenicity in the SIVmac239 cytoplasmic tail. 
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A
 Brightfield            whole cell                   cytoplasm  plasma membrane (PM) PM intensity Ch 2
Supplemental Figure 2-1: Imaging flow cytometry channels and masking strategy
(A) Channel definitions for imaging flow cytometry on ImagestreamX. Left grayscale: 
brightfield, channel 1; Green: channel 2, Envelope; Blue: channel 7, DAPI; Grayscale: 
brightfield, channel 9; Red: channel 11, Gag. Images shown are a single !GY-infected 
CEMx174 cell. (B) Masking strategy for imaging flow cytometry. Masks displayed in 
each column are as labeled. Cells were fitted with a plasma membrane mask using the 
brightfield channel (channel 1) as defined: An object mask dilated by 0.33µm was used 
to define the entire cell (“whole cell”). Next, an object mask eroded by 2.97 µm was 
used to define the cytoplasm of the cell (“cytoplasm”). The plasma membrane (PM) 
mask was defined as “whole cell and not cytoplasm” (right panel). Within this mask, the 
median pixel intensity feature of channel 2 was used to measure the median intensity of 
Env signal within the plasma membrane. The area intensity feature was applied to 
measure the total area within the plasma membrane mask that was positive for Env 
signal. Env signal positivity was defined as Env signal above a pixel intensity threshold 
of 67. 
B
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Supplemental Figure 2-2: Imaging flow cytometry gating strategy
Gating strategy for evaluation of Env distribution on infected CEMx174 cells. 
Top panel, rows 1-2: gating strategy for identification of DAPI+Gag+Env+ single, 
focused cells. Bottom panel: Env distribution gating with phenotypic gates identified.
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Supplemental Figure 2-3: Imaging flow cytometry phenotypic gates for 
DAPI+Gag+Env+ cells
A repesentative image of phenotype from within each gate is displayed 
(insets). The corresponding location of the displayed cell on the scatterplot is 
marked by a green cross. Top, punctate phenotype; middle, partial rim 
phenotype; bottom, diffuse phenotype.
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CHAPTER 3 
 
 
 
 
Mutations in the Env Cytoplasmic Tail Partially Restore Pathogenicity of an 
SIVmac239 Variant Lacking a Tyr-Dependent Trafficking Signal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   91	  
Abstract 
SIVmac239 infection of Asian macaques recapitulates key features of HIV-1 
infection of humans, including high peak viral loads, acute depletion of CD4+ T cells 
in GI lamina propria, and gradual decline of CD4+ T cells in peripheral blood. 
SIVmac239∆GY is an SIVmac239 derivative with a deletion of residues 720 and 721 
of the membrane-proximal tyrosine dependent trafficking motif in the envelope (Env) 
cytoplasmic tail domain. This virus has been evaluated in rhesus (RhM) and pig-
tailed (PTM) macaques and despite replicating to a high acute peak comparable to 
SIVmac239, it lacks characteristic pathogenic features of its parent virus. RhM 
infected with SIVmac239∆GY develop AIDS, but do not exhibit depletion of CD4+ T 
cells in gastrointestinal lamina propria, microbial translocation, or macrophage 
infection. PTM infected with SIVmac239∆GY also develop high peak viremia, but a 
majority (19/21) of infected animals rapidly control plasma virus to <102 RNA 
copies/ml, exhibit only a mild and transient decrease in gut CD4+ T cells, and remain 
healthy. Two PTM had high set-points and died with similar phenotypes as 
SIVmac239∆GY-infected RhM. In all progressing animals, additional mutations in 
the cytoplasmic tail of Env were observed, which we hypothesized could be 
compensating for alterations in pathogenesis induced by ∆GY. We selected two of 
these mutations for further study, an R722G identified in all progressors, and a ∆QTH 
(residues 734-736) that produced novel tyrosine motifs, either YFQI or YFQL. To 
determine whether these mutations were sufficient to restore a pathogenic phenotype 
to SIVmac239∆GY, we inoculated naïve PTM with SIVmac239∆GY R722G or 
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SIVmac239∆GY R722G + YFQL and monitored plasma virus, macrophage infection, 
and CD4+ T cells in peripheral blood and GI lamina propria. We also sequenced 
plasma virus at multiple timepoints to evaluate the evolution of any additional 
mutations.  
All animals developed high peak viremia but diverged into two distinct 
phenotypes not determined by their inoculum. Progressors (3/6) had high set-points 
and declining peripheral CD4+ T cells, and two of these animals died with AIDS at 36 
and 37 weeks post-infection. Controllers (3/6) developed very low or intermediate 
set-points and remained healthy. In all animals, but progressors more than controllers, 
there were trends toward more severe and sustained depletion of gut CD4+ T cells 
than historical SIVmac239∆GY controls. At terminal timepoints, single genome 
amplification (SGA) of plasma virus showed that 2 of 2 SIVmac239∆GY R722G-
infected progressors developed additional Env mutations that reconstituted 
endocytosis motifs, while the SIVmac239∆GY R722G + YFQL-infected progressor 
had few additional mutations in the cytoplasmic tail. The functional significance of 
novel mutations in in vitro assays is under investigation. This study highlights the 
critical importance of the membrane-proximal tyrosine motif to SIVmac239 
pathogenesis. Despite the addition of partially compensatory mutations to the 
inoculum, ∆GY renders SIVmac239 unable to fully escape host immune responses. 
Additional knowledge of the mechanistic role of the GYxxΦ motif through in vitro 
studies may allow improved design of compensatory mutants that restore its function 
in animals and provide insight to viral determinants of pathogenicity. Understanding 
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immune responses that control SIVmac239∆GY in PTM could also direct 
immunogen design for future vaccine efforts. 
 
Introduction 
Human immunodeficiency virus (HIV) infection of humans and simian 
immunodeficiency virus (SIV) infection in Asian macaque models have similar viral 
kinetics and induce a number of characteristic pathologic effects.153 While using the 
well-characterized SIV infectious molecular clone (IMC) SIVmac239 in rhesus 
(RhM) and pig-tailed (PTM) macaque models of HIV infection, plasma viremia peaks 
at roughly two weeks post-infection with plasma viral loads typically between 106 
and 108 viral RNA copies/ml.148,159,164,283 With the onset of antiviral immune 
responses, viremia decreases to a set-point viral load between 104 and 106 copies/ml, 
which is maintained for several months with progression to AIDS usually occurring 
within one year post-infection.148,159,160,284 Early events in SIVmac239 infection 
include rapid and profound depletion of CD4+ CCR5+ T cells in gastrointestinal (GI) 
lamina propria, compromise of GI epithelial barrier integrity with translocation of 
microbial products from the gut lumen into systemic circulation, and infection of 
macrophages.139,140,142,148,149,224,225,236,284–287 The presence of microbial products in 
tissue and blood contributes to a state of chronic immune activation in infected hosts, 
with increased proliferation and activation of T cells observed, as well as 
upregulation of pro-inflammatory cytokines such as the interleukins IL-1β, IL-6, IL-
18, and tumor necrosis factor alpha (TNF-α).8,142,145,217,288 As disease progresses, T 
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central memory (TCM) cells can no longer maintain a functional population of CD4+ T 
effector cells, and as it is gradually depleted, the host becomes susceptible to 
opportunistic infections and neoplasms characteristic of immunodeficiency.289 In 
macaques, this simian immunodeficiency syndrome is highly reminiscent of AIDS in 
humans, characterized by a blood CD4+ T cell count of <200 cells/µl, a blood CD4+ T 
cell percentage of <15%, or an AIDS-defining complication such as pneumocystis 
pneumonia.290  
 
Our laboratory has previously described an SIVmac239 mutant with a two 
amino acid deletion in the envelope (Env) cytoplasmic tail domain.221–223 Deletion of 
glycine-720 and tyrosine-721 ablates key residues of the highly conserved membrane-
proximal tyrosine motif (i.e. YxxΦ) and the virus, SIVmac239ΔGY, has been studied 
in both RhM (n=10) and PTM (n=21).221–223 This deletion is stable and has not been 
observed to revert to wildtype sequence in vivo when studied for periods of 1-2 years 
in RhM and >2 years in PTM.221–223 In both species, peak plasma viremia of 
SIVmac239ΔGY is equivalent to that of parental SIVmac239, though in RhM it is 
delayed by ~7 days.222 Moreover, in SIVmac239ΔGY infection, GI lamina propria 
CD4+ T cells are largely spared, with only mild and transient depletion, and are 
reconstituted to pre-infection levels by week 30 post-infection in both RhM and PTM. 
This is in stark contrast to SIVmac239 infection, where severe CD4+ T cell depletion 
occurs early and is never reconstituted even with antiretroviral therapies.291 In 
addition, while infected macrophages are abundantly detectable in SIVmac239-
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infected RhM and PTM, only rare infected macrophages are detectable in 
SIVmac239ΔGY-infected animals in early and chronic infection. While RhM and 
PTM exhibit similar peak viremia, the set-point viral load in PTM is markedly lower; 
mean 45 RNA copies/ml, compared to a mean of 3.9 x 104 for RhM.222,223 
Specifically, 15/19 animals controlled viremia to below the limit of detection (<15 
RNA copies/ml).223 Long term, 90% (19/21) of PTM remained healthy, with low set-
points, while all four RhM followed into the chronic phase did eventually develop 
AIDS, including small declines in peripheral CD4+ T cell counts late in infection and 
AIDS-defining illnesses (Table 1).222,223  
 
In progressing animals (4/4 RhM, 2/21 PTM), additional mutations arose in 
the Env cytoplasmic tail and were maintained in a predominance of viruses isolated 
from animals late in infection.222,223 Importantly, by SGA of plasma virus, the ∆GY 
mutation was stable in all amplicons in the 6 progressing animals throughout 95 
weeks of infection. An additional mutation was found immediately flanking the ∆GY 
mutation (R722G), observed in at least some amplicons in 6/6 animals. In two RhM, 
a remarkable deletion (∆QTH) of amino acids 734-736 created two novel tyrosine 
motifs, either YFQI or YFQL, depending on the reading from of the 9 nucleotide 
deletion. While the R722G was seen with or without ∆QTH, the ∆QTH mutation was 
seen only in the context of the R722G mutation. An S727P point mutation was also 
observed in 1/4 RhM. S727P had been noted in an SIVmac239∆GY-infected RhM 
progressor in a small pilot study of three animals.221 S727P has been characterized in 
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vivo in RhM and is associated with partial restoration of gut targeting and acute 
depletion of GI lamina propria CD4+ T cells.292 However, S727P did not fully 
reconstitute a pathogenic phenotype as seen in SIVmac239 infection, nor did it permit 
robust infection of macrophages.292 
 
In Chapter 2, SIVmac239∆GY mutants (Ch. 2, Fig. 1) were evaluated in a 
variety of in vitro assays to determine if these changes restored to SIVmac239∆GY 
any of the properties that were lost from parental SIVmac239. As we demonstrated, 
∆GY reduced the Env content of virions produced in rhesus macaque PBMCs and 
slightly attenuated growth when compared to SIVmac239. The R722G mutation 
alone restores Env content to that of SIVmac239, with more modest increases seen 
with S727P or R722G + ∆QTH (YFQI or YFQL). Alone, the ∆QTH mutation 
(producing either the YFQI or the YFQL sequence) exhibited a markedly impaired 
replicative capacity that was largely restored when the R722G mutation was added. In 
CEMx174 cells infected with HEK-293T-produced virus, this decrease in virion Env 
content occurs in spite of equal or higher levels of Env present on the surface of 
infected cells. Together with the observation that a higher percentage of SIVmac239-
infected cells have punctate Env surface distribution, while SIVmac239∆GY Env is 
diffusely distributed, this implies a failure of Env to target to sites of 
budding.275,293,294 Defects in Env targeting and incorporation into virions could affect 
formation of the virological synapse, provide a possible explanation for the observed 
in vivo properties, including decreased mucosal transmission, reduced infection of 
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CD4+ T cells in GI mucosa, and impaired infection of 
macrophages.69,110,117,240,251,280,295 
 
In this Chapter, we evaluated the ability of two novel mutations characterized 
in vitro to restore pathogenicity to SIVmac239∆GY. We constructed IMCs containing 
∆GY with R722G alone or with ∆QTH (generating the YFQL mutation) and infected 
naive PTM. The R722G mutation was selected because it appeared in all progressing 
animals regardless of species, and became fixed in 2/2 progressing PTM.222,223 ∆QTH 
(YFQL) was selected on the basis of its documented ability to restore endocytic and 
basolateral sorting functions at levels that were comparable to wildtype SIVmac239 
(Ch. 2, Fig. 6 & 9). The aim of this study was to determine which aspects of the 
SIVmac239 in vivo phenotype are attributable to the endocytosis and basolateral 
sorting functions of the membrane-proximal tyrosine motif that are restored by 
R722G and ∆QTH, and how this conserved region of Env contributes to SIV 
pathogenesis. 
 
Methods 
Ethics statement 
The Tulane University Institutional Animal Care and Use Committees approved all 
experiments using pig-tailed macaques (protocol 3617). The Tulane National Primate 
Research Center (TNPRC) facility is accredited by the Association for Assessment 
and Accreditation of Laboratory Animal Care International and follows 
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recommendations of the Guide for the Care and Use of Laboratory Animals.296 The 
NIH Office of Laboratory Animal Welfare assurance number for TNPRC is A4499-
01. All clinical procedures were performed under the direction of a laboratory animal 
veterinarian. Macaques were anesthetized for phlebotomy using 10 mg/kg ketamine. 
Laboratory animal veterinarians performed all surgeries including jejunal resections 
and lymph node biopsies. Prior to general anesthesia, preanesthetics acepromazine 
and glycopyrolate, were administered. General anesthesia was induced with 10 mg/kg 
ketamine hydrochloride or 8 mg/kg tiletimine-zolazepam. Animals were intubated 
and maintained on an isoflurane oxygen mixture. Analgesia intraoperatively and 
postoperatively was achieved with buprenorphine. All possible measures were taken 
to minimize discomfort of macaques during this study. Animals were monitored daily 
post-surgery for signs of illness and medical intervention was undertaken as needed. 
Euthanasia was performed in accordance with the recommendations of the panel on 
Euthanasia of the American Veterinary Medical Association. Tulane University 
complies with the NIH policies on animal welfare, the Animal Welfare Act, and all 
other applicable federal, state, and local laws.  
 
Animals, viral inoculations, and sample collection 
(Pyone Aye, Andrew Lackner, TNPRC) 
A total of 6 male pig-tailed macaques were used in this study. All macaques were 
housed and maintained at TNPRC. Animals were inoculated intravenously (IV) with 
100 50% tissue culture infective dose (TCID50) of SIVmac239ΔGY R722G (n=3) or 
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100 TCID50 of SIVmac239ΔGY R722G + YFQL. 12 pig-tailed macaques housed at 
TNPRC were used as historical controls and had been inoculated with 100 TCID50 
SIVmac239ΔGY IV (n=8) or 100 TCID50 SIVmac239 IV (n=4) as described in a 
previous study.223 Viruses were produced in 293T cells transfected with plasmids 
containing full-length proviral DNA. Viruses were quantified by determining TCID50 
on rhesus macaque peripheral blood mononuclear cells (PBMCs).  Prior to use, all 
animals tested negative for antibodies to SIV, simian T cell leukemia virus (STLV), 
and type D retrovirus, and were negative by PCR for type D retrovirus. Prior to all 
procedures, macaques were anesthetized by an intramuscular (IM) injection of 10 
mg/kg ketamine hydrochloride. Blood samples and small intestinal biopsies 
(duodenal pinch biopsy via endoscopy and jejunal resectional biopsy samples) were 
collected under anesthesia (ketamine hydrochloride or isoflurane) at various times 
from each animal as described in relevant figures. Two macaques died during the 
course of the study; the remaining 4 animals were euthanized following final sample 
collection. Complete necropsies were performed on all deceased and euthanized 
animals. All animals were maintained at TNPRC in accordance with standards of the 
Association for Assessment and Accreditation of Laboratory Animal Care and the 
Guide for the Care and Use of Laboratory Animals prepared by the National Research 
Council. The TNPRC Institutional Animal Care and Use Committees approved all 
studies.  
 
Quantitation of viral load in plasma 
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(Yuan Li, Mike Piatak, Jeff Lifson, NCI)  
Plasma viral loads at each timepoint were measured using a reverse transcription-
PCR (RT-PCR) assay with a limit of detection of 15 SIV RNA copies/ml.297  
 
Lymphocyte isolation from intestinal tissues  
(Faith Schiro, Pyone Aye, TNPRC)  
Cells were collected from pig-tailed macaques either by endoscopic pinch biopsies of 
the small intestine or by 2-cm surgical resections of jejunum at multiple time points. 
Biopsy and intestinal cell isolation procedures have been previously described.284,298 
Briefly, intestinal cells were isolated by EDTA-collagenase double digestion followed 
by Percoll density gradient centrifugation. 
T cell immunophenotyping and activation/proliferation  
(Workineh Torben, Bapi Pahar, TNPRC)  
T cell immunophenotyping was performed on isolated lamina propria lymphocytes 
(LPLs) and anticoagulated whole blood. Immunophenotyping of LPLs was performed 
using antibodies against CD3 (SP34), CD4 (L200), and CD8 (SK1 or SK2) (BD 
Biosciences, San Jose, CA). Immunophenotyping of whole blood was performed 
using antibodies against CD3 (SP34), CD8 (SK1 or SK2), CD4 (L200), CD95 (DX2), 
and CD28 (28.2) (BD Biosciences; except CD28 [28.2], Beckman Coulter). Cells 
were stained for 30 min at room temperature in the dark. CD4+ and CD8+ 
lymphocytes from lamina propria and peripheral blood were analyzed for activation 
and proliferation by measuring the expression of HLA-DR and Ki67, using Anti-
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HLA-DR (G46-6) and Anti-Ki67 (B56) respectively; both the activation and 
proliferation antibodies were from BD Biosciences. For Ki67 staining, cells were 
permeabilized (BD cytofix/cytoperm solution) for 20 min at 4oC, and then stained 
with Ki67 for 30 min at room temperature in the dark. Lymphocytes were analyzed 
for percent positive or fraction of baseline for HLA-DR and Ki67 expression at 
various time points and compared to historical controls from SIVmac239 or 
SIVmac239ΔGY-infected controller pig-tailed macaques. Samples were analyzed 
using a FACS LSRII or a FACS Aria flow cytometer (BD Biosciences). Flow 
cytometry data were analyzed using FlowJo software (TreeStar, Inc., Ashland, OR). 
Peripheral blood or gut LPLs were analyzed by gating of side-scatter and forward-
scatter, lymphocytes, CD3+ cells, CD4+ cells, and, if used, CD28+ CD95+, CD28+ 
CD95-, and CD28- CD95+ cells. Absolute cell counts from whole blood were 
measured by multiplying complete blood count (CBC) values by the percentages of 
each cell subset population as determined by flow cytometry.  
 
In situ hybridization (ISH) and quantitation of SIV positive cells in tissue 
(Robert Blair, TNPRC) 
Tissue samples were fixed in Z-Fix (Anatech, Battle Creek, MI) and embedded in 
paraffin, and 5-µm-thick sections were cut and adhered to charged glass slides. SIV 
RNA in situ hybridization (ISH) was then performed, as described previously.299 
Quantification of SIV RNA ISH-positive cells was performed on jejunal sections at 
multiple timepoints and compared to SIVmac239 or SIVmac239ΔGY-infected 
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historical time-matched control samples. Images were collected using liquid crystal 
tunable filter multispectral imaging (Nuance multi- spectral imaging system; CRI, 
Inc., Woburn,MA) . All slides were scanned at medium power (10x) to identify if ISH 
positive cells were present.  Slides containing infected cells were then evaluated for 
the number of infected cells/mm2, intensity (I) of the staining, and the presence of a 
reticular staining pattern in lymphoid follicles.  The number of infected cells/mm2 
was determined by counting the number of infected cells in 10 random, contiguous, 
40x fields (total area = 4 mm2), starting in the most densely infected area. Slides were 
also scored based on the intensity of staining of the infected cells with 1+= light, 2+= 
moderate, and  3+ = marked.  
 
Confocal microscopy 
(Robert Blair, Xavier Alvarez-Hernandez, TNPRC)  
Double- and triple-label confocal microscopy was performed for colocalization of 
SIV RNA with cell type-specific markers to identify the immunophenotype of 
infected cells, as previously described.300 Immunofluorescent labeling of T cells 
(rabbit polyclonal anti-CD3 [Dako]) or macrophages (mouse IgG1 monoclonal anti-
CD68 [Dako] or CD163 [Serotec]) was performed after ISH, as previously 
described.300 Following incubation with the primary antibodies (anti-CD3, anti-CD68, 
anti-CD163) and subsequent washes, secondary antibodies were applied (Alexa Fluor 
488- or 647-conjugated goat anti-rabbit or goat anti-mouse IgG1  [Invitrogen, 
Carlsbad, CA]). Confocal microscopy was performed using the sequential mode to 
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independently capture fluorescence from the different fluorochromes (Leica 
Microsystems, Exton, PA). NIH Image v1.62 and Adobe Photoshop v7 software were 
used for color correction: Alexa 488 (green), Alexa 568 (red), Alexa 647 (blue), and 
differential interference contrast (DIC) (gray scale). In selected animals and tissues, 
the numbers of infected cells by phenotype were quantitated as described 
previously.222 
 
Single genome amplification (SGA) 
(Samra Elser, Carolyn Reid, Brandon Keele, NCI) 
SGA and direct sequencing was performed on plasma samples from all six animals at 
week 2, week 10, and at additional timepoints for individual animals. The full env 
gene was sequenced using a limiting-dilution PCR to ensure that only one amplifiable 
molecule was present in each reaction mixture, as described previously.158,222,223 
Sequence alignments were generated with Clustal W and used to create alignments 
shown as highlighter plots Unrooted neighbor-joining trees were constructed in 
Clustal W and excluded gaps and corrected for multiple substitutions. APOBEC 
signature mutations were identified with Hyper-Mut (www.hiv.lanl.gov). 
 
 Statistical analysis 
All statistical analyses were performed with GraphPad Prism v6.0g (GraphPad 
Software, Inc., La Jolla, CA). Pairwise comparisons were conducted using Kruskal-
Wallis tests as samples sizes were insufficient to assess normality. The Holm-Sidak 
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test was used to adjust p-values for multiple comparisons. Where applicable, results 
are expressed as mean ± standard error of mean. 
 
Nucleotide sequence accession numbers. All sequences in this study were deposited 
in GenBank. 
 
Results 
Viral dynamics of SIVmac239ΔGY R722G±YFQL in pig-tailed macaques  
Pig-tailed macaques were inoculated intravenously (IV) with 100TCID50 
SIVmac239ΔGY R722G (n=3) or SIVmac239ΔGY R722G + YFQL (n=3) (Fig. 1). 
Plasma viral loads for individual SIVmac239ΔGY R722G±YFQL-infected animals 
are shown in Figure 2. KV51, KV73, and KV75 were inoculated with 
SIVmac239ΔGY R722G, while KV52, KV74, and KV76 received SIVmac239ΔGY 
R722G + YFQL. All SIVmac239ΔGY R722G±YFQL-infected animals developed 
high peak plasma viral loads (mean 4.83 x 106 ± 1.44 106 RNA copies/ml, Fig. 
3A&B) that were not significantly different from those of SIVmac239 and 
SIVmac239ΔGY-infected historical controls (Fig. 3B). During chronic phase, animals 
diverged into two phenotypic groups. Progressors (two SIVmac239ΔGY R722G and 
one SIVmac239ΔGY R722G + YFQL) developed high set-points (defined as mean 
plasma viral load at ≥week 20 post-infection),  while controllers (one 
SIVmac239ΔGY R722G and one SIVmac239ΔGY R722G + YFQL) developed very 
low to intermediate set-point viral loads. Mean plasma viremia over time, grouped by  
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Table 3-1: Features of SIVmac239 and SIVmac239!GY infection in macaques
Infection phenotypes of SIVmac239 (left column) or SIVmac239!GY (right three columns) 
are shown for progressor rhesus and progressor or controller pig-tailed macaques.
SIVmac239 
RhM & PTM 
SIVmac239!GY  
RhM 
progressors 
(4/4) 
SIVmac239!GY  
PTM controllers 
(19/21) 
SIVmac239!GY  
PTM 
progressors 
(2/21) 
 
Acute peak 
viremia 
 
High 
(106-108 RNA copies/ml) 
High 
(107-108 RNA copies/ml) 
High 
(106-107 RNA copies/ml) 
High 
(106-107 RNA copies/ml) 
Set-point 
viremia 
 
High 
(106-108 RNA copies/ml) 
Intermediate 
(104-105 RNA copies/ml) 
Low  
(<100 RNA copies/ml) 
Intermediate 
(103-105 RNA copies/ml) 
CD4+ T cells 
in GI lamina 
propria 
Rapid and 
sustained depletion 
Mild and transient 
depletion 
Mild and transient 
depletion 
 
Mild and transient 
depletion 
 
CD4+ T cells 
in peripheral 
blood 
Gradual decline Stable, small 
decline late 
Stable near 
baseline level 
Stable, small 
decline late 
Macrophage 
infection 
Present Absent Absent Absent 
CNS disease Present Absent Absent Absent 
AIDS Yes Yes No Yes 
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phenotype (progressor or controller), is shown in Figure 3A. Set-point viral loads for 
progressors (3/6) were significantly higher, while controller set-point viremia was not 
significantly higher than for historical SIVmac239ΔGY-infected controllers (Fig. 
3B).223 Two progressors, KV51 and KV73, both infected with SIVmac239ΔGY 
R722G, died at week 36 and 37 post-infection (Fig. 2). At necropsy, both animals had 
lesions consistent with simian AIDS, with death due to pulmonary or aortic 
thrombi.159,284 
 
Dynamics of CD4+ T cells in peripheral blood during chronic infection  
During infection of macaques with SIVmac239, CD4+ T cells gradually 
decline as a percentage of CD3+ lymphocytes in the peripheral blood (Fig. 4A). In 
contrast to SIVmac239, SIVmac239ΔGY controllers maintain a stable population of 
CD4+ lymphocytes throughout infection. While neither SIVmac239ΔGY 
R722G±YFQL progressors nor controllers exhibited loss of CD4+ T cells in blood 
comparable to SIVmac239, progressors trended toward lower percentages of CD4+ 
cells in blood than controllers or than SIVmac239ΔGY-infected PTM (Fig. 4A). 
CD4+ T cells counts in SIVmac239ΔGY R722G±YFQL controllers were 
indistinguishable from SIVmac239ΔGY, while progressors showed a slight decrease 
at greater than 20 weeks post-infection. Note: 2/3 progressors died between weeks 35 
and 40 post-infection and thus longer term CD4+ T cell dynamics are based on a 
single surviving progressor. Thus, although R722G±YFQL did not produce CD4+ T 
cell depletion similar to that observed in SIVmac239 infection, there is some  
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Figure 3-1: SIVmac239 mutants for infection of naive pig-tailed macaques
Six naive pig-tailed macaques were inoculated intravenously with 100TCID50 of 
one of two infectious molecular clones: SIVmac239!GY + R722G (n=3) or 
SIVmac239!GY + R722G + !QTH (YFQL) (n=3)
!"
gp41 cytoplasmic tail 
       SIVmac239 YIVQMLAKLRQGYRPVFSSPPSYFQQTHIQQDPALPTREGKERDGE…
∆GY YIVQMLAKLRQ--RPVFSSPPSYFQQTHIQQDPALPTREGKERDGE…
R722G YIVQMLAKLRQ--GPVFSSPPSYFQQTHIQQDPALPTREGKERDGE…
YFQL + R722G YIVQMLAKLRQ--GPVFSSPPSYFQ---LQQDPALPTREGKERDGE…
#$%&'()$"
*+()),)-"
"./%(,)"
0!1 """"""""" """""""""""""""""""021 " " """""""""""031 " " "041 " """""""""""""""""""051"
	   108	  
  
0 5 10 15 20 25 30 35 40 45 50 55 60
101
102
103
104
105
106
107
Week
Lo
g 1
0
vR
NA
 c
op
ie
s/
m
L
KV52
0 5 10 15 20 25 30 35 40 45 50 55 60
101
102
103
104
105
106
107
Week
Lo
g 1
0
vR
NA
 c
op
ie
s/
m
L
KV74
0 5 10 15 20 25 30 35 40 45 50 55 60
101
102
103
104
105
106
107
Week
Lo
g 1
0
vR
NA
 c
op
ie
s/
m
L
KV75
0 5 10 15 20 25 30 35 40 45 50 55 60
101
102
103
104
105
106
107
Week
Lo
g 1
0
vR
NA
 c
op
ie
s/
m
L
KV76
SIVmac239!GY R722G SIVmac239!GY R722G + YFQL
0 5 10 15 20 25 30 35 40 45 50 55 60
101
102
103
104
105
106
107
108
Week
Lo
g 1
0
vR
NA
 c
op
ie
s/
m
L
KV51
?
0 5 10 15 20 25 30 35 40 45 50 55 60
101
102
103
104
105
106
107
Week
Lo
g 1
0
vR
NA
 c
op
ie
s/
m
L
?
KV73
Figure 3-2: Plasma viral loads of SIVmac239!GY R722G ±YFQL-
infected pig-tailed macaques
Plasma viral loads of individual PTM infected with SIVmac239!GY R722G  
(left column) or SIVmac239!GY R722G + YFQL (right column). 
SIVmac239!GY R722G-infected animals are KV51, KV73, and KV75. 
SIVmac239!GY R722G + YFQL-infected animals are KV52, KV74, and 
KV76.
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evidence that there is greater loss of peripheral CD4+ T cell than in 
SIVmac239ΔGY infection. 
 
SIVmac239∆GY R722G±YFQL progressors exhibit increased infection and 
depletion of gut CD4+ T cells compared to controllers or SIVmac239∆GY  
SIVmac239 infection is known to cause rapid and sustained depletion of 
CD4+ lymphocytes in the GI tract lamina propria.140,237 In contrast, our prior studies 
have shown that SIVmac239∆GY-infected pig-tailed macaques experience only mild 
decreases in CD4+ lamina propria lymphocytes (LPL) and that these cell numbers 
cover and are maintained at near-pre-infection levels throughout infection, even in 
animals that progress to AIDS.223 Due to the divergent phenotype between 
SIVmac239 and SIVmac239∆GY, we examined CD4+ T cell dynamics in gut LPL to 
determine whether addition of YFQL and/or R722G allowed the virus to infect and 
deplete cells in this compartment. Shown are CD4+ T cells in gastrointestinal lamina 
propria of SIVmac239∆GY R722G±YFQL progressors or controllers as a percentage  
of CD3+ lymphocytes (Fig. 4B) and as fold change from pre-infection baseline 
samples (Fig. 4C), with data from historical ∆SIVmac239GY-infected controllers for 
comparison. As previously described, SIVmac239∆GY-infected PTM exhibited a 
mild reduction (average cell count 53% of baseline) in gut CD4+ cells (Fig. 4B&C). 
The kinetics of this change were delayed compared to SIVmac239, with peak 
depletion occurring at week 4 post-infection, while SIVmac239 depletes CD4+ LPL 
by week 2 post-infection.139,140,223,224 CD4+ LPL in SIVmac239ΔGY-infected animals  
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recovered to pre-infection levels by week 34 post-infection (average percentage of 
baseline LPL CD4+ cells 96% at week 34, Fig. 4C).  
 
Progressor SIVmac239ΔGY R722G±YFQL-infected PTM exhibited a 
reduction to 28% of baseline at week 2 post-infection, while controllers manifested a 
delayed and milder depletion (maximal depletion, 41% of baseline, week 4 post-
infection) (Fig. 4B). By week 34 post-infection, SIVmac239ΔGY R722G±YFQL 
controllers recovered CD4+ gut LPLs to average 108% of pre-infection levels, similar 
to historical SIVmac239ΔGY-infected PTM, which recovered to an average 96% of 
baseline (Fig. 4C). SIVmac239ΔGY R722G±YFQL progressors did not recover 
CD4+ T cells in gut to pre-infection baseline, but remained at average 44% (week 34) 
of pre-infection count (Fig. 4C). Thus there was a trend of more rapid and severe 
reduction in CD4+ gut LPL in SIVmac239ΔGY R722G±YFQL infection over 
SIVmac239ΔGY. 
 
Increased immune activation in SIVmac239∆GY R722G±YFQL progressors  
Due to differences in CD4+ cell dynamics between SIVmac239ΔGY 
controllers and SIVmac239ΔGY R722G±YFQL-infected animals, we hypothesized 
that there might be differences in proliferation of CD4+ or CD8+ T cells. Expression 
of the proliferation marker Ki67 is used as a marker for immune activation.249,301,302 
We measured intracellular Ki67 expression by flow cytometry and examined the 
percentage of Ki67+ CD4+ or CD8+ lymphocytes. SIVmac239ΔGY controllers show  
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Figure 3-4: CD4+ T lymphocytes in peripheral blood and small intestine
(A) Percent CD4+ of CD3+ T lymphocytes in peripheral blood of SIVmac239!GY R722G 
±YFQL progressors and controllers. SIVmac239 and SIVmac239!GY historical data are shown 
for comparison. (B) Percent CD4+ of CD3+ T lymphocytes in small intestine of SIVmac239!GY 
R722G ±YFQL progressors and controllers. SIVmac239 and SIVmac239!GY historical data are 
shown for comparison. (C) Fold change from baseline of CD4+ T lymphocytes in 
SIVmac239!GY R722G ±YFQL progressors and controllers. SIVmac239!GY historical data are 
shown for comparison.
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only a small increase over baseline in percentage of Ki67+ CD4+ cells in blood and 
gut at week 2 post-infection (Fig. 5A), which returns to baseline and remains stable 
over subsequent timepoints. SIVmac239ΔGY R722G±YFQL progressors and 
controllers show substantial increases in Ki67+ CD4+ cells in blood and GI LPL over 
baseline, with a slight delay from SIVmac239ΔGY. For SIVmac239ΔGY 
R722G±YFQL-infected animals, the increase in proliferation occurs at week 4 post-
infection, in comparison to week 2 for SIVmac239ΔGY (Fig. 5A&C). Comparative 
data of Ki67 expression is not available for SIVmac239-infected PTM, but a prior 
study showed that Ki67+ CD4+ cells in blood declined during acute (2 week) infection, 
similar to other CD4+ T cell populations, then rebounded to high levels (30-40% of 
CD4+ cells) after 2 weeks post-infection.148 
 
 
Although SIVmac239ΔGY animals have an increase in Ki67+ CD8+ cells at 
week 2 that is of greater magnitude in GI LPL than blood, this returns to baseline by 
week 10. In contrast, both SIVmac239ΔGY±YFQL-infected progressors and 
controllers continue to show increases in Ki67+ CD8+ cells in both compartments 
through chronic infection, though this is again more evident in blood (Fig. 5B&D). 
There were trends toward a greater magnitude during early infection and persistence 
of immune activation in SIVmac239ΔGY±YFQL-infected progressors than in 
SIVmac239ΔGY±YFQL-infected controllers. Thus, although there was considerable 
variation, progressing animals exhibited a subtle trend towards increased Ki67 
expression over time. 
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Figure 3-5: Percent Ki67+ of CD4+ and CD8+ T lymphocytes in peripheral 
blood and small intestine.
Percentage of Ki67+CD3+CD4+ or Ki67+CD3+CD8+cells in peripheral blood or GI 
lamina propria lymphocytes (GI LPL) from SIVmac239!GY R722G ±!QTH-
infected PTM was determined at pre-infection baseline and for multiple timepoints 
during infection. Mean ± SEM is graphed for each group. SIVmac239!GY 
historical data is shown for comparison. (A) Percent Ki67+ of CD4+CD3+ T 
lymphocytes in peripheral blood. (B) Percent Ki67+ of CD8+CD3+ T lymphocytes 
in peripheral blood. (C) Percent Ki67+ of CD4+CD3+  T lymphocytes in GI LPL. 
(D) Percent Ki67+ of CD8+CD3+ T lymphocytes in GI LPL. 
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Characterization and quantitation of SIVmac239∆GY R722G±YFQL infected 
cells in tissue  via in situ hybridixation 
To assess the ability of SIVmac239ΔGY R722G±YFQL to infect cells in 
various tissue compartments, peripheral lymph node and small intestinal (jejunal) 
biopsies were obtained at multiple timepoints during early and late infection. Jejunal 
biopsies were available from for SIVmac239ΔGY- and SIVmac239ΔGY 
R722G±YFQL-infected animals at week 2 post-infection. In situ hybridization of gut 
biopsies at two weeks post-infection showed a higher frequency of infected cells in 
SIVmac239ΔGY R722G±YFQL (Fig. 6B) compared to SIVmac239ΔGY-infected 
animals (Fig. 6A), although this did not reach statistical significance (Fig. 6C). 
Terminal jejunal biopsies were obtained at varied times post-infection between 
groups due to differences in disease progression between viruses. SIVmac239-
infected animals showed high levels of infected cells at necropsy in jejunum (mean 
10.06 infected cells/mm2) while SIVmac239ΔGY-infected animals had 0 positive 
cells identified (Fig. 6C). SIVmac239ΔGY R722G±YFQL-infected animals had 
small numbers of infected cells in jejunum at necropsy (average 0.33 infected 
cells/mm2) (Fig. 6C). 
 
Lymph node samples from week 2 post-infection were available from all 
groups. At week 2, SIVmac239-infected animals had the highest average infected 
cells per mm2, 7.42 versus 1.45 for SIVmac239ΔGY-infected and 4.17 for 
SIVmac239ΔGY R722G±YFQL-infected (Fig. 7A). Lymph node biopsies were also  
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Figure 3-6: SIV RNA in situ hybridization (ISH) of jejunal biopsy 
Select SIV+ cells are indicated by arrows. Bar = 200 µm (A) SIVmac239!GY-
infected animal jejunal biopsy, week 2 (historical sample processed for comparison, 
animal GG10). (B) SIVmac239!GY R722G ±YFQL-infected jejunal biopsy, week 2 
(shown, SIVmac239!GY R722G-infected animal KV51). (C) Quantification of 
infected cells per mm2 at week 2 and terminal timepoints for SIVmac239!GY R722G 
±YFQL. SIVmac239 (terminal only) and SIVmac239!GY (week 2 and terminal) 
historical samples were processed by the same methods for comparison.
	   117	  
  
SIV
ma
c2
39
!G
Y
!G
Y R
72
2G
 ±Y
FQ
L
0
1
2
3
10
20
30
SI
V 
in
fe
ct
ed
 c
el
ls
/m
m
2
Week 2
Figure 3-7: SIV RNA in situ hybridization of peripheral lymph nodes 
Infected cells by in situ hybridization (SIV RNA positive cells counted per mm2 of tissue) in 
peripheral lymph node (LN) for SIVmac239!GY R722G ±YFQL. SIVmac239 and 
SIVmac239!GY historical samples were processed and quantified by the same methods for 
comparison.(A) Infected cells quantified from peripheral lymph node biopsy at week 2 post-
infection. (B) Infected cells quantified from peripheral lymph node biopsy at necropsy.
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obtained at necropsy for SIVmac239, SIVmac239ΔGY, and SIVmac239ΔGY 
R722G±YFQL-infected animals. SIVmac239 infected animals showed high levels of 
infected cells at necropsy (mean 10.25 infected cells/mm2) while SIVmac239ΔGY-
infected animals had 0 positive cells identified, similar to the results observed in 
jejunal biopsies (Fig. 7B).  SIVmac239ΔGY R722G±YFQL animals had small 
numbers  
Of infected cells in lymph node at necropsy (average 0.25 infected cells/mm2, Fig. 
7B).  
A distinctive feature of SIVmac239∆GY infection is greatly decreased to 
absent macrophage infection, even in areas of tissue where SIV infected CD3+ T cells 
are identified.222,223 Consistent with previous results, confocal microscopy of jejunal 
biopsies from one SIVmac239∆GY-infected macaque at week 2 post-infection and 
necropsy had no identifiable infected macrophages, although numerous CD68+ 
CD163+ macrophages were present (Fig. 8A). In week 2 post-infection and necropsy 
tissue samples from SIVmac239ΔGY R722G±YFQL progressors, low but detectable 
numbers of infected macrophages were observed, although levels were not 
comparable to SIVmac239 (Fig. 8B&C). Two SIVmac239 animals were sampled at 
the terminal timepoint and multiple infected macrophages were observed, as well as 
uninfected macrophages and infected CD3+ T cells (Fig. 8D&E).  
 
 
Envelope cytoplasmic tail undergoes further sequence evolution during long 
term infection with SIVmac239∆GY R722G±YFQL 
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Sequence evolution of env during infection with mutant viruses is of great 
interest, as selection for additional mutations within this gene can provide information 
as to motifs that are important for pathogenesis.190,207,209,248,292,303,304 Particularly, 
mutations that arise in multiple animals and become fixed over the course of infection 
likely indicate that acquisition of these changes was advantageous to the virus.187,305  
 
Viral RNA was isolated from plasma samples at week 2, week 10, and long 
term (>week 22) timepoints from all animals with sufficiently high viral loads (i.e., 5 
of 6 animals). Single genome amplification (SGA) was performed on each sample 
and env genes were sequenced. Of note, engineered mutations in the inoculum (∆GY, 
R722G, YFQL) were maintained in all amplicons throughout infection. At week two 
post-infection, no consensus or fixed mutations were apparent in env when its 
sequence was compared to the inoculum from each animal, indicating that 
SIVmac239ΔGY R722G ± YFQL was able to replicate to high viral peaks (average 
4.83±1.44 x 106 RNA copies/ml) in each animal without the addition of new changes 
(Fig. 9). At week 10 post-infection, mutations began to arise in multiple amplicons, 
including the previously identified V67M in the C-terminus of gp120. In one 
progressing animal (KV73, infected with SIVmac239∆GY R722G), a ∆QTH 
mutation in 1/22 amplicons was identified at week 10 (Fig. 11). The nucleotide 
deletion was such that a YFQI (identical to that seen previously in a 
SIVmac239∆GY-infected RhM progressor) was created. This deletion was different  
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from that engineered into the inoculum for the SIVmac239∆GY R722G +YFQL 
animals, ruling out the possibility that this single sequence was a contaminant. 
 
V67M, previously characterized as one of three gp120 mutations that confer 
macrophage tropism to SIVmac316, was observed in all animals by week 20 or 
later.287 We have also observed this mutation arising in SIVmac239ΔGY-infected 
RhM and PTM progressor animals.222,223 Additionally, multiple animals developed 
the R751G mutation that has been described as a correction for suboptimal nucleotide 
sequence in SIVmac239.190,306 Interestingly, while 4/5 animals developed the R751G 
in a predominance of amplicons, the one surviving progressor began to lose this 
mutation late in infection and it was nearly absent by week 40 post-infection; 
however, a flanking E750G arose instead in this animal. E750G and R751G were not 
mutually exclusive, however; 3/5 animals (2/3 progressors) manifested both changes. 
Multiple other Env mutations observed in a majority of amplicons in at least two 
SIVmac239ΔGY R722G±YFQL-infected animals are shown in Figure 10. 
 
Of the three progressors, two (KV51 and KV73) received SIVmac239∆GY 
R722G, and one (KV74) received SIVmac239∆GY R722G + YFQL). Both 
SIVmac239ΔGY R722G animals died between week 36 and 37 post-infection. 
Interestingly, the ∆QTH mutation was observed in each of these animals. In KV51, it 
first appeared at week 18 in 26/29 amplicons, and evolved to consensus in 26/26 
amplicons at week 34, the last timepoint sampled. The ∆QTH deletion in this animal  
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Figure 3-8: In situ hybridization & confocal microscopy of infected macrophages  
Images are taken with a 40x objective. CD68+ macrophages (green), CD3+ T cells (blue), 
SIV RNA (red), and DNA (white). Select SIV+ cells are indicated by arrows. Bar = 20 
µm. (A) Jejunum from SIVmac239!GY-infected GG10 at week 2 post-infection. (B) 
Jejunum from SIVmac239!GY R722G-infected KV51 at week 2 post-infection. (C) 
Lymph node from SIVmac239!GY R722G + YFQL-infected KV76 at week 2 post-
infection. (D) Lymph node of SIVmac239-infected IK37 at terminal timepoint. (E) 
Jejunum of SIVmac239-infected IK37 at terminal timepoint. 
Insets show higher magnification of CD68+ cells demonstrating intranuclear staining of 
SIV RNA (B-E) or lack thereof (A). 
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initially created a YFQI mutation, but in 7 of 19 amplicons at week 18, a point 
mutation also occurred that altered the amino acid sequence to YFQL. By week 34, 
all 26 amplicons contained the ∆QTH corresponding to a YFQL sequence, suggesting 
that a leucine in the Y+3 position was preferred.  In KV73, as noted above, in 1/22  
amplicons at week 10 (Fig. 11) a ∆QTH was observed that generated the YFQI 
sequence, although this sequence was lost at later timepoints. A cluster of additional 
mutations emerged just downstream from the site of the ΔQTH (Fig. 11). These 
changes were T735I, Q739R, and P744L, and after the initial appearance of the 
P744L mutation in 21 of 22 amplicons at week 18, all three mutations became nearly 
fixed, occurring in 20/21 amplicons at the terminal sample (week 34). The P744L is 
especially interesting, as it is adjacent to the leucine residue at position 743 and could 
represent formation of a dileucine motif, possibly forming a new endocytosis 
signal.64,95,244,245 It is also notable that T735I, Q739R, and P744L, like the ∆QTH, 
overlap with exon 2 of rev and tat (Fig. 12).95,244,307 The rev reading frame is 
maintained, though a point mutation is introduced at residue 31 (G31S) (Fig. 12A). 
Remarkably, the Tat protein is predicted to have multiple point mutations arising 
from these 3 changes, including a truncation due to residue Q96 changing to a stop 
codon as a result of the P744L mutation in Env (Fig. 12B). The ability of this novel 
dileucine to mediate endocytic and basolateral sorting function, as was shown for 
YxxΦ motifs created by ∆QTH, is currently under investigation using in vitro assays 
as described in Chapter 2. Collectively, the SGA findings highlight that, despite the 
presence of R722G and ∆QTH, there remains pressure for the virus to evolve  
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Figure 3-9: Highlighter plots of env sequences from SIVmac239!GY R722G ± YFQL- 
infected PTM at acute peak viremia
Single genome amplification was performed at week 2 post-infection and highlighter plots of 
Env sequences were generated for each animal. SIVmac239 is included as the reference 
sequence in all plots. Engineered Env deletions (!GY, "QTH, denoted by gray bars in all 
sequences) and the point mutation R722G (denoted by yellow bar in all sequencs) Mutations 
that evolved in vivo in each animal are indicated by green, blue, yellow, or purple bars and are 
distributed randomly throughout sequences.
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Figure 3-10: Predominant Env mutations identified in !GY R722G ± "QTH 
infected pig-tailed macaques.
Mutations shown appeared in at least two SIVmac239!GY R722G ± "QTH 
infected pig-tailed macaques and were present in a majority of amplicons at the 
final timepoint sampled.
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Figure 3-11: gp41 cytoplasmic tail mutations in SIVmac239!GY R722G- infected 
progressors at terminal timepoint
(A) Viral load graphs for SIVmac239!GY R722G- infected progressors. Death is indicated by a 
red cross. Green arrows indicate timepoints when single genome amplification (SGA) was 
performed on plasma samples. (B) gp41 cytoplasmic tail mutations observed in SIVmac239!GY 
R722G- infected progressors at various timepoints. The number of amplicons sequenced at each 
timepoint and the number containing the indicated mutation are listed. (C) Location within the 
gp41 cytoplasmic tail of mutations in each animal that appear to reconstitute known or predicted 
endocytosis motifs.
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!"
 SIVmac239 …ANTSSASNKPISNRTRHCQPEKAKKETVEKAVATAPGLGR*
∆GY …ANTSSASNKPISNRTRHCQPEKAKKETVEKAVATAPGLGR*
 ∆QTH (YFQI) …ANTSSASNK--SNRTRHCQPEKAKKETVEKAVATAPGLGR*
∆QTH (YFQL) …ANTSSASNN--SNRTRHCQPEKAKKETVEKAVATAPGLGR*
KV51 (R722G) …ANTSSASNK--SNRTRHCQPEKAKEETVEKAVATAPGLGR*
KV73 (R722G) …AHTSSASNKSISNGTQHC*PEKAKKETVEKAVATAPGLGR*
KV74 (R722G YFQL) …ANTSSASNK--SNRTRHCQPEKAKEETVEKAVATAPGLGR*
!"#$%&% !"#$%'%
()#*)!++#)+%
Tat 
""#$ """"""""""" """"""""""""""""""""%$ " " """"""""""!$$ " """""""""""""""""""""""""""!!$"
A
B
Figure 3-12: Rev and Tat sequences from SIVmac239!GY + R722G ±YFQL progressors
SIVmac239, SIVmac239!GY, and SIVmac239!GY + !QTH (YFQI or YFQL) Rev and Tat are 
shown for comparison. Mutations in the inoculum for each animal (in addition to !GY) are shown 
beside animal IDs.
!"
   SIVmac239 …RKRLRLIHLLHQTNPYPTGPGTANQRRQRKRRWRRRWQQL…
∆GY …RKRLRLIHLLHQTNPYPTGPGTANQRRQRKRRWRRRWQQL…
 ∆QTH (YFQI) …RKRLRLIHLLHQTN--PTGPGTANQRRQRKRRWRRRWQQL…
∆QTH (YFQL) …RKRLRLIHLLHQTT--PTGPGTANQRRQRKRRWRRRWQQL…
KV51 (R722G) …RKRLRLIHLLHQTT--PTGPGTANQRRQRRRRWRRRWQQL…
KV73 (R722G) …RKRLRLIHLLHQTNPYPTGPSTANQRRQRRRRWRRRWQQL…
KV74 (R722G YFQL) …RRRLRLIHLLHQTT--PTGPGTANQRRQRRRRWRRRWQQL…
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()#*)!++#)+%
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additional mutations in gp41 that may compensate additionally for the ∆GY mutation 
and contribute to pathogenicity. 
 
Discussion 
 This study evaluated, using a pig-tailed macaque model, the effects of selected 
mutations acquired in vivo during long term SIVmac239ΔGY infection. R722G and 
ΔQTH (residues 734-736 of Env) were engineered into an SIVmac239ΔGY IMC 
with the goal of determining whether the addition of these mutations would be 
sufficient to produce SIVmac239-like pathology in naïve PTM. The evolution of the 
R722G mutation became fixed in both SIVmac239ΔGY-infected animals pig-tailed 
macaques that exhibited a progressor phenotype.222,223 It was also identified in at least 
some amplicons in all four rhesus macaques inoculated with SIVmac239ΔGY. The 
ΔQTH mutation, which, as we demonstrated in Chapter 2, recreates an endocytosis 
signal, had appeared in two of four RhM progressors, and only in amplicons in which 
the R722G mutation was already present.222 This remarkable deletion of nine 
nucleotides spans three reading frames (env, rev, and tat) and results in an Env 
sequence, YFQL, that conforms to a YxxΦ trafficking motif (Chapter 2). 
SIVmac239ΔGY R722G and SIVmac239ΔGY R722G + YFQL were chosen for 
testing in vivo because the former was associated with disease progression in 2/2 
PTM, and the latter contained both components of the trafficking signal (glycine and 
YxxΦ, although not adjacent as in SIVmac239) ablated by the ΔGY mutation.62,64,66,72  
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As with SIVmac239 and SIVmac239ΔGY, the engineered viruses replicated 
to high acute peaks at 14 days post-infection in all six animals. In contrast to 
SIVmac239ΔGY, 3 of 6 animals (KV51, KV73, and KV74) were identified as 
progressors, with high set-point viral loads, and two additional animals (KV52 and 
KV76) developed low to intermediate set-points. Only one animal (KV75), inoculated 
with SIVmac239∆GY R722G, controlled viremia to <15 RNA copies/ml as is seen in 
typical SIVmac239ΔGY infection of PTM.223 Two progressors (KV51 and KV73, 
both infected with SIVmac239ΔGY R722G) died at week 36 and 37 post-infection, 
respectively, and arteriopathies (pulmonary and aortic thrombi) were identified at 
necropsy, consistent with previous necropsy findings in the two SIVmac239ΔGY-
infected PTM  that progressed to AIDS.223 The third progressor was infected with 
SIVmac239ΔGY R722G + YFQL. Two animals with intermediate set points (KV52 
and KV76), designated as controllers in our analysis, were infected with 
SIVmac239ΔGY R722G + YFQL, while KV75, which controlled viremia to below 
the limit of detection, was infected with SIVmac239ΔGY R722G. Findings for CD4+ 
T cell dynamics in gut, discussed further below, showed a greater decrease in 
progressors, although not to levels typically seen in SIVmac239 infection. Thus, 
although our sample size was small, it appears that the introduction of putative 
compensatory changes into the SIVmac239∆GY background did not fully 
reconstitute the pathogenic phenotype of SIVmac239.  However, 3 of 6 animals 
developed high viremia and two died with AIDS-related complications, indicating 
some increase in pathogenicity over SIVmac239∆GY. We did not observe a clear 
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gain of function in vivo for SIVmac239ΔGY R722G + YFQL over SIVmac239ΔGY 
R722G alone. However, further sequence evolution in the two SIVmac239ΔGY 
R722G progressing animals (one developing the previously described ∆QTH 
mutation, the other developing point mutations T735I, Q739R, and P744L), may 
represent additional compensation for the ΔGY mutation and are discussed further 
below. 
 
Historical SIVmac239ΔGY RhM and PTM progressors have exhibited a 
unique disease course that induces immune pathology but lacks many of the features 
of SIVmac239. Hallmarks of SIVmac239 pathology include high peak and set-point 
viremia, infection of macrophages at the 14-21 day timepoints, massive infection and 
irreversible depletion of CD4+ T cells in gut lamina propria, gradual decline of 
peripheral blood CD4+ cells, and systemic immune activation.142,148,159,170,225,284,309,310 
SIVmac239ΔGY-infected progressors maintain intermediate or high set-point 
viremia.222 In contrast to SIVmac239, SIVmac239ΔGY-infected progressors and 
controllers have very rare to no infected macrophages identifiable by confocal 
microscopy, both at peak and late in infection. This is not thought to be due to less 
robust infection in general, as uninfected macrophages were frequently observed in 
areas of tissue with an abundance of SIV RNA+ CD3+ T cells.223,292 Relatively high 
plasma viremia in SIVmac239ΔGY progressors is evidence of ongoing infection and 
replication, so lack of macrophage infection is unlikely to represent low levels of 
productively infected cells overall.223 Finally, SIVmac239ΔGY disease is 
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distinguished from SIVmac239 by preservation of CD4+ gastrointestinal lamina 
propria lymphocytes (GI LPL). This population of cells is a site of massive viral 
infection acutely, and is typically depleted by 2 weeks post-infection with 
SIVmac239.140,224 Subsequent to this timepoint, CD4+ GI LPL are rarely identified in 
SIVmac239 infected animals, and SIV+ cells of this immunophenotype are even more 
rare due to their relative depletion in the lamina propria compartment.140 In contrast, 
while infection of CD4+ GI LPL is observed in SIVmac239ΔGY progressors, only a 
small decrease is seen during early infection, and by week 34 post-infection, a return 
to baseline percentage is observed in a majority of animals.223 Translocation of 
bacterial products (LPS) from the gut lumen and soluble CD14 (sCD14) are similarly 
unchanged in SIVmac239ΔGY controllers and progressors, while they are increased 
in SIVmac239 infection.142,148,222,223 As microbial translocation is thought to be a 
major contributor to immune stimulation and chronic immune activation that is 
implicated in development of AIDS, SIVmac239ΔGY progressors are an important 
cohort for evaluation of other factors that result in chronic immune pathology and 
underlie disease progression.8,142,145,148,311,312 
 
Despite a majority of SIVmac239ΔGY R722G±YFQL-infected animals  
failing to control viremia below the limit of detection, characteristic pathologic 
features of SIVmac239 infection were not evident in these animals. Instead, the two 
progressors that died (both infected with SIVmac239ΔGY R722G) exhibited a 
disease course that is typical of historical SIVmac239ΔGY-infected progressors; 
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immune activation, thrombocytopenia, and arteriopathies, in the absence of 
characteristics of simian AIDS such as macrophage infection, gut CD4+ T cell 
depletion, and central nervous system (CNS) disease.140,159,223,224,236,237,313–316 Neither 
of the SIVmac239ΔGY R722G-infected animals that died (nor the third progressor, 
which was alive at termination of the study) had significantly increased levels of 
macrophage infection; quantitative data on CNS infection is not yet available. While 
depletion of gut CD4+ LPL was more severe and prolonged than in SIVmac239ΔGY-
infected animals, it did not approach the potency of SIVmac239 at infecting these 
cells.139,140,222–224 Further, only intermediate levels of infected cells were counted in 
lymph node tissue samples at week 2 and at terminal timepoints compared to 
SIVmac239 (high) and SIVmac239ΔGY (0-rare), consistent with the intermediate 
set-point viremia in these animals.  
 
Based on these findings, it is likely that while addition of R722G and YFQL 
confers some advantage to SIVmac239ΔGY, these mutations alone are not sufficient 
to fully compensate for ablation of the membrane-proximal tyrosine motif and to 
reconstitute the pathogenicity of parental SIVmac239. This conclusion is underscored 
by single genome amplification (SGA) sequencing performed on viremic animals late 
(>30 weeks) post-infection. Two controllers and one progressor infected with 
SIVmac239ΔGY R722G + YFQL developed few mutations in a majority of 
amplicons, including V67M (seen in SIVmac239ΔGY progressors and associated 
with macrophage tropism in SIVmac316) and R751G, an optimization mutation well 
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characterized in SIVmac239.190,287,306,317 In contrast, SIVmac239ΔGY R722G-
infected progressors showed additional attempts to form endocytosis motifs, with one 
animal developing the previously characterized ΔQTH (creating a YFQL sequence) 
and the other sampling ΔQTH early in infection but having a predominance of three 
mutations at death: T735I, Q739R, and P744L. The development of a leucine at 
position 744 is especially interesting, as residue 743 in SIVmac239 is also a leucine.63 
Dileucine motifs in general are known to mediate endocytosis of transmembrane 
proteins in eukaryotic cells.62,72,85,228,233,238,318,319 The C-terminal dileucine motif of 
HIV-1 (conserved in SIVmac239) is an AP-2 dependent endocytosis signal that has 
functional redundancy with the membrane-proximal tyrosine motif.64 In HIV-1, the 
terminal dileucine is also a mediator of association with AP-1, which is thought to be 
an important adapter protein for basolateral sorting function.245 The evolution of this 
dileucine may indicate selection for endocytic and/or basolateral sorting function by 
development of a novel sequence. 
 
The presence of these additional mutations in the cytoplasmic tail provides 
evidence that R722G alone is not sufficient to restore all functions of the membrane-
proximal tyrosine motif to SIVmac239ΔGY. However, there is evidence that a 
endocytosis and basolateral sorting motif in the membrane-proximal region is 
associated with development of disease, as both SIVmac239ΔGY R722G-infected 
animals that died with high viral loads developed the ΔQTH that creates a confirmed 
functional endocytosis motif. While ΔQTH occurred only transiently and in a single 
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sequence for KV73, the P744L mutation in this animal may represent an alternative 
method to recreate these functions. Although the presence of ΔQTH seems slightly 
deleterious or at least not beneficial early in disease, there appears to be pressure for 
the virus to reconstitute endocytosis motifs during chronic infection, as this occurred 
independently in two different animals. The ΔQTH (KV51) is a confirmed 
endocytosis signal, and P744L (KV73) conforms to the described dileucine 
endocytosis motif,  though we have not yet determined whether this sequence is 
capable of mediating endocytosis and/or basolateral sorting functions.62,64,72,319 
 
Despite this selection, it appears that SIVmac239ΔGY R722G + YFQL is less 
effective than the wildtype GYRPV sequence at performing the functions of the 
GYxxΦ motif, as none of the animals inoculated with SIVmac239ΔGY R722G + 
YFQL developed fatal disease. This could be due to decreased efficiency in directing 
Env targeting compared to wildtype Env, or to an as yet unknown function of this 
motif in the host. Additional functions of the membrane-proximal tyrosine motif are 
suggested by the finding in Chapter 2 that R722G with or without YFQL did not 
reconstitute wildtype distribution of Env on the surface of CEMx174 cells, despite 
restoring endocytosis and basolateral sorting. Mechanistic studies of Env constructs 
containing ΔGY and the P744L are underway to establish whether this motif is also a 
functional endocytosis and basolateral sorting signal as was determined for YFQL. If 
so, there will be significant evidence that these functions are important for 
development of disease in animals. However, the mechanism by which the 
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membrane-proximal tyrosine motif contributes to macrophage infection and targeting 
of mucosal CD4+ T cells in the host has not been fully elucidated, as this is not 
restored even by addition of mutations that confer the functions of virion Env 
incorporation, endocytosis, and basolateral sorting.  
 
A highly unusual finding is that the P744L also results in introduction of a 
stop codon that truncates the Tat protein at residue 96, as the Tat second exon has 
been demonstrated to be important for chronic replication of SIV in animals. When 
macaques were infected with an SIVmac239 variant  with a stop codon at the end of 
the tat first exon, multiple animals reverted to an open reading frame to restore the 
second exon.307 We are currently investigating the splicing pattern used by this 
mutant to determine if a truncated protein was truly predominant in vivo. Interestingly, 
all three progressors also had mutations in known CD8+ T cell epitopes in Tat, likely 
indicating pressure on the virus to evolve to escape these responses.308 This 
observation provides further evidence that cell-mediated immunity, via CD8+ and 
possibly CD4+ CTLs, is important in control of SIVmac239∆GY and may be a 
critical mechanism of protection from pathogenic challenge. 
 
Microbial translocation due to loss of gastrointestinal epithelial barrier 
function has been established as a major contributor to the chronic immune activation 
that underlies AIDS progression.142,143,320 At least one study found that depletion of 
CD4+ T cells in GALT was necessary, but not sufficient, to induce AIDS in rhesus 
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macaques.321 This is in contrast to our findings in initial studies of SIVmac239ΔGY, 
in which animals with partial or complete restoration of CD4+ T cells in GALT after 
the acute phase nevertheless developed disease.222,292 These findings imply that 
chronic immune activation in SIV infection is a result of other factors besides 
sustained gastrointestinal epithelial dysfunction. Transcriptomic studies of pathogenic 
and nonpathogenic hosts of SIV have identified strong type I interferon responses in 
multiple tissues of both groups, but a failure to downregulate these responses post-
acutely in pathogenic hosts.220,322 It is possible that the mild decrease in GALT CD4+ 
T cells in SIVmac239ΔGY-infected controllers does not induce sufficient 
proliferation and inflammatory responses to result in chronic immune activation. 
Further, the trend of greater depletion and increased proliferation in SIVmac239ΔGY 
R722G±YFQL progressors may contribute to an inflammatory environment in GALT 
and to systemic immune activation. 
 
In SIVmac239ΔGY infection, GALT CD4+ T cells are ultimately 
reconstituted, and the preservation of these cells permits the development of cytokine 
responses that would be absent in SIVmac239 infection and may also help mediate 
control of acute inflammation.223 T regulatory cells (Treg) are CD4+CCR5+ T cells that 
modulate the immune response by reducing activation of other T cells.135,323 It has 
been proposed that loss of Tregs could contribute to chronic immune activation by 
elimination of signals that normally downregulate inflammation.324 Preservation of 
these and other CD4+ T cells in SIVmac239ΔGY infection could help modulate 
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inflammatory responses in the gut, minimizing gut damage and aiding in prevention 
of disease progression. Increased severity of depletion in SIVmac239ΔGY 
R722G±YFQL infection may be sufficient to dysregulate inflammation and 
contribute to development of disease. Markers of microbial translocation (LPS, 
sCD14) were not evaluated in this study, but should be considered for future studies 
to determine if gut damage occurs with SIVmac239ΔGY R722G±YFQL. Although 
increased microbial translocation is not necessary for disease progression in the 
SIVmac239ΔGY model, its presence would indicate a gain of function for 
SIVmac239ΔGY R722G±YFQL over SIVmac239ΔGY. An alternative explanation is 
that SIVmac239ΔGY infection preserves CD4+ cells that contribute actively to 
control of viral replication, whether through providing help to CD8+ T cells or by 
acting as cytotoxic T lymphocytes (CTLs) themselves.134,325–327 There is evidence for 
HIV-specific CD4+ CTLs, and the preservation of this population in SIVmac239ΔGY 
might be important for contributing to control of viremia.282 
 
An open question is why ΔQTH or another putative endocytosis signal was 
selected for during chronic infection, when its presence in the inoculum did not 
provide a clear gain of function. Our in vitro results showing decreased replication in 
PBMCs and lower Env on virions, both improved by addition of R722G, indicate an 
inherent fitness defect resulting from the ΔQTH that is independent of the effect of 
the host immune system. ΔQTH overlaps with the rev and tat reading frames, it could 
be speculated that decreased fitness in cell culture is related to mutations in these 
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proteins. Rev is important for env transcription, and mutations in this protein could 
lower cellular Env levels.259,264 As R722G increases Env on virions by an 
undetermined mechanism, it may be that R722G can compensate for a Rev defect by 
raising cellular Env. This hypothesis is currently under investigation. Potentially, the 
presence of YFQL may be irrelevant acutely, becoming advantageous only later in 
infection, when the ability to evade adaptive immune responses is a greater 
determinant of propagation than replication fitness alone.  
 
A possible mechanism for this phenomenon is the relative contribution to 
spreading infection of cell-free versus cell-to-cell spread. Early in infection, large 
amounts of virus are present in plasma, and combined with an abundance of target 
cells, cell-free spread is likely sufficient to achieve high peak viremia.280 This is 
especially true as cells that mediate innate immunity, such as plasmacytoid dendritic 
cells,  predominantly exist in lymphoid tissue compartments rather than peripheral 
circulation.328 Env incorporation into virions mediated by the membrane-proximal 
tyrosine motif may be the dominant predictor of acute viral replication, and thus 
SIVmac239ΔGY R722G and SIVmac239ΔGY R722G + YFQL can perform equally 
well. Following induction of adaptive immune responses, including development of 
antibodies against circulating virus, cell-to-cell spread that allows for clandestine 
propagation of virus without exposure to antibody may become more 
significant.278,284 Cell-to-cell spread of virus occurs by formation of a virological 
synapse, a link between the infected donor cell and a naïve target cell.112,116,279 In 
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HIV-1, interaction between Env on the infected cell and CD4 on the surface of the 
recipient cell is the primary mediator of synapse formation.110,271,329 As such, defects 
in Env trafficking could substantially affect the efficiency of cell-to-cell spread and 
render the virus more dependent on cell-free modes of transmission.89,115,271,273 In 
addition to exposing the virus to selection pressure that could require compromise of 
fitness to evade immune responses raised by the host, cell-free spread has other 
disadvantages. Cells producing low levels of viral gene products may be able to 
compensate for this by concentrating viral transfer to a single area of the 
membrane.110 The membrane-proximal tyrosine motif may be important in trafficking 
Env to virological synapses and R722G may not confer targeting functions to 
SIVmac239ΔGY despite restoring Env content on virions. Therefore, if YFQL 
confers endocytic and targeting functions to SIVmac239ΔGY independent of virion 
Env, viral sequences with this or other sequences with similar functions may be 
selected for only later in the context of ΔGY and R722G. This model would explain 
the similar acute peak of the SIVmac239ΔGY R722G + YFQL compared to 
SIVmac239ΔGY R722G, and the later selection for ΔQTH and P744L in 
SIVmac239ΔGY R722G-infected progressors. 
 
Evaluation of SIVmac239ΔGY R722G in larger numbers of animals may 
provide greater insight into selection of sequence motifs in gp41 during chronic 
infection. The progressor versus controller phenotype could be more fully evaluated if 
PTMs were MHC typed prior to infection and alleles associated with long term 
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nonprogressor status excluded.171,173,330,331 However, continued controversy over the 
role of MHC in control of SIV in PTM may make selection of susceptible individuals 
more difficult. Inocula that include additional putative compensatory mutations, such 
as V67M, E750G, and/or R751G could also be considered for testing to determine 
whether the presence of these mutations during acute infection assists in restoring 
macrophage infection and CD4+ GI LPL depletion. As V67M is one of the mapped 
determinants of in vitro macrophage infection in SIVmac316, perhaps it is also 
critical to SIVmac239ΔGY, although it is dispensable for macrophage infection by 
SIVmac239 in vivo.225,287 This study further emphasizes the critical function of the 
membrane-proximal tyrosine motif in SIVmac239 pathogenesis and indicates that 
addition to SIVmac239ΔGY of combinations of mutations that independently mediate 
the functions of this motif in in vitro assays are nevertheless not sufficient to 
reestablish a wildtype natural history in pig-tailed macaques.  
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Overview 
The HIV envelope (Env) protein is a vital contributor to the viral life cycle as 
the mediator of entry into permissive cells and as a shield for conserved epitopes 
against the host immune system. Lentiviruses consistently have envelope 
transmembrane (gp41) domains with particularly long cytoplasmic tails that extend 
into the virion core.293 Within gp41, all primate lentiviruses have a conserved GYxxΦ 
sequence.63 Strict conservation in a typically sequence-diverse protein implies 
functional importance of this domain, and indeed the Env cytoplasmic tail has been 
implicated in myriad aspects of HIV and SIV virology, including incorporation of 
envelope into virions (thus affecting infectivity), recycling of Env from the surface of 
infected cells, and polarized budding of HIV from lymphocytes.63,66,70,71,89,90,108,245 
Despite extensive investigation, the mechanisms by which this domain confers such 
functions have yet to be fully characterized. We have previously performed in vivo 
studies of the SIVmac239 mutant SIVmac239ΔGY, which has two critical amino 
acids deleted from the membrane-proximal tyrosine motif. In both rhesus and pig-
tailed macaques, SIVmac239ΔGY replicates to a high acute peak, but is defective in 
its ability to infect macrophages and to efficiently infect and deplete CD4+ T cells in 
the gut lamina propria.222,223 In rhesus macaques, animals progress to AIDS while 
maintaining CD4+ T cells in gut, and this progression is correlated with additional 
mutations in the Env cytoplasmic tail. In pig-tailed macaques, SIVmac239ΔGY is 
controlled by host immune responses to <100 copies per ml in 90% of animals, 
though two animals progressed to AIDS with similar pathologic findings as rhesus 
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macaques.223 SIVmac239ΔGY-infected pig-tailed macaques develop robust 
polyfunctional T cell responses from the preserved gut CD4+ cells, are protected from 
homologous challenge, and can control heterologous SIV and SHIV challenges (A. 
Lackner & J. Hoxie, unpublished data).  
 
In Chapter 2, we evaluated differences between SIVmac239ΔGY and its 
parent virus, the pathogenic infectious molecular clone (IMC) SIVmac239, in a 
number of in vitro assays to determine the effect of ablating this motif on viral fitness 
and Env protein function. SIVmac239ΔGY was found to have decreased Env on 
virions, defects in endocytosis and basolateral targeting, and altered distribution of 
intracellular and surface Env. Small defects in replication in macaque PBMCs were 
also observed. Mutations that arose in vivo in progressing animals restored function to 
SIVmac239ΔGY to variable degrees, with some improving replication or virion Env 
content and others reconstituting functional trafficking signals for endocytosis and 
basolateral sorting, which, like the wildtype tyrosine motif, were dependent on the 
adaptor protein complex AP-2 for endocytic function.65,66,71,245 
 
In Chapter 3, we sought to determine if mutations that arose in 
SIVmac239∆GY-infected animals that progressed to disease could reconstitute the 
pathogenic phenotype of SIVmac239. We inoculated naïve pig-tailed macaques with 
two novel IMCs containing ΔGY and one or more putative compensatory mutations 
in an SIVmac239 background. One group of three animals received SIVmac239ΔGY 
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with R722G, a point mutation that restores Env on virions but does not form a 
trafficking motif; the second group of three received SIVmac239ΔGY R722G + 
ΔQTH (YFQL), resulting in the addition of a novel YxxΦ domain to the proximal 
cytoplasmic tail. In Chapter 2, we showed that YFQL could mediate both endocytosis 
and basolateral sorting function. Like SIVmac239 and SIVmac239ΔGY, novel 
viruses achieved high acute peak viremia. In general, animals infected with 
SIVmac239ΔGY R722G±YFQL exhibited increased acute depletion and reduced 
recovery of gut CD4+ cells compared to SIVmac239ΔGY. Animals then diverged into 
two phenotypes. Progressors were characterized by high set-point viremia, more 
severe and sustained depletion of gut CD4+ T cells, trends toward increased immune 
activation in blood and gut, and development of AIDS in 2/3 animals. Controllers had 
undetectable to intermediate set-points, maintained CD4+ cells in blood and recovered 
gut CD4+ cells to baseline levels, and did not develop AIDS. Unlike SIVmac239ΔGY 
PTM controllers, progressors maintained high viremia for the duration of the study, 
and two of three died within 35 weeks with arteriopathies and lymphadenopathy that 
are typical AIDS-related complications in this species.153,170,220,310 Although no 
controllers developed disease, and one controlled viremia to below the limit of 
detection similar to SIVmac239ΔGY-infected PTM, the two remaining animals 
(KV52 and KV76, infected with SIVmac239ΔGY R722G + YFQL) had intermediate 
levels of viremia that were greater than typically seen with SIVmac239ΔGY. Rare 
infected macrophages could be identified but were markedly reduced compared to 
macrophage infection typically seen in SIVmac239 infection.  
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Two of three progressors were infected with SIVmac239ΔGY R722G and 
developed additional mutations in the Env cytoplasmic tail that recapitulated 
observations in previous studies, i.e. further attempts to reconstitute trafficking motifs. 
However, as none of the animals infected with SIVmac239ΔGY R722G + YFQL 
developed AIDS, and two were controllers, it appeared that addition of the 
endocytosis motif was not advantageous to the virus early in infection. A possible 
explanation for this finding is that the components of the GYxxΦ domain function 
somewhat independently. While Env incorporation into virions, perhaps mediated by 
the glycine, may be important for the virus at all stages of infection, trafficking 
functions of the YxxΦ sequence may be more relevant in the presence of the adaptive 
immune response. 
 
Mapping of Functions of the gp41 Membrane-Proximal Tyrosine Motif 
As discussed, despite differing from the parent virus SIVmac239 by only a 
two amino acid deletion in the cytoplasmic tail of gp41, SIVmac239ΔGY is 
distinguished by a number of in vitro traits that are restored to varying degrees by the 
addition of gp41 mutations identified in SIVmac239ΔGY-infected progressor animals 
from previous studies. A notable effect of ΔGY is the decrease in virion Env content 
compared to wildtype. This observation has been consistent across multiple cell types 
and is improved by addition of the point mutations S727P or R722G, but not by the 
ΔQTH that creates novel YxxΦ sequences. In contrast, intracellular localization to 
perinuclear regions and endocytic and basolateral sorting function are restored to 
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near-wildtype levels by addition of ΔQTH, but not by S727P or R722G. These 
findings suggest that although there may be overlap, virion Env incorporation and 
intracellular trafficking are primarily controlled by separate residues within the 
GYxxΦ motif. In previous studies, both the glycine and the tyrosine have been shown 
to contribute to endocytosis for SIV Env,66 though in the present study addition of a 
YxxΦ domain in the form of YFQL without a preceding glycine allowed endocytosis 
rates comparable to SIVmac239. Additionally, while earlier work has examined the 
effect of deletions in the Env cytoplasmic tail on Env incorporation into virions, this 
has been only in the context of tail truncations or ablation of the tyrosine 
residue.96,108,332 Earlier findings that these mutations increase Env on virions are 
consistent with the hypothesis that the glycine positively modulates Env incorporation 
into particles, as this residue was not disrupted.108,244 Further, if the YxxΦ sequence 
affects virion Env by removing the protein from the cell surface and thus decreasing 
its incorporation into particles, mutations that ablate functional portions of this motif 
would be expected to increase virion Env. Alanine scanning mutagenesis could 
confirm that Gly-720 is a positive regulator of Env content and that the YxxΦ motif 
decreases virion Env. 
 
A second function of the GYxxΦ motif appears to involve specific 
localization of envelope on the surface of infected cells. We and others have 
established that mutations to endocytosis motifs increase cell surface Env, a finding 
confirmed by this study.66,76,108,244 Previously, cell surface Env has been positively 
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correlated with virion Env content;63,71,108,109,240 thus the contradiction of increased 
surface but decreased virion Env in SIVmac239ΔGY was surprising. An important 
observation of our study is that, by imaging flow cytometry, all ΔGY-containing 
mutants tested, including one containing a ΔQTH, have a lower percentage of cells 
with punctate Env distribution compared to SIVmac239. There is evidence in HIV 
that budding occurs preferentially from specific regions of the plasma membrane and 
is controlled by Env, as polarized budding is abolished in the absence of 
Env.88,89,232,333 A prior study specifically found that mutation of the membrane-
proximal tyrosine residue in HIV resulted in a reduced percentage of infected cells 
displaying polarized distribution of p24.89  
 
ΔGY may decrease Env recycling from the cell surface and/or specific 
targeting of Env to sites of budding, which could result in increased protein on the 
cell surface but a decrease in virion Env. The dual effect of removal of the glycine 
(decreasing Env on virions) and the tyrosine motif (altering Env trafficking to sites of 
budding) may result in significant defects to virion Env. However, failure of addition 
of R722G and YFQL to rescue punctate Env distribution indicates that thr presence of 
components of the signal is not equivalent to the wildtype sequence, suggesting that 
correct positioning of the glycine relative to the YxxΦ sequence, or of the YxxΦ 
sequence relative to the membrane spanning domain, may be required for additional 
functions of the motif. 
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Addition of R722G does raise Env levels on the cell surface, above 
SIVmac239ΔGY levels, and rescues virion Env, but does not confer a wildtype Env 
cell surface distribution. Raising the quantity of Env available on the cell surface 
might increase Env on virions through passive incorporation, without explicitly 
targeting Env to budding sites. Addition of ΔQTH (YFQL) lowers Env levels on cells 
to be equivalent to SIVmac239ΔGY and maintains increased Env on virions, yet does 
not rescue a wildtype punctate phenotype, implying that nonspecific incorporation 
into virions is not the primary driver of rescue. The resolution of cell images from 
imaging flow cytometry is relatively low, so it is possible that YFQL improves Env 
targeting to sites of budding (though perhaps not as efficiently as the wildtype 
sequence) but that small differences in distribution are less apparent due to the overall 
increase in cell surface Env imparted by the R722G. Imaging of Env localization with 
electron microscopy could improve resolution and address this limitation. Co-
localization imaging of Env with cellular proteins known to be incorporated into 
virions, such as CypA, could evaluate localization of mutant Envs relative to sites of 
budding.334 It is also possible that CEMx174 cells, a human lymphocyte cell line, do 
not perfectly recapitulate what occurs in macaque cells in vivo. Despite these 
limitations, the model described would explain the ability of mutations in the GYxxΦ 
domain to both positively and negatively regulate Env on particles and unifies the 
apparently paradoxical alterations to cell surface and virion Env conferred by various 
cytoplasmic tail mutations. 
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The effects of cytoplasmic tail mutations on viral growth in vitro are less 
clear. Acute SIVmac239ΔGY replication in vivo is on par with SIVmac239.222,223 In 
contrast, we detected a small but reproducible decrease in peak replication of 
SIVmac239ΔGY compared to SIVmac239 in PBMC cell culture. Although not 
performed quantitatively, there appeared to be a delay in replication in CEMx174 
culture as well (discussed in Ch. 2 Fig. 12), and prior studies in this cell line 
demonstrated that SIVmac239 will outcompete SIVmac239ΔGY during a 35 day 
culture.221 Control of replication of SIVmac239ΔGY after acute infection and its 
inability to deplete gut CD4+ cells also implies some degree of immunologic 
susceptibility that is incompletely rescued by additional gp41 mutations. In vitro, 
ΔQTH mutations (creating YFQI or YFQL) were extremely deleterious to the virus 
and nearly abrogated replication, but SIVmac239ΔGY YFQI and YFQL were rescued 
to SIVmac239ΔGY-levels of replication by addition of R722G. Addition of S727P or 
R722G to SIVmac239ΔGY alone did not result in significantly improved replication 
in PBMCs, despite these mutations being selected for both in vitro (S727P) and in 
vivo even in the absence of the ΔQTH. Two questions are thus raised by these 
findings: 1) What replication advantage is rendered by R722G and S727P? and 2) by 
what mechanism does R722G rescue replication of ΔQTH? 
 
The first question could be explained by increases in Env on virions, which 
correlates with increased infectivity, as the membrane-proximal tyrosine residue of 
HIV has been directly shown to be important for both virion Env content and 
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infectivity of particles.96,108,109,335 Greater infectivity would be an obvious advantage 
to replication in vitro and in vivo, but we did not consistently observe improved 
replication of SIVmac239ΔGY in PBMCs when R722G or S727P were added. 
However, serial passage of SIVmac239ΔGY in CEMx174 cells resulted in selection 
for S727P, indicating that this mutation is advantageous for replication in a human 
cell line. One possibility is that variations in permissivity of host PBMCs to viral 
replication resulted in inconsistencies in viral replication.336 We attempted to mitigate 
this effect by performing growth assays in cultures of PBMCs pooled from three 
independent donor animals. A mixed lymphocyte reaction resulting from mixing of 
donor cells from major histocompatibility type-disparate animals could also affect 
target cell availability, susceptibility to viral infection, or spread of virus, if cellular 
immune responses are generated to varying degrees in culture.337 However, we 
observed consistent results for comparisons between SIVmac239 and 
SIVmac239ΔGY, implying that variation in susceptibility and release of chemokines 
or activation of cellular immunity in vitro is likely playing a minor role. 
 
It is also possible that R722G and S727P have an effect on the ability of the 
virus to evade host immune responses, particularly humoral immunity, which would 
not be evident in vitro. This theory is consistent with the ability of SIVmac239ΔGY 
to replicate to high acute peaks in vitro, as humoral immune responses do not control 
viremia in naïve animals during acute infection.57,338–340 Mutations in gp41, 
particularly cytoplasmic tail truncations, have been well documented to increase 
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neutralization resistance and increase infectivity.109,208,341 We have established that 
neutralizing antibodies do not contribute to control of SIVmac239ΔGY in vivo, as 
SIVmac239ΔGY-infected PTM controllers do not develop neutralizing antibody 
activity against SIVmac239ΔGY.223 The possibility remains of non-neutralizing 
antibody responses contributing to SIVmac239ΔGY control. Assays of antibody-
dependent cell-mediated cytotoxicity (ADCC), have yielded less conclusive results (J. 
Hoxie, G. Ferrari, unpublished data). Supporting their possible contribution to control, 
however, is the recent finding that mutations in the HIV and SIV membrane-proximal 
tyrosine motif have been shown to increase susceptibility to ADCC by increasing 
envelope exposure on infected cells.342 CD8+ cells are critical to host control of 
SIVmac239ΔGY, as evidenced by rapid rebound of viremia following CD8 depletion 
in controlling PTM and regain of control upon reconstitution of these cells, and this 
may be due to their role mediating ADCC in vivo.223 The specific cell type and 
mechanism responsible for control in SIVmac239ΔGY-infected animals is a point of 
ongoing investigation. ADCC responses are a leading candidate for a mechanistic 
explanation, and higher Env on R722G or S727P virions may increase resistance to 
this response in vivo. This hypothesis is consistent with the lack of replication 
enhancement observed in PBMCs in vitro versus the selection for these mutations in 
animals. 
The selection of S727P in vitro during serial passage of SIVmac239ΔGY 
could be explained if this mutation does impart a small replication advantage that is 
only evidenced over long term culture. PBMC growth assays were performed for 14 
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days due to declining viability of target cells over this period. Serial passage in the 
CEMx174 cell line occurred over a period of many weeks (approximately 3-5 days 
per passage for a total of 20 passages), resulting in a large number of rounds of 
replication in comparison to PBMC growth assays. The additive effect of small 
differences in infectivity or replication efficiency over many rounds would also be 
relevant in vivo, and again could explain discrepancies between performance of these 
viruses in PBMCs in vitro versus in CEMx174 serial passage and in animals. As 
S727P and R722G are never found in the same genome in vivo, R722G would not be 
expected to arise with S727P in this assay.222,223 However, additional serial passage 
experiments might yield the R722G instead of the S727P if these mutations confer 
similar but non-synergistic advantages. 
 
A final point is the possibility that these mutations could affect gp120 
conformation, which could alter receptor or antibody binding and result in positive or 
negative consequences for the virus. Truncation of the gp41 cytoplasmic tail has been 
linked to changes in gp120 ectodomain conformation, although the mechanism 
underlying this effect is not clear.212 At this time, specific investigations into the 
conformation of gp120 in SIVmac239ΔGY and other mutants have not been made. 
There is some evidence against this theory; SIVmac239ΔGY is not more 
neutralization sensitive than SIVmac239 in assays using sera from SIVmac-infected 
rhesus macaques.223 Additionally, we have not observed obvious defects in binding of 
the monoclonal antibody 7D3, which binds a conformational epitope in the CCR5 
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binding site of gp120, during flow cytometry staining.343 However, given the 
evidence that ADCC may be important for control of this virus in vivo, assessment of 
conformation via epitope mapping with monoclonal antibodies could be considered. 
 
The second query regarding the relationship of R722G to the rescue of ΔQTH 
is more complex. As discussed previously in Chapters 2 and 3, in addition to creating 
novel YxxΦ motifs in Env, ΔQTH mutations affect the second exon of the Rev and 
Tat proteins. In each of these, the deletion of the canonical second exon splice 
acceptor site forces an alternative splicing pattern to occur. The effects of this 
mutation are slightly different for YFQI and YFQL (Ch. 3, Fig. 12), but both delete 
two amino acids from Rev (residues 25 and 26) and from Tat (residues 87 and 88). In 
Rev, this deletion occurs in the first multimerization domain.260 Multimerization of 
Rev is required for nuclear import and its function in mediating export of unspliced or 
singly spliced viral mRNA from the nucleus.259,264,344 If the ΔQTH mutation ablates 
functional residues and affects the ability of Rev to oligomerize, Rev function may be 
substantially affected. Further, SIV Rev has been shown to be important for optimal 
env expression.267 ΔQTH could therefore represent a second blow to virion Env levels 
in addition to the effect of ΔGY. The dual hit of ΔGY and ΔQTH might reduce virion 
Env to levels insufficient for efficient viral infectivity, producing the strongly 
attenuated phenotype observed in PBMC growth assays.  
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The tat open reading frame is also affected by ΔQTH, which produces a 
deletion of residues 87 and 88. The Tat second exon was initially shown to be 
dispensable for viral growth in vitro.345 However, subsequent work has demonstrated 
that, at least for HIV, multiple functions depend on the Tat second exon. These 
include efficient replication in vitro in peripheral blood lymphocytes via NF- κB 
activation and LTR stimulation, delay of apoptosis in infected T cells, and modulation 
of the induction of interferon stimulated genes (ISGs) in dendritic cells and 
macrophages.256,257,346 It is also notable that the Tat second exon appears to be 
important for efficient infection of monocyte-derived macrophages in vitro, which 
could explain why ΔQTH mutants exhibit some improvements in pathogenicity but 
still fail to infect macrophages to the extent of SIVmac239.255 While there are myriad 
roles for the Tat second exon, ΔQTH does not overlap with mapped functional 
domains in Tat, and so the specific effect of this mutation is not fully known.347 
Interestingly, one investigation found that the Tat second exon is important for 
chronic replication in vivo. Rhesus macaques infected with an SIVmac239 mutant 
missing the second exon of Tat displayed a high peak viremia followed by a very low 
set-point, similar to SIVmac239ΔGY in pig-tailed macaques. Multiple animals in this 
study developed mutations to open the tat reading frame and restore the Tat second 
exon, implying that its function is important in vivo.307 Thus, while it is likely that the 
ΔQTH mutation has some effect on the function of Rev and Tat, we have not yet 
evaluated the expression or function of these proteins in SIVmac239ΔGY ΔQTH 
mutants and can only speculate as to the effect of this deletion. 
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It is possible that the addition of R722G improves replication of YFQI and 
YFQL by increasing total intracellular Env and compensating for a possible reduction 
in Env transcripts due to the deletion in Rev. There is some preliminary evidence that 
R722G does globally increase steady state intracellular Env levels (Scott Lawrence, 
unpublished data). However, in transfected cell lines, ΔQTH does not substantially 
decrease Env on virions below the level of SIVmac239ΔGY. We were not able to 
assess Env levels on PBMCs for SIVmac239ΔGY + YFQI or YFQL due to very low 
levels of infection of these cells. It is possible that SIVmac239ΔGY YFQI and YFQL 
virions produced in PBMCs have very low levels of Env and that this explains their 
poor replication. Initial infection in both PBMCs and CEMx174s (in which 
SIVmac239ΔGY YFQI and YFQL did grow, albeit poorly) was established by viral 
stocks produced in 293T cells, indicating that 293T-produced virions have adequate 
Env levels to mediate initial infection. SIVmac239ΔGY YFQI and YFQL growth in 
CEMx174 cells was sufficient to allow the R722G mutation to arise, indicating 
replication levels that permitted evolution and selection for Env tail mutations. It is 
possible that similar low level replication also occurred in PBMCs and that the length 
of time and larger population of target cells in CEMx174 culture explains the 
apparent improved replication in this cell type, i.e. that infection is not quantitatively 
more efficient in CEMx174 cells than in PBMCs. It should be considered that, as 
CEMx174 are a human-derived cell line lacking CCR5, the virus must use human 
CD4 and alternative coreceptors such as GPR15 for entry.348 CEMx174 cells also 
express CXCR4, and although SIVs are typically CCR5-tropic and do not acquire 
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CXCR4 tropism, it is possible that discrepancies in coreceptor use could occur 
between SIVmac239 and SIVmac239ΔGY-based mutants.204,349 We tested entry 
dependence on CCR5 density of SIVmac239ΔGY compared to SIVmac239 and did 
not appreciate differences between the two viruses, although the possibility of 
alternative coreceptor use by ΔGY-containing mutants has not been fully explored.  
 
To assess the effect of ΔQTH on viral function, the ΔQTH (YFQI and YFQL) 
mutations could be introduced to SIVmac239 in the absence of ΔGY. Virion Env 
content and growth of these viruses in CEMx174 cells and PBMCs could clarify 
whether the observed growth defects are due to a double hit to Env of ΔGY and 
ΔQTH, or if the Rev and Tat alterations might be deleterious independent of Env. 
Mutations that affect only Rev and Tat, and not Env, could also be tested in the 
context of ΔGY to better map determinants of the SIVmac239ΔGY ΔQTH growth 
phenotype. Additional mechanistic studies are required to fully understand the effects 
of gp41 mutations on Env function of SIVmac239, and may improve our 
understanding of the benefit of these mutations in vivo. 
 
Role of gp41 in Mediating Pathogenicity: Insights from env Evolution 
The findings of this in vivo study with regard to effects of gp41 mutations on 
viral natural history were somewhat unexpected. It is always difficult to make 
concrete assertions when studies are performed in small numbers of animals. 
However, overarching themes included 1) the acquisition of endocytosis and 
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basolateral sorting motifs in progressing animals during chronic infection with 
SIVmac239ΔGY R722G and 2) that the presence of the same motifs during early 
infection did not appear to impart an advantage to the virus. 
 
Both SIVmac239ΔGY R722G-infected progressors, which died before week 
40 post-infection, developed confirmed or putative trafficking motifs in the region of 
the SIVmac239ΔGY deletion. In one animal, a ΔQTH arose in a single genome at 
week 10 post-infection, but during late infection this disappeared and was replaced by 
three amino acid substitutions, one of which (P744L) created a novel dileucine motif. 
The second animal developed a ΔQTH (residues 734-736 of Env) previously 
observed in SIVmac239ΔGY-infected RhM progressors (YFQI), which became 
nearly fixed by week 20 and had changed almost entirely to YFQL by week 34. 
Neither sample could have been contaminated by samples from SIVmac239ΔGY 
R722G YFQL-infected animals. Although the ΔQTH mutations creating the YFQI 
and YFQL both delete residues 734-736, they are offset by one nucleotide, and YFQI 
rather than YFQL was observed in each of the SIVmac239ΔGY R722G infected 
progressors. We confirmed in Chapter 2 that YFQI and YFQL represent functional 
endocytosis and basolateral sorting motifs. Assays for these functions, as described in 
Chapter 2, are currently being performed on SIVmac239ΔGY containing the P744L 
mutation in association with the other mutations that were observed (T735I and 
Q739R). If this motif also confers endocytosis and/or basolateral sorting, we will 
have powerful evidence that these functions are critical for the virus during long term 
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infection. Reacquisition of these functions through separate mechanisms in multiple 
animals would represent convergent evolution toward a common function. The 
ΔQTH mutation is extremely unusual in that it affects three proteins in multiple 
reading frames and requires deletion of nine nucleotides in a typically conserved 
region of envelope. The P744L is selected early in infection, and results in the 
introduction of a stop codon in the second exon of Tat. Tat truncations typically 
revert in vivo, so evolution of a stop codon is a novel finding and suggests strong 
selection pressure on Env in this context. Concerning ΔQTH, for such a large and 
nonconservative deletion to become fixed in vivo also implies a significant benefit to 
the virus, the mechanism of which is not fully understood. ΔQTH clearly contributes 
to gain of function and likely is advantageous in vivo given the origin of this mutation 
in animals. Selection during chronic infection favors the hypothesis that addition of 
this mutation to the inoculum would result in an improvement in pathogenesis, i.e. 
greater restoration of SIVmac239ΔGY defects such as targeting of mucosal CD4+ 
cells or macrophage infection, as well as ability to cause AIDS in macaques. 
Conversely, fewer SIVmac239ΔGY R722G + YFQL animals progressed to AIDS 
than SIVmac239ΔGY R722G alone. The apparent lack of advantage of the presence 
of ΔQTH during early infection, coupled with its selection during chronic infection, 
suggests that the function of this motif may be more important during the chronic 
phase.  
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A second possible consequence of disrupting Env targeting, which would 
come into play much more strongly in vivo, is disturbance of virological synapses. As 
discussed in Chapter 1, virological synapses are interactions that form between 
surface Env on an infected cell and CD4 receptors on an uninfected target cell.117,295 
In addition to permitting more efficient infection of target cells due to concentrated 
presentation of virus, cell-to-cell spread through virological synapses also minimizes 
exposure of viral antigen to the host immune system by allowing protected transfer of 
virions between cells.117,271,295 This mechanism may permit replication to occur in 
SIVmac239 infection even in the face of humoral immune responses and result in the 
virus depleting target cells and the onset of AIDS. In contrast, a virus that was 
efficient at cell-free spread but impaired in cell-to-cell replication might be 
significantly hindered at the onset of humoral immunity. Although neutralizing 
antibodies are not a factor in control of SIVmac239ΔGY or resistance to pathogenic 
challenge viruses, the virus could be susceptible to non-neutralizing antibodies that 
mediate ADCC. This is consistent with the finding that CD8 depletion of 
SIVmac239ΔGY controllers results in a spike of viremia during depletion and that 
control is regained when CD8+ cells are reconstituted.223 Thus, cell mediated 
immunity, whether in the form of cytotoxic T lymphocytes, ADCC, or other 
uncharacterized mechanisms, is clearly the primary driver of SIVmac239ΔGY control. 
As such, avoidance of extracellular antigen exposure by decreasing Env on the cell 
surface and facilitating cell-to-cell spread would potentially be beneficial for 
propagation of SIVmac239ΔGY. This would be especially true during later infection 
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when antibody responses are in play. Cell-to-cell spread is also thought to be 
important in tissues; the gut lamina propria, for instance, is extremely cellular and has 
high concentrations of potential target cells, as well as CD8+ T cells that could be 
deleterious to viral spread.136 The relative ratio of virus to target cell may be lower in 
tissues, favoring cell-to-cell spread and creating a greater disparity in propagation 
efficiency of SIVmac239 versus SIVmac239ΔGY. Specific impairment of cell-to-cell 
spread through virological synapses due to failure of Env targeting is a possible 
explanation for SIVmac239ΔGY’s poor depletion of CD4+ T cells in gut despite its 
ability to replicate to a robust acute peak. 
 
Why, then, does ΔQTH not appear to be favorable for the virus during early 
infection over the R722G alone? R722G may overcome the defect in virion Env 
incorporation by increasing total levels on the cell surface, without specifically 
targeting Env to sites of budding and virological synapse formation. In this model, 
R722G would provide no improvement to the second proposed targeting function of 
the tyrosine motif. Early during infection, this may be less important, and cell-free 
spread sufficient for generating high acute peak viremia. Due to higher virion Env 
levels, R722G alone may be more infectious than a virus with R722G and ΔQTH. 
After adaptive immune responses are activated, evasion of antibody-mediated 
immunity by cell-to-cell spread may be more important. This pressure would favor 
evolution of trafficking motifs, as was observed in SIVmac239ΔGY R722G-infected 
progressors. Ultimately, all progressors and the two viremic controllers (5/6 animals) 
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were populated with viruses with Env proteins containing known or suspected 
intracellular trafficking motifs. If R722G alone could not mediate this function, over 
time, R722G progressors would be driven to select for endocytosis motifs that could 
promote virological synapse formation and cell-to-cell spread, such as ΔQTH. 
Dileucine motifs are not known to be involved in formation of virological synapses, 
although it is possible that a dileucine-based signal could mediate basolateral sorting 
or Env targeting to plasma membrane microdomains. 
 
In summary, we have found evidence for the functional importance of the 
gp41 membrane-proximal tyrosine motif both in vitro and in vivo. Residues in this 
signal are involved in mediating incorporation of Env into virions, controlling 
distribution of Env on the cell surface, and in directing endocytosis and trafficking of 
this protein within the cell. These functions appear to coalesce to target Env to sites of 
budding and perhaps virological synapse formation on the plasma membrane (Fig. 1). 
We hypothesize that disruption of this motif impairs Env incorporation into virions as 
well as cell-to-cell spread in vivo, rendering the virus more susceptible to control by 
cellular and non-neutralizing antibody-mediated immune responses. In addition, 
preservation of CD4+ T cells in GALT, possibly due to impaired mucosal spread as a 
result of defects in synapse formation, results in robust polyfunctional cellular 
immune responses from CD4+ T cells. These responses could function to provide 
CD4+ help to CD8+ T cells, or could perform independently in a cytotoxic CD4+ killer 
cell role. ThCTLs (cytotoxic CD4+ T cells) have been identified in HIV+ patients,  
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Figure 4-1: Model for the role of the gp41 membrane-proximal tyrosine 
motif in SIV pathogenesis.
Intracellular trafficking functions of the GYxx! motif are described in gray 
boxes. Red boxes indicate implications of these functions for pathogenesis. 
Known interactions with host proteins are listed as relevant. 
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and similar SIV-specific cells with apparent cytotoxic capabilities (i.e. 
granzyme) have been described in macaques infected with a live attenuated 
SIV.282,325–327,350 Low level replication of SIVmac239ΔGY that provides continuous 
antigenic stimulation is likely a contributor to the development of protective immune 
responses and is consistent with prior findings that increased replication of live 
attenuated vaccine strains correlates with stronger protection against challenge.181,351 
Both CD4+ and CD8+ cellular responses may contribute to host control of viremia in 
SIVmac239ΔGY infection and to protection from pathogenic challenge that has been 
observed in these animals.  
 
Selection pressure in vivo to repair the defect imparted by ΔGY has revealed 
that functions of the GYxxΦ motif may be partially rescued by independent evolution 
of components of this motif. However, at least in vivo, novel mutations do not appear 
to function as efficiently as the wildtype sequence and, alone, are not sufficient to 
restore SIVmac239-like pathogenesis to SIVmac239ΔGY. This incomplete rescue 
may be due to the inability of novel motifs to mediate all functions of the SIVmac239 
GYxxΦ (i.e. full rescue of some functions), or due to partial rescue of all functions 
that is nonetheless inferior to SIVmac239. These studies have confirmed that the 
membrane-proximal tyrosine motif of primate lentiviruses is intimately involved in 
facilitating multiple aspects of viral pathogenesis, and that there is strong selection 
pressure in vivo and in vitro to restore functions of the motif that are ablated by a 
deletion in the motif. The contribution of the membrane-proximal tyrosine motif to 
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gastrointestinal targeting should not be overlooked, though our studies have made 
clear that this source of chronic immune activation is not required for development of 
AIDS in macaques. Immune responses that are raised against SIVmac239ΔGY are 
unique in their ability to prevent acquisition or facilitate control of pathogenic 
challenge viruses, and further characterization of mechanisms underlying 
SIVmac239ΔGY control can provide valuable information regarding correlates of 
protection. Antibody mediated, neutralization-independent responses appear to be 
capable of mediating protection in the absence of a neutralizing antibody response 
and elicitation of such a response could represent a desirable goal for immunogen 
design. 
 
Future Directions 
Future studies for the in vitro and in vivo aspects of this project have been 
mentioned throughout this Chapter. In vitro, a pressing interest is to map the Env 
incorporation function of the GYxxΦ domain. Assessment of virion Env levels of a 
virus with only a Gly-720 deletion (SIVmac239ΔG) would confirm that this residue 
is critical for mediating Env incorporation, as well as contributing to Env endocytosis. 
Additionally, functional evaluation of the P744L mutant acquired by 
SIVmac239∆GY R722G-infected animal KV73 is important for testing of our model. 
P744L creates a dileucine motif ([DE]XXXL[LI]) in the region of the ΔGY mutation, 
which could mediate endocytosis or intracellular Env trafficking. Examination of this 
mutant in functional assays for virion and cellular Env content, endocytosis, 
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subcellular localization, and basolateral sorting will provide critical information on a 
potential model for convergent evolution of the cytoplasmic tail in vivo. If multiple 
mutations arise in different animals that confer the same gain-of-function phenotype, 
an extremely strong case can be made for the importance of these functions to the 
virus during chronic infection. Additionally, the phenotype of SIVmac239 + ΔQTH 
(without ΔGY) could provide insight into the effect of the Rev and Tat mutations on 
viral function. Further specific studies to mutate only Rev and Tat in either 
SIVmac239 or SIVmac239ΔGY while preserving the wildtype Env sequence at 
amino acids 734-736 would be helpful to ascertain whether the effect of ΔQTH was 
related primarily to changes in Env or in accessory proteins. SIVmac239 is functional 
when using the noncanonical splice acceptor site A7, as occurs in ΔQTH.254 However, 
ΔQTH also results in additional deletions to Rev and Tat, the effect of which has not 
been characterized.  
 
Another area of interest is in more specifically characterizing the effect of 
ΔGY on Env distribution on infected cells. As the lipid envelope of HIV is enriched 
for particular host plasma membrane lipids and proteins, HIV budding appears to 
preferentially target host plasma membrane microdomains termed lipid rafts, with 
gp41 being implicated in determining targeting.107 Sucrose gradient 
ultracentrifugation could be used to separate raft-associated host protein fractions 
from cytosolic fractions and the fraction enriched in SIV Env of SIVmac239 Env 
compared to SIVmac239ΔGY.352,353 Differences in host protein fraction association 
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would provide biochemical evidence for failure of Env targeting function in 
SIVmac239ΔGY. Given the resolution limitations of the imaging flow cytometry 
used in this thesis, imaging of virological synapses using higher resolution techniques 
such as electron microscopy in SIVmac239 and SIVmac239ΔGY infected cell culture 
would be particularly interesting.272 High resolution images of this structure would 
allow us to definitively establish the ability of SIVmac239ΔGY and its derivatives to 
target to sites of synapse formation. These assays could also be performed in PBMCs, 
pre-sorted to identify SIV-infected cells, as a more physiologically relevant model. 
 
In vitro results for the above assays may help determine the path forward for 
in vivo studies. If the novel dileucine at amino acids 743 and 744 is determined to be 
functional, a SIVmac239ΔGY with this mutation added could be used to inoculate 
naïve macaques to characterize its ability to cause disease in vivo. Further studies in 
pig-tailed macaques could also be conducted to determine whether an additional 
cocktail of mutations could fully restore pathogenesis to SIVmac239ΔGY. For 
example, addition of V67M, which arises in all SIVmac239ΔGY progressors and is 
associated with macrophage tropism in SIVmac316, may affect macrophage infection 
if included in the inoculum.222,223,287 Other commonly described mutations that may 
improve replication of SIVmac239ΔGY include the E750G and R751G. R751G is 
characterized in SIVmac239 and is unlikely to be a critical determinant of the 
differential phenotype of SIVmac239ΔGY and SIVmac239.306 However, the additive 
effects of several mutations may provide a small advantage to SIVmac239ΔGY in 
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early infection and, in doing so, tip the competitive balance to allow viral escape from 
host immune responses.  
 
It would also be advisable to investigate SIVmac239ΔGY R722G±YFQL in 
larger groups of pig-tailed macaques, and to perform MHC typing on these animals, 
which was not done in the present study. It is possible that the single animal that 
controlled SIVmac239ΔGY R722G may have had a viremia phenotype influenced by 
controller MHC alleles.171–173,331 This animal had the lowest peak viremia and was the 
only SIVmac239ΔGY R722G infected animal that remained alive, in contrast to the 
other two animals that died prior to week 40 post-infection. Larger sample sizes and 
MHC genotyping would reduce the possibility of confounding variables affecting our 
assessment of in vivo pathogenesis of these viruses. Finally, for the original six 
animals and for any additional animals, analysis of cellular and humoral immune 
responses would provide valuable information for comparison to SIVmac239ΔGY 
controllers and for SIVmac239ΔGY R722G±YFQL infected progressors versus 
controllers. Differences in magnitude, breadth, or epitope targets in animals with 
differing outcomes would help identify immune responses that correlate with control 
of viremia. 
 
SIVmac239ΔGY and its derivatives are valuable tools for characterizing the 
functions and sequence requirements of the gp41 proximal tyrosine motif and for 
mapping determinants of pathogenicity in env. This virus also holds promise as a live 
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attenuated vaccine model, in which unprecedented protection against diverse 
challenge strains has been elicited. We have confirmed that the membrane-proximal 
GYxxΦ motif is a critical mediator of essential Env trafficking functions, and found 
that residues within this motif make independent contributions to facilitate virion 
assembly and spreading infection. Through mutational analysis, we determined that 
components of this signal, while capable of restoring multiple functions of the 
wildtype domain, are not equivalent to the SIVmac239 sequence in their ability to 
produce a pathogenic infection. Identification of motifs and their associated functions 
that correlate with restoration of each aspect of SIVmac239 natural history provides 
insight to mechanisms of SIV pathogenesis. Thus, we have shown that the primate 
lentivirus gp41 membrane-proximal GYxxΦ motif is indispensible for mediating Env 
incorporation into virions, for trafficking of the protein within cells and at the cell 
surface, and in resistance to immune responses in vivo, possibly related to formation 
of the virological synapse and facilitation of cell-to-cell spread. 
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